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ABSTRACT

Risk Factors for Early and Late Onset Depression and Subsequent Risk for Alzheimer’s
Disease and Related Dementias in an Older Adult Population
by
Jordan Kugler, Doctor of Philosophy
Utah State University, 2021

Major Professor: JoAnn T. Tschanz, Ph.D.
Department: Psychology
Alzheimer’s Disease and related dementias (ADRD) and depression are two
conditions that often result in significant functional impairment and are widespread in
prevalence, globally affecting 35.6 million and 264 million people, respectively. There is
evidence for a connection between ADRD and depression, such that those with a history
of depression are more likely to develop ADRD in late life. However, extant literature
has yet to examine genetic and psychosocial factors that contribute to earlier or later
onset of depression between males and females and how these factors in turn may confer
risk for ADRD in a single sample. The present study utilized extant data from the Cache
County Study on Memory In Aging (CCSMA). Participants underwent clinical
assessments, repeated triennially over the course of 12 years. Participants were further
linked to data from the Utah Population Database (UPDB) and Medicare claims data.
Results from Study 1 showed that in early life, death of a spouse, possession of the minor
allele for BDNF gene Rs2072446 (NGF/BDNF receptor p 75NTR) (males only) and
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corticosteroid use (females only) were associated with higher odds of early life
depression. In late life, death of a mother (males only), death of a spouse, death of a
child, hospitalizations of self and family and corticosteroid use (females only) were
associated with higher odds of late life depression. Chronic pain conditions and number
of vascular health conditions were associated with reduced odds of late life depression for
both males and females. Further, some BDNF-related genes modified the association
between stressful life events and depression in both males and females. Results from
Study 2 showed that late life depression was associated with increased risk of dementia
only in males, and that chronic depression was associated with reduced odds of dementia
among females. The present study identified several risk factors that contribute to a
comprehensive model of risk for depression across the lifespan. Further, our results
support depression as a risk factor for dementia in late life amongst males. Implications
from this work suggest early intervention with depression is important to reduce future
risk of dementia.
(221 pages)
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PUBLIC ABSTRACT

Risk Factors for Early and Late Onset Depression and Subsequent Risk for Alzheimer’s
Disease and Related Dementias in an Older Adult Population
Jordan Kugler

The Cach County Study on Memory in Aging (CCSMA) was a research study
that followed 5092 participants aged 65 or older over the course of 12 years, examining
risk and protective factors for dementia. One of these factors was depression history,
which has evidence for a connection with dementia, such that those with a history of
depression are more likely to develop dementia later in life. However, the existing
literature has yet to examine sex differences, genetic and psychosocial factors that
contribute to earlier or later onset of depression and how these factors in turn might later
increase risk for dementia.
The current research contained two related studies. The fist study looked at how
several life events, such as death of a spouse, chronic conditions, such as having diabetes,
and genetic factors, such as the presence and of certain genes related to brain derived
neurotrophic factor (BDNF), related to depression in early life and late life. The second
study looked at how depression in early life and late life related to risk for dementia. The
results of these studies showed that certain life events reliably led to depression in early
life and late life for males and females, specifically death of a spouse. In late life
depression, death of a mother (males only), death of a spouse, death of a child,
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hospitalizations of self and family and corticosteroid use (females only) were associated
with increased risk of late life depression. Chronic pain conditions and number of
vascular health conditions were associated with reduced likelihood of having late life
depression for both males and females. Further, the presence of some BDNF-related
genes changed the relationship of stressful life events and depression. Finally, late life
depression was associated with increased risk of dementia only in males and having both
early and late life depression was associated with reduced likelihood of having dementia
among females. These results provide evidence that early identification of depression and
awareness of risk factors for depression is important, particularly as history of depression
may increase risk for dementia among males.
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Introduction

Dementia and depression are two conditions that may result in significant
functional impairment; both are widespread with high prevalence, globally affecting 35.6
million and 264 million people, respectively (World Health Organization, 2017).
Dementia most commonly occurs in late life (i.e., after age 60) and refers to a
constellation of symptoms that negatively impacts cognitive functioning and results in
significant functional impairment (American Psychiatric Association [APA], 2013).
Alzheimer’s Disease (AD), a degenerative brain disorder, is the leading cause of
dementia and is estimated to account for up to 60-80% of all dementia cases in the United
States alone (Reitz et al., 2011; Mayeux & Stern, 2011). Due to the aging of large birth
cohorts and medical advances that prolong life, the number of people likely to be affected
by AD and related dementias (ADRD) is expected to increase drastically in the
approaching decades (Prince et al., 2013). As such, a large body of research has been
devoted to understanding the risk factors and etiology of ADRD (Braak et al., 2011;
Breteler, 2000; Toshitake et al., 1995).
In contrast to ADRD, depression occurs throughout the lifespan, and is
characterized by a persistent low affect or mood, lack of pleasure in daily experiences
and frequent thoughts of hopelessness (APA, 2013). The highest prevalence rates of
depression are observed in early life (i.e., before age 50) and late life (i.e., after age 60;
National Institute of Mental Health [NIMH], 2018; Gatz et al., 1993; Djernes, 2006).
Unlike ADRD, there are several effective treatments for depression, however many
individuals do not receive these treatments (Mitchell et al., 2010; Djernes, 2006;

2
González et al., 2010). Some instances of depression are also resistant to treatment
(Nemeroff, 2007; Thomas et al., 2013). Untreated, depression may result in significant
functional impairment and poor health outcomes, including mortality (Lépine & Briley,
2011; Rodda et al., 2011). Further, depression has been characterized by the World
Health Organization (WHO) as the leading cause of disability and the leader among all
mental health conditions in the global burden of disease (WHO, 2017). Researchers have
posited that an interaction of biological vulnerabilities and environmental stressors, such
as traumatic life events and chronic health conditions often result in depression (ColodroConde et al., 2018), though risk factors may differ for the occurrence of depression at
various points in the lifespan (Baldwin & Tomenson, 1995).
There is evidence for a connection between ADRD and depression in longitudinal
studies, such that those with a history depression are more likely to develop ADRD in
late life (see review: Bennett & Thomas, 2014; Geerlings et al., 2008). A number of
studies have explored the relationship between depression and ADRD, with three
hypotheses typically emerging: 1) Depression is an independent risk factor for ADRD, 2)
Depression is a prodromal feature of ADRD and 3) Depression is a coincidental finding
resulting from the loss of functioning associated with ADRD (Bennett & Thomas, 2014).
While the majority of research featuring longitudinal samples supports depression as an
independent risk factor for ADRD (Blazer, 2003; Ownby et al., 2006; Wilson et al.,
2008), few studies have considered the potential differences in risk for those by age of
depression onset.
Differences in symptom presentation have been observed for early onset
depression (Manepalli et al., 2011) and late onset depression (Hegeman et al., 2012). This
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observation may suggest that depression in early life is experienced differently than
depression occurring in late life. Further, risk factors also differ (Baldwin & Tomenson,
1995), with evidence suggesting inherited biological vulnerabilities, such as family
history of psychiatric illness (Klein et al., 2001), combined with acute stressors (Riso et
al., 2002), increase an individual’s risk for early onset depression. Comparatively, studies
that explored risk factors for late onset depression suggest that chronic stressors, such as
poor cardiovascular health, low socioeconomic status, and others are related to increased
risk for the condition (Valkonova & Ebmeier, 2013). Interestingly, research has also
found that acute stressors appear to be less robustly related to late life depression in
comparison to early life depression (Kraaij, et al., 2002). However, differences in risk
factors by depression onset has not been examined in a single sample.
Biological alterations in brain structures, such as the hippocampus, have been
observed in the aftermath of depressive episodes (Ding et al., 2015; Lee & Kim, 2010;
Rapp et al., 2006; Warner, et al., 2006). Studies have found evidence of reduced neuronal
(brain cell) health and functioning, as well as reduced hippocampal volumes in
individuals following a depressive episode (Lee & Kim, 2010; Warner et al., 2006).
Further, several studies have observed that neurotrophin levels (which are proteins that
promote neuronal survival and differentiation) are significantly lower in those with
depression compared to that of healthy controls (Karege et al., 2002; Sen et al., 2008).
Interestingly, similar changes have been observed in persons with ADRD (Vijayakumar
& Vijayakumar, 2012). Indeed, hippocampal atrophy is considered a reliable biomarker
of the neurodegeneration associated with ADRD (Vijayakumar & Vijayakumar, 2012;
Schuff et al., 2009) and decreased neurotrophin levels have been associated with
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increased risk for ADRD (Lin et al., 2014; Wenzler et al., 2017). These studies suggest
that depression and ADRD may share a similar pathophysiology (Lewis, 2002; Treadway
et al., 2015).
Underscoring the link between depression and ADRD are a number of risk factors
that are shared between these conditions. In particular, poor cardiovascular health
(Frasure-Smith et al., 1993; Lewis, 2002; Treadway et al., 2015;), exposure to traumatic
or stressful life events (Riso et al., 2002; Tschanz et al., 2013) family history (Green et
al., 2002; Klein et al., 2001; Loy et al., 2014) and genetic polymorphisms related to Brain
Derived Neurotrophic Factor (BDNF; Matyi et al., 2017) and apolipoprotein E (Ye et al.,
2016) are all linked to increased risk for both depression and dementia. Sex differences
in prevalence rates are also observed for depression and ADRD, such that prevalence
rates for females are significantly higher compared to males for both conditions (Green et
al., 2002; Loy et al., 2014). However, there is limited research examining common risk
factors in a single sample. Further, no study has examined whether these risk factors are
differentially related to age of depression onset (early vs. late), and how depression onset
relates to risk for ADRD.
The present project proposes two studies: 1) to examine risk factors related to
early life- and late life-onset depression and 2) to examine the relationship between early
life and late life onset depression and ADRD. Each study will use data from the Cache
County Study on Memory in Aging (CCSMA), which included 5,092 participants who
were studied for antecedent risk factors and followed for dementia surveillance over the
course of 12 years. Further, participants in the CCSMA were also linked to records in the
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Utah Population Database (UPDB), which allowed for additional demographic, vital
statistics and health data to be used in the present project.

6
Study 1
Risk Factors for Depression in Early Life and Late Life

Introduction

Nearly 7.1% (17.3 million) of adults in the United States experienced at least one
episode of clinically severe depression (National Institute of Mental Health; NIMH,
2018). A clinically severe episode of depression, frequently referred to as a “major
depressive episode” is defined by the Diagnostic and Statistical Manual of Mental Health
Disorders, 5th edition (DSM-5) as a period of at least two weeks during which an
individual experienced depressed mood and/or loss of interest or pleasure in daily
activities, along with several other symptoms, nearly every day in that period (American
Psychiatric Association [APA], 2013). The age range for those experiencing a first major
depressive episode varies considerably. Middle aged or younger adults (aged 50 or less)
show the highest prevalence at nearly 21%, whereas those over age 50 show prevalence
rates between 15 and 20% (National Institute on Aging, 2007; NIMH, 2018). However,
some studies suggest that the prevalence of major depressive disorder with late life onset
is much higher, as depression in late life often goes undiagnosed and untreated (Mitchell
et al., 2010; Djernes, 2006). Several epidemiological studies show that the prevalence of
major depression symptoms across the lifespan appears to spike in early adulthood and
again in late life (Djernes, 2006; Gatz et al., 1993). Evidence also suggests that the
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clinical presentation (i.e., typically endorsed symptoms) of major depression in early life
differs from that in late life (Manepalli et al., 2011).
Studies have reported on differences in the presentation of depression symptoms
at various ages (Manepalli et al., 2011). One study of 1,498 patients aged 18-75 found
that younger adults (age 18-35) were more likely to report greater irritability and
agitation, weight gain, hypersomnia, global negative beliefs and comorbid anxiety
symptoms, whereas middle aged adults (age 36-50), were more likely to experience,
insomnia, somatic symptoms, social isolation, problems with attention, and decreased
motor functioning. The latter group also experienced a greater number of depressive
episodes (Manepalli et al., 2011). Older adults (age 50 or higher) tended to report higher
suicidality, chronic pain, and cognitive impairment, the latter two of which may be
symptoms or contributing factors for depression (Manepalli et al., 2011). A meta-analysis
of 11 studies examined differences in the presentation of depression in younger adults
(age 35-45 years) and older adults (age 64-73 years). The authors reported that younger
adults reported more feelings of chronic guilt and decreased sexual functioning, whereas
older adults tended to report more somatic health symptoms and decreased attention
(Hegeman et al., 2012).
Research has also suggested sex differences in symptom presentation of
depression across the lifespan. A meta-analysis of 32 studies and 108,260 inpatient and
outpatient adults found that women reported a greater frequency and intensity of
depression symptoms relative to men, including more changes in appetite, weight gain
and sleep disruption (Cavanagh et al., 2017). A study of 170 younger depressed
outpatients (M[SD] age in years= 32[11.29]) found that females reported a greater
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increase in appetite and weight gain compared to males (Carter et al., 2000). Another
study of 217 older depressed adult inpatients (M[SD] age in years= 50.3[16]) found that
males tended to show more blunted affect, decreased sex drive and a more rigid (i.e.,
unchanging) experience of emotions. In the latter sample, females reported more emotion
dysregulation (i.e., rapidly changing emotions) and dysphoria (Winkler et al., 2004).
Differences in the clinical presentation of depression based on onset age and sex may
suggest that depression is experienced differently at different stages of life and may be
affected by unique risk factors in early and late adulthood.
Etiological models of depression have historically emphasized the diathesis-stress
model (England & Sim, 2009), which posits that an interaction of risk/vulnerability
factors (diathesis) and stressful life circumstances (stress) sets the stage for symptoms of
depression to develop (England et al., 2009). One example of a well-researched diathesisstress model is the Biosocial Theory of Borderline Personality Disorder, which posits a
biological vulnerability to experiencing intense emotions (e.g., greater sensitivity to
emotional stimuli and a slow return to baseline emotionality) interacts with a chronically
invalidating social environment (e.g., caregivers/social networks that punish effective
communication of emotion) to increase an individual’s risk for developing borderline
personality disorder (Linehan, 2018). Diathesis-stress models of depression have been
extensively studied to identify at-risk-populations that may benefit from prevention
strategies (See review, Fiske et al., 2009).
Age of first onset of symptoms (often examined in diathesis-stress models) is a
critical factor in understanding the severity and lifetime occurrence and recurrence of
depressive episodes. As noted above, prevalence rates for major depressive disorder vary
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considerably across the lifespan and the distribution for the age of first onset of major
depressive disorder shows a similarly wide age range (Kessler et al., 2005). Indeed, major
depressive symptoms in childhood are relatively rare, with an estimate of less than 5% of
all depression cases occurring before age 12 (Kessler et al., 2005). However,
approximately 25% of all depression cases occur before age 19 and 50% before age 32,
suggesting that major depression is relatively common in earlier in life (Kessler et al.,
2005). Early onset major depression is associated with greater functional impairment and
a chronic course (England & Sim, 2009; Hollon et al., 2006; Zisook et al., 2004). For
example, research on lifetime mental health outcomes found that those with adolescentonset depression also had higher rates of personality disorders (Fava et al., 1996) and a
greater overall number of psychiatric symptoms when compared to those with onsets in
mid or late life (Zisook et al., 2004). Additionally, depression before the age of 18 is
associated with more negative physical health outcomes, including poorer health, greater
health care utilization and more severe functional impairment relative to physical health
conditions (Keenan-Miller et al., 2007).
Sex differences also emerge in early life depression. Salk and colleagues (2017)
completed two separate meta-analyses examining gender differences in major depression
across the lifespan. Their first meta-analysis examined 65 articles constituting 1,716,195
individuals and found that women were more likely to be diagnosed with depression
relative to men across the lifespan (OR=1.95, 95% confidence interval [CI]=[1.88,2.03],
d=.37). This gender difference emerged early in life, at age 12 (OR=2.37, 95% CI=[1.68,
3.37], d=.48) and peaked during adolescence at ages 13-15 (OR=3.02, 95%
CI=[2.76,3.02], d=.61). Following adolescence, gender differences in the occurrence of
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major depression declined gradually, but remained significant (OR= >1.71, d=>.30)
throughout the lifespan (Salk et al., 2017).
Approximately 10% of new onsets of major depressive disorder occur in
individuals older than age 56 (Kessler et al., 2005). However, late onset major depression
often goes undiagnosed and untreated (see review, Djernes, 2006). Similar to depression
in early life, those who experience late life (e.g., after age 55) depression also report a
number of mental and physical health conditions (Rodda et al., 2011). Several physical
health comorbidities have been associated with depression in late life (Blazer, 2003),
including neurocognitive impairment (see reviews: Alexopoulos et al., 2002; Bennett &
Thomas, 2014) problematic weight loss (Morley & Kraenzle, 1994), cardiovascular
disease and other chronic medical conditions (Frasure-Smith et al., 1993), lower selfrated health (Han, 2002), disability (Alexopoulos et al., 1996; Zeis et al., 1996), and
lower bone mineral density (Lyles, 2001; Robbins et al., 2001), all of which result in
higher overall use of medical services (Huang et al., 2000; Luber et al., 2001). Further, a
study examining insurance claims of 618,780 adults (age in years M=41) in the United
States found that those with a diagnosis of depression had higher costs of overall health
care for somatic health conditions and complaints, underscoring the associations between
depression, physical health and overall well-being (Welch et al., 2009). Higher rates of
non-suicide mortality (pooled OR 1.75; Geerlings et al., 2002) have also been associated
with late life depression (Conwell et al., 2002; Shah et al., 2016). Taken together, both
early and late onset depression are associated with a number of mental and physical
health conditions that negatively impact quality of life. Understanding the factors that
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increase risk for depression at early or later ages may identify targets for effective
prevention or early intervention of depression across the lifespan.
Risk factors for early and late onset depression differ. In early life, family history
of severe depression, psychiatric illness (Klein et al., 2001), criminality or psychopathy
(Jaffee, 2002), low birth weight (i.e., birth weight of less than 5.5 pounds; Mallen et al.,
2008), early life motor skill deficits (Jaffee, 2002) and certain genes (D’Souza et al.,
2016; Haeffel et al., 2008), are associated with higher risk of depression; these factors
however have lower associations with later onset depression (Blazer et al., 2003).
Additionally, specific psychosocial factors, such as stressful life events, have been
extensively linked to risk for early life depression (see review, Mandelli et al., 2015). In
particular, acutely stressful life events, such as death or severe illness of immediate
family members (Riso et al., 2002), witnessing or experiencing family violence (Kessler
& Magee, 1993), death of a parent before age 18 (Kessler & Magee, 1993) and childhood
trauma (Mandelli et al., 2015) appear to significantly increase the risk for major
depression in early life. Chronic stressors such as, frequent physical illness (McGonagle
& Kessler, 1990), chronic pain (McGonagle & Kessler, 1990), financial difficulty
(McGonagle & Kessler, 1990), marital conflict (McGonagle & Kessler, 1990),
inadequate social support (Jaffee, 2002) and low socioeconomic status (Jaffee, 2002)
have also been implicated as risk factors, but have been less well studied. From a
diathesis-stress perspective, it appears that early onset depression is most likely to occur
in individuals with inherited vulnerability factors, which interact with exposure to acute
or chronic stressors in such a way as to decrease resilience for major depression.
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Risk factors for late-onset depression are complex and multifaceted, and several
of these factors include chronic health conditions. For example, certain diseases that are
relatively common in late life are associated with significantly increased risk of late life
depression. Diabetes (OR= 1.51, 95% Confidence Interval [CI]=[1.30,1.76], p=<.001),
cardiovascular disease (OR=1.76, 95% CI= [1.52,2.04], p=<.001) and stroke (OR=2.11,
95% CI=[1.61,2.62]) are all associated with higher risk (Valkanova & Ebmeier, 2013,
p=<.001). Inherited risk factors however, appear to have an inconsistent relationship with
late life depression. Family history, a robust predictor of depression in early life (Baldwin
& Tomenson, 1995; Klein et al., 2001), is less common in late life depression (Fiske et
al., 2009; Hopkinson, 1964). One study found that only 8.3% of those with depression
onset after the age of 50 had a positive family history, compared to 20.1% for those with
onsets before the age of 50 (Hopkinson, 1964). Genetic factors however, show some
associations with onset of depression in late life (Blazer, 2003; Gatz et al., 1992). For
example, one study of 306 older adults examined central serotonin neurotransmission
dysregulation and found that a mutant allele of a single polymorphism in the rate-limiting
enzyme of neuronal serotonin synthesis was found in nearly 10% of older depressed
patients, but not in non-depressed individuals (Zhang et al., 2005). Psychosocial stressors
that are traumatic, intense and short-lived, such as death of a loved one, are less robustly
related to depression risk in late life compared to early adulthood (Fiske et al., 2009;
Torges et al., 2008). Further, other negative life events such as death of a significant
other, severe illness of significant other and severe illness of self, were associated with
higher rates of depression in late life, although effect sizes were marginal (See review,
Kraaij et al., 2002). Indeed, one meta-analysis noted that the largest associations between
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acute negative life events and depression in late life were between the aggregated total
number of negative life events and total number of “daily hassles” (i.e., events that
require small behavior adjustments, such as unexpected visitors; Kraaij, et al., 2002).
This suggests that in late life, single, acutely stressful life events, even those that are
unexpected and/or traumatic, may represent less of a risk factor compared to an
accumulation of frequent and chronic negative life events and daily stressors.
Accompanying major depression (of early or late onset) are biological changes in
the brain (Phillips, 2017). Recent studies report that major depressive episodes are
associated with hippocampal changes including neuronal atrophy, reduced volume, and a
decrease in neuronal regeneration (Lee & Kim, 2010; Warner et al., 2006). A possible
contributing factor to hippocampal changes is a decrease in neurotrophin levels in the
brain (Duman & Monteggia, 2006). Neurotrophins are a family of proteins that facilitate
survival, function and differentiation of neurons in the brain and central nervous system,
most notably in the hippocampus (Duman & Monteggia, 2006). In humans, neurotrophins
include Brain Derived Neurotrophic Factor (BDNF), Nerve Growth Factor, Neurotrophin
3 and Neurotrophin 4-5 (Phillips, 2017). Of these neurotrophins, BDNF has been
implicated in the etiology and pathophysiology of depression in both human and animal
studies (Lee & Kim, 2010; Phillips, 2017; Sen et al., 2008).
Karege and colleagues (2002) first observed that BDNF serum levels were lower
in patients with major depression compared to healthy controls. Several studies have
since replicated these findings (see review: Sen et al., 2008). A meta-analysis of 11
studies that examined BDNF serum levels and major depression found strong support
across the aggregated sample of 748 adults in the association between low BDNF serum
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levels and patients with major depression (Sen et al., 2008). Further, the authors reported
that in eight studies that examined the relationship between BDNF serum levels and
patients treated with anti-depressants, BDNF levels reliably increased after a course of
antidepressant treatment (Sen et al., 2008). Another study investigating the longitudinal
associations of BDNF serum levels and depression among 1,751 individuals found that
those with chronic or recently remitted depression (i.e., 1-6 months removed from a
depressive episode) had lower levels of BDNF in serum compared to those with incident
(acute) depression or no depression (Bus et al., 2015). Based on this finding, the authors
suggested that BDNF serum levels may decrease after a major depressive episode and
may contribute to preventing recovery or to increasing an individual’s vulnerability to
future depressive episodes (Bus et al., 2015). Further, the authors found that among those
with persistent depression, having experienced a greater number of negative life events
was associated with a sharper decrease in serum BDNF levels (Bus et al., 2015). Indeed,
lower BDNF serum levels in early adulthood are associated with a greater number of
traumatic experiences in childhood (Aas et al., 2014; Mandelli et al., 2015), (Aas et al.,
2019). Thus, BDNF signaling may underlie the relationship between adverse life events
and depression. Additional studies have reported associations between lower serum
BDNF levels and depressive episodes among those with severe mental illness
(Nuerenberg et al, 2016) including patients with schizophrenia or a bipolar-related
disorder (Aas et al., 2019).
Although research implicates BDNF as having a role in major depression, the
method used in most human studies relies on measuring BDNF in serum or plasma,
which reflects BDNF levels in the body and not necessarily levels present in the brain.
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This complicates the interpretability of the findings described above, as BDNF is
produced not only in the central nervous system, but throughout the body in various
tissues and in multiple cell types (Karege et al., 2005). Additionally, BDNF production
can be stimulated by food intake (Stanek et al., 2008) and physical activity (Tang et al.,
2008), both of which may further confound the relationship between BDNF and
depression.
A related, but independent line of research, is the examination of BDNF-related
genes. Extant research has fully mapped the BDNF gene in humans to chromosome 11
(Maisonpierre et al., 1991). Multiple single nucleotide polymorphisms (SNPs) have been
implicated in the alteration of synthesis and/or functioning of BDNF and its receptors,
including rs56164415 (BDNF C270T), rs2289656 (BDNF receptor trkB), rs2072446
(Neurotrophic growth factor/ BDNF receptor p75NTR) and rs6265 (BDNF Val66Met;
Hwang et al., 2006; Taylor et al., 2005; Matyi et al., 2017). The snp, rs6265 (BDNF
Val66Met) in particular has been identified as being associated with heightened risk for
depression in late life (Hwang et al., 2006; Taylor et al., 2007). For example, one study
found that adults aged 65 years were two and a half times more likely to be depressed if
they carried the met allele compared to homozygous val allele carriers (Hwang et al.,
2006). However, replication of this association has yielded inconsistent results, with one
meta-analysis of 14 studies and over 12,000 adults (Age range= 26-70) concluding that
BDNF Val66Met was not associated with depression in their aggregated sample, but that
BDNF Val66Met was associated with higher odds of depression for men compared to
women (Verhagen et al., 2010). Interestingly, another meta-analysis of 22 studies and
14,233 individuals (Age range= 9-65) examined the relationship between recent life
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stress, depression and BDNF Val66Met across the lifespan. The results that showed
BDNF Val66Met moderated the relationship between life stress and depression (Hosang
et al., 2014), such that those who were carriers of met and experienced greater life stress
were at greater risk for depression than those with a homozygous val allele. Taken
together, SNPs of BDN-related genes, in particular BDNF Val66Met, may represent a
biological vulnerability factor for depression. However, no study to date has examined
the interactive effects of BDNF-related gene polymorphisms with specific life stressors
by the onset age of depression.
Taken together, a large body of research has examined risk factors for major
depression throughout the lifespan. Major depression is unique among mental health
conditions, in that it may present at almost any point throughout the lifespan, but are most
prevalent in early and late adulthood. The etiology of depression is complex and as such,
a comprehensive model of risk for depression across the lifespan has eluded researchers
to this point. The diathesis-stress model may capture the complex interaction of
biological, psychosocial and environmental risk factors. Further, research on neurotrophic
factors, specifically BDNF, may play a role, potentially as a vulnerability factor.
However, few studies have examined BDNF-related gene polymorphisms and their
relationship to major depression of early or late onset. The purpose of the present study is
to examine risk factors for early and late onset depression, including BDNF-related
genes, as well interactions between BDNF-related genes and psychosocial risk factors.
The research questions and hypotheses follow:
1) Are acutely and chronically stressful events, differentially related to early-life
onset depression and late-life onset depression?
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Hypotheses: I hypothesized that acutely stressful life events may show individual
associations with both early- and late-onset depression but would be more
strongly related to early-onset depression. Further, I hypothesized that chronic life
stressors would be related to both early-and late-onset depression, but would show
a stronger association with late-onset depression.
2) Are there differences in polymorphisms of specific BDNF-related genes and
early and late onset depression? Do these genotypes moderate the association of
stressful life events with early and late onset depression?
Hypothesis: I hypothesized that BDNF-related genes would be associated with
increased risk for both early-and late-onset depression. I further hypothesized that
BDNF-related genes will moderate the association between acutely stressful life
events, chronic life stressors and early/late onset depression, such that those with
at least one copy of the minor allele for each gene and exposure to stressful life
events (acute or chronic) would exhibit the highest risk.

Method

Participants
In the present study, participants were selected from an extant dataset comprised
of a large, population-based cohort of individuals living in semi-rural Utah. This sample
of participants was recruited to participate in the Cache County Study on Memory in
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Aging (CCSMA), which examined risk factors related to cognitive decline and ADRD in
older adults. The CCSMA began collecting data from participants in 1995 and completed
its data collection in 2007. Participants were assessed in four triennial waves during this
12-year period (Breitner et al., 1999). In total, the CCSMA collected data on 5,092
individuals who were over 65 years of age and resided in Cache County, Utah. Data from
these participants were further linked to records in the Utah Population Database
(UPDB). The UPDB includes records for over 11 million individuals residing in Utah and
is frequently used in epidemiological and public health research (Norton et al., 2006;
Cannon-Albright et al., 2019). Reportedly, 5,091 of 5,092 (99.99%) participants in the
CCSMA were successfully linked to at least one record in the UPDB. The present study
utilized data from those participants who were successfully linked from the CCSMA to
the UPDB with non-missing data in relevant databases.

Procedure
All study procedures for the CCSMA were approved by the Institutional Review
Boards of Utah State University, Duke University and the Johns Hopkins University. In
1995, a cohort of 5,657 individuals were identified as being eligible for the CCSMA, of
which 5,092 (90%) were enrolled into the study (Breitner et al., 1999). A more detailed
description of all recruitment procedures, methods and participant selection is available
elsewhere (see Breitner et al., 1999). To summarize these procedures briefly, participants
completed a multi-staged screening and assessment protocol in waves 1-4 to determine
the presence or absence of dementia, along with the presence or absence of various risk
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factors related to dementia. Participants’ clinical data from a clinical assessment
(physical, neurological exam, and neuropsychological assessment) and subsequent MRI
and a panel of labs for dementia work up were reviewed by an expert clinical panel who
categorized participants according to cognitive status, including diagnoses of dementia
(Breitner et al., 1999). Those who were not diagnosed with dementia were subsequently
followed in three additional waves of follow-up.

Data Sources linked with the UPDB
The UPDB was initially created as a large multigenerational family history
dataset for residents of Utah. Genealogy records, birth certificates, death certificates
census records, drivers license information and hospital records are linked to the UPDB,
resulting in over 16 million records for more than 11 million individuals (see
https://uofuhealth.utah.edu/huntsman/utah-population-database/). Additionally, claims
data from Medicare (which provides health care insurance coverage for qualifying
individuals 65 years of age and over) are linked to the UPDB. Thus, via the UPDB, data
on participants of the CCSMA were expanded greatly as described below. The
Institutional Review Boards of Utah State University, the University of Utah and the
Utah Resource for Genetic and Epidemiological Research approved the usage of the
UPDB in conjunction with data from the CCSMA.
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Lifetime Depression Status
At each wave, participants in the CCSMA were also assessed for depression
history and current depression symptoms. At baseline and each subsequent wave,
participants completed a depression history screener. The depression screening items
included: “1) In your lifetime, have you ever had a period of two weeks or more when,
nearly every day you felt sad, blue or depressed? 2) In your lifetime, have you ever had a
period of two weeks or more when, nearly every day you lost all interest and pleasure in
things that you usually cared about or enjoyed? 3) In your lifetime, have you ever had a
period of two weeks or more when, nearly every day you felt unusually cross or
irritable?” Those who endorsed at least one key symptom of depression from the screener
were further assessed via the Diagnostic Interview Schedule (DIS; Robins et al., 1981); at
waves 3 and 4 all participants completed the DIS (Steffens et al., 2000). Participants who
endorsed sufficient diagnostic criteria on the DIS (i.e., 5 of 9 possible depression
symptoms) were assigned a diagnosis of major depressive disorder (MDD; Robins et al.,
1981; American Psychiatric Association, 1987; Steffens et al., 2000). Those who did not
meet full criteria for MDD but who reported persistent depressed mood and at least two
other symptoms of depression were assigned a diagnosis of minor depression (Robins et
al., 1981; American Psychiatric Association, 1987; Steffens at el., 2000). The DIS has
been extensively validated for its diagnostic accuracy, sensitivity and ease of
administration in large research studies (Regier et al., 1984; Robins et al., 1982).
Additional diagnoses of major depression were assigned through examination of
medication history, with the endorsement of an antidepressant for the indication of
depression being considered positive for a diagnosis of MDD or minor depression,
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regardless of self report on the DIS (Steffans et al., 2000). Finally, in the absence of data
within the CCSMA, Medicare claims were examined for ICD codes related to depression.
The presence of any of the following ICD-9 codes was used to designate depression
status in Medicare claims and death certificate databases: 296.20. 296.21, 296.22, 296.23,
296.24, 296.25, 296.26, 296.30, 296.31, 296.32, 296.33, 296.34, 296.35, 296.36, 309.00,
309.10,309.28, 311.00, 300.40. Those who did not report depression in the CCSMA but
did have Medicare codes for depression were added to the late life depression group.
Early life onset depression and late life onset depression were determined through
self-report of the approximate date that depression symptoms (lasting at least two weeks)
first began, or if lacking the approximate date, the date that anti-depressants were
prescribed, or earliest Medicare claim code corresponding to major or minor depression.
Early life onset depression was coded differently based upon sex. More specifically, for
women early onset depression was coded for those who met criteria for MDD, a single
major depressive episode or minor depression prior to their age at menopause. For men,
the cut off age for early life onset depression was determined based upon previous
literature, with those who met criteria for MDD, a single major depressive episode or
minor depression prior to age 60 being coded as Early Life Depression (Baldwin et al.,
1995; Fiske et al., 2009; Zisook et al., 2004). Late life onset depression was coded as
those who reported the above conditions but with first onset after menopause age for
females and after age 59 for males.
Data from Medicare claims were used to further ascertain any additional episodes
of depression not otherwise reported in CCSMA (see below). Including depression
diagnoses from Medicare claims, the present study used a multiple level variable for
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depression, coded as 1= no reported symptoms of depression, 2=early onset depression
(major or minor) only, 3= early and late life onset depression (major or minor) and 4=
late life onset depression (major or minor) only.

Acute Stressors
Acutely stressful life events were conceptualized as short-term life events that
result in significant distress but which do not occur with great frequency across the
lifespan. The following acutely stressful life events have previously shown a relationship
to early life and late life onset depression and were available in the UPDB. Each stressful
life event was coded as having occurred prior to the first depressive episode in early life
or late life, consistent with the age of onset for depression coding.

Death of an Immediate Family Member
Data from death certificates available in the UPDB were utilized to obtain the
number of deaths of an immediate family member (i.e., mother, father, sibling, offspring)
for participants in the CCSMA and the age at which the death occurred. The age of the
participant at the time of death of an immediate family member was then compared to
their age of first depressive episode in early life and late life. Those who reported a
family member death prior to their first depressive episode were coded as positive risk
factor.
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Death of a Spouse
Data from death certificates available in the UPDB were used to obtain the
approximate date of death of spouses for participants in the CCSMA. The age of the
participant at the time of their spouse’s death was then compared to the participant’s age
of first depressive episode in early life and late life. Those who reported the death of a
spouse prior to the date of their first depressive episode in early life were coded as having
early life death of a spouse, those who experienced the death of a spouse after menopause
(females) or after age 59 (males) were coded as having late life death of a spouse.

Participant Hospitalizations
Data that was linked from the UPDB and Medicare claims were used to
determine the frequency of hospitalizations of participants in the CCSMA across their
lifespan. Dates of hospitalizations were only available for participants over 65 years of
age (because Medicare eligibility starts at 65 years of age for the majority of individuals),
as such the total number of participant hospitalization admit days only reflects
hospitalizations that occurred after the late life cutoff for both males and females.
Participants total number of days hospitalized were summed for a total value that reflects
the total number of days hospitalized after the participant reached 65 years of age.
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Immediate Family Member Hospitalizations
Linked data from the UPDB were used to determine the frequency of
hospitalizations of immediate family members of participants in the CCSMA across their
lifespan. Dates of hospitalizations were only available for participants 65 years of age and
older, as such the total number of immediate family member hospitalization admit days
only reflected hospitalizations that occurred after the late life cutoff for both males and
females. Participants’ total number of immediate family member days hospitalized were
summed for a total value that reflected the total number of days hospitalized after the
participant reached 65 years of age.

Total Acutely Stressful Life Events
A total score for aggregated acutely stressful life events in early life and late life
was calculated. The total acutely stressful life events in early life was calculated by
taking the sum total of the number of deaths of parents, siblings, spouses and offspring
that occurred before the age of first depressive episode in early life. The total acutely
stressful life events in late life was calculated by taking the sum total of the number of
deaths of parents, siblings, spouses, offspring, self-hospitalizations, as well as parents,
siblings, spouses and offspring hospitalizations that occurred before the age of first
depressive episode in late life.
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Chronic Stressors
Several chronically stressful life events or circumstances based upon data from
both the CCSMA and UPDB were examined. Chronic stressors were conceptualized as
life events or circumstances that frequently cause discomfort and are present for long
periods of time. These stressors tended to cause a lower amount of distress, but were
present with far greater frequency compared to acute stressors.

Low Socioeconomic Status (SES)
Data from the UPDB and CCMS were used to determine socioeconomic status
across the lifespan. Birth certificates of participants in the CCSMA were examined for
parents’ reported profession. These data were previously coded using an algorithm
described by Nam & Powers (1983), which utilized census information regarding the
relationship between education and income that is associated with individual occupations
(Norton et al., 2011). Five discrete categories were used, with “1” reflecting the lowest
range of socioeconomic status and “5” reflecting the highest (Norton et al., 2011).

Vascular Health
Vascular risk factors were assessed during interviews where medical and
medication risk factor information was collected; these were administered at each wave
of the CCSMA. These items assessed the presence or absence of medical conditions
and/or medications related to vascular health: 1) Congestive Heart failure 2) Diabetes
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Mellitus 3) Myocardial Infarction 4) Cerebrovascular Accident (e.g., stroke) 5)
Hypertension (high blood pressure) 6) Hypercholesterolemia 7) Atrial Fibrillation 8)
Atherosclerosis 9) Obesity 10) Other Dysrhythmia (see Appendix I). An example item
includes, “Have you ever been told by a doctor that you had hypertension or have you
ever been treated for hypertension?” Data on cardiovascular conditions was also drawn
from Medicare claims data. More specifically, ICD-9 codes for the above conditions were
matched to participants in the CCSMA if endorsed. The specific ICD-9 codes for
vascular conditions included: hypertension (401.1, 401.9), hypercholesterolemia
(272.39), type 2 diabetes mellitus (250, 205.12, 205.02, obesity (278, 278.01),
myocardial infarction (410.01-410.91; 412), cerebrovascular accident (strokes of multiple
etiologies; 433.01, 433.11, 433.21, 433.31, 433.81, 434.01, 434.11, 435.8, 435.9), atrial
fibrillation (427.31) and other arrythmias (427, 427.1, 427.2, 427.32, 427.41, 427.42,
427.69, 427.61, 472.81, 427.89), congestive heart failure (428), and atherosclerosis
(440.9, 440.8, 437, 440). All vascular health conditions were coded for date of earliest
onset or diagnosis and compared to date of onset for ADRD for those so affected. Those
who experienced a vascular health condition prior to age of dementia onset were retained
for the present study, those whose age of vascular condition onset was equal to or after
their age of dementia onset were excluded from analyses about vascular condition
stressors.
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Chronic Pain Condition In Late Life
At each wave of the CCSMA and as part of the medication history, participants
were asked if they had ever experienced any painful for inflammatory conditions as,
"Now I have a list of ailments that can be major or minor problems to people. Almost
everyone is bothered by some of these ailments at some time, so they are things that are
easy to forget. However, these ailments are very important in our study, and for that
reason I would like you to think very carefully over your past and try to remember if you
have ever been bothered by any of these problems." The list of conditions considered as
chronic pain conditions and their associated ICD-9 codes included arthritis (711-716),
gout (274.9), bursitis (727.3), headaches or migraine headaches (784, 346), pain from
injury, accidents (338.1), back pain or aches (724.5), or chronic pain from other medical
conditions (338.2). Medicare claims data-were also used to supplement conditions that
result in chronic pain, including fibromyalgia, arthritis, ulcer, back/neck problems, and
multiple pains (Scott et al., 2007).

BDNF-Related Genes
Participants in the CCSMA provided a buccal-swab sample in Wave 1 and blood
samples in Waves 3 and 4, from which DNA was extracted for genotyping (Breitner et
al., 1999). Standard TaqMan® Assays (Life Technologies) was used to obtain genotyping
for BDNF-related SNPs rs6265, rs2289656, rs2072446, and rs56164415 from the
extracted blood samples and/or buccal samples (Matyi et al., 2017). In the present study
we conducted exploratory analyses to determine the frequency of polymorphisms of
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BDNF-related genes in our sample and collapsed minor allele carriers into a single
category compared to those lacking the minor allele due to sparseness in the sample.

Covariates
Several established covariates for depression were also included in the present
study. These covariates included age at study enrollment (for late life depression
analysis), education, which was collapsed into less than high school education or high
school diploma and greater (Bjelland et al., 2008; Scarmeas et al., 2006), marital status,
which was collapsed into married or all other statuses (Inaba et al., 2005; Steenland et al.,
2009) corticosteroid use, which was coded as having been taking a corticosteroid
regularly for at least 2 weeks prior to first depressive episode. Each of these covariates
were included based on extant literature that showed associations to depression. Figure 1
summarizes the conceptual model of risk factors with lifetime depression status.
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Analytic Plan
Inclusion criteria for the present study were: 1) No diagnosis of dementia at wave
1 (baseline) and 2) Outcome data of: a) no depression or b) depression in early life, early
and late life or late life only. Demographic characteristics of the sample were examined
with respect to those who had a depression diagnosis compared to no depression across
the lifespan. Differences between groups were examined using analysis of variance
(ANOVA), Fisher’s exact tests and chi-square analyses where appropriate. For
exploratory analysis, bivariate associations of all acutely stressful life events, chronic life
stressors, BDNF-related genes and covariates with lifetime depression status were
examined using ANOVA, Fisher’s exact tests, correlations, multinomial regression and
logistic regression where appropriate.
After examination of the bivariate associations of the above variables in separate
models for males and females, several variables were collapsed due to sparseness. More
specifically, due to sparseness of specific vascular health conditions (e.g., congestive
heart failure) in late life (See Table 3), vascular health conditions were collapsed into a
single variable that indicated the number of vascular health conditions that were present
prior to the first depressive episode (range 0-10). Additionally, after examination of
collinearity diagnostics (tolerance and variance inflation [VIF]), self-hospitalizations,
spouse hospitalizations, sibling hospitalizations and offspring hospitalizations were
collapsed into a single variable due to multi-collinearity (VIF= >4.5; Ringle et al., 2015).
As such, the hospitalization variable that was used in all analyses that included acute
stressors reflects the sum of total days hospitalized of the participants, their spouses,
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siblings and offspring. The bivariate relationships and counts of specific vascular health
conditions and total hospitalized days of self, spouse, siblings and offspring are listed in
Appendix 1.
To answer research question 1, which stated “Are certain types of stressful life
events, specifically acutely stressful events and chronic life stressors, differentially
related to early life onset depression and late life onset depression?” A multi-step
process was utilized to reach a parsimonious, final binary logistic regression model.
Given the number of predictors associated with acutely stressful life events and chronic
life stressors in early and late life, multi-collinearity of predictors was a concern for these
analyses (Daoud, 2017)). As such, we attempted to utilize Least Absolute Shrinkage and
Selection Operator (LASSO) regularization to quantitatively account for multicollinearity in the model and better understand the most valuable predictors for a
parsimonious model. However, the present study utilized SPSS v.27 to complete all
analyses, which is the first version of SPSS with a statistical package that includes
LASSO. Unfortunately, SPSS v.27 was unable to complete the LASSO analysis with the
variables included for this project. More specifically, LASSO within SPSS requires all
variables to be coded as positive integers (Numeric values greater than 0) and treats “0”
codes as missing. Although our categorical variables were relatively simply transformed
into categories that corresponded to positive values, this created a multitude of problems
for both acutely stressful events and chronic life stressors that were continuous variables
in which the value “0” had meaning. As such, LASSO was not able to be utilized in the
analyses as originally planned.
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Instead, separate logistic regression models for each group of predictors (acutely
stressful life events and chronic life stressors) were conducted, with stratified models
developed for males and females. Models were run separately by type of life stressor, as
either acutely stressful life events (events that cause intense distress, but occur
infrequently) or chronic life stressors (conditions or events that occur frequently and
incur, low level discomfort). Additionally, carriers of the minor alleles of BDNF-related
genes were examined as biological vulnerability factors and included as chronic
variables. The analyses proceeded as follows:
Model 1 examined the impact of acutely stressful life events in early life on early
life depression, chronic depression and late life depression using multinomial logistic
regression. Model 1 included lifetime depression status (early life, chronic and late life)
as the categorical outcome variable and death of mother in early life, death of father in
early life, number of sibling deaths in early life, death of a spouse in early life, death of a
child in early life, marital status, years of education and corticosteroid use as predictors.
Model 2 examined acutely stressful life events that occurred in late life as
predictors of late life depression utilizing binary logistic regression. Model 2 included
late life depression as the binary outcome variable and death of mother in late life, death
of father in late life, number of sibling deaths in late life, death of a spouse in late life,
death of a child in late life, total hospitalized days of self and immediate family members
in late life, marital status, years of education and corticosteroid use as predictors.
Model 3 examined the same predictors as Model 2, but with chronic depression
(early life and late life) as the binary outcome variable.
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Chronic life stressors and biological vulnerability factors (BDNF-related genes)
were also examined in separate models for early and late life predictors in males and
females. Model 4 examined the relationship of chronic life stressors on early life
depression using binary logistic regression. Model 4 included early life depression status
as the binary outcome variable and BDNF-related genes, early life socioeconomic status,
corticosteroid use, marital status and education as predictors.
Model 5 examined the relationship of chronic life stressors with late life
depression status using binary logistic regression. Model 5 included late life depression
as the binary outcome variable and late life chronic pain condition, number of vascular
health conditions, BDNF-related genes, adulthood socioeconomic status, corticosteroid
use, marital status, education and age at study enrollment as predictors.
Model 6 examined the same predictors as model 5, but with chronic depression as
the binary outcome variable.
To examine research question 2, which stated “Are there differences in the
occurrence of specific BDNF-related genes and early and late onset depression? Do
these genotypes moderate the association of stressful life events with early and late onset
depression?” binary logistic regression models were built in which interactions between
each BDNF-related gene’s genotype and all acutely stressful life events were examined in
predicting lifetime depression status. Bivariate logistic regression analyses were
conducted to assess the relationship of each genotype for each gene and acute stressor
and the additive effect of their interaction in separate models for males and females.
Those with significant interactions were examined in a fully adjusted model with
covariates.
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Results

Demographics of The Total Sample
There were 5069 participants who met eligibility criteria for the present study. Of
those eligible participants, 1818 (35.6%) were diagnosed with either major or minor
depression in either early life, late life or in both early and late life. The majority of the
sample with depression reported late life depression only (n=1094; 21.5%). In the overall
sample, participants were more likely to be female, married, white and have completed a
high school education (see Table 1). Those with depression were more likely than those
without depression to be younger at baseline and identify their biological sex as female
(see Table 1).

Table 1
Descriptive Characteristics of the Total Sample (n=5069) of Older Adults Enrolled in the Cache County Study on
Memory in Aging Who Were Eligible for the Study 1.
No depression
Symptoms
n=3251
Variable

n (%)/M(SD)

Early Life
Depression
Only
n= 331
n (%)/M(SD)

Early and
Late Life
Depression
n= 393 n
(%)/M(SD)

Late Life
Depression
Only
n=1094
(%)/M(SD)

f-test/Chi-square statistic

Age at study
76.43 (7.51)
74.08 (6.84) 74.03 (6.91) 75.18 (6.76
F (5068)=24.75, p=<.001
enrollment
Biological Sex
χ2(5069) =203.54. p=<.001
Male
1614 (74.9%) 126 (5.8%)
97 (4.5%)
317 (14.7%)
Female
3251 (64.1%) 331 (6.5%)
393 (7.8%)
1094 (21.6%)
Ethnicity
χ2(5069)= 15.92, p=.60
White
3230 (64.2%) 329 (6.5%)
391 (7.8%)
1082 (21.5%)
Non-white
21 (<.01%)
* (*%)
* (*%)
* (*%)
Married
2217 (67.3%) 219 (6.7%)
220 (6.7%)
637 (19.3%)
χ2(5064)= 50.08, p=<.001
High School Education 3240 (64.1%) 331 (6.6%)
392 (7.8%)
1090 (21.6%) χ2(5053)= 3.28 p=.35
Note. * indicates that the number was suppressed in compliance with the Health Insurance Portability and
Accountability Act (HIPAA).
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Analysis of Variance (ANOVA) and chi square statistics were conducted to
examine differences in lifetime depression status by occurrence of acutely stressful life
events (See Table 2). Among acutely stressful life events, death of a father was more
likely to occur in early life, and there were a higher number of participants with late life
depression compared to early or chronic depression who experienced death of a father in
early life (See Table 2). Similarly, death of a mother in early life occurred more
frequently than in late life, and there were more participants who reported late life
depression, compared to early or chronic depression, who experienced early life death of
a mother. There were higher numbers of sibling deaths that occurred in late life compared
to early life, and those with late life depression tended to experience a higher overall
number of sibling deaths compared to those with chronic depression (See Table 2).
Further, death of a spouse was most commonly experienced in late life, and among those
who experienced it, more participants had late life depression than chronic depression.
There were a higher number of participants who experienced death of a child in late life
compared to early life, and of those who did, a greater number reported experiencing late
life depression than chronic depression (See Table 2). There was a difference in the mean
number of total hospitalized days of self and immediate family across depression status,
such that those with chronic or late life depression tended to have more days of
hospitalization of self and family. Finally, there was a higher mean total of acutely
stressful life events experienced for the participants with late life depression relative to
those with chronic or early life depression (See Table 2).

Table 2
Means, Standard Deviations, F-Tests or Chi-Square Statistics of Lifetime Depression with Acute Life Stressors
No depression
Symptoms
n=3251
n (%)/M(SD)
Variable
Father’s Death
Early Life
2292 (65.8%)
Late Life
656 (58.1%)
Mother’s Death
Early Life
1778 (67.3%)
Late Life
1178 (59.4%)
Sibling Deaths
Early Life
.78 (1.07)
Late Life
2.09 (1.99)
Death of Spouse
Early Life
105 (47.7%)
Late Life
1553 (59.7%)
Death of Child
Early Life
386 (64.4%)
Late Life
462 (60.6%)
Hospitalizations-Late
9.24 (7.83)
Total Stressful Events
Early Life
3.52 (1.28)
Late Life
-

Lifetime Depression
Early Life Early and Late
Depression
Life
Only
Depression
n= 331
n= 393
n (%)/M(SD)
216 (6.2%)
73 (6.5%)
161 (6.1%)
133 (6.7%)

n (%)/M(SD) n (%)/M(SD) F-test/Chi-square statistic
χ2(4613) =24.13, p = <.001
265 (7.6%)
711 (20.4%)
102 (9.0%)
298 (26.4%)
χ2(4623) =32.09, p = <.001
190 (7.2%)
512 (19.4%)
174 (8.8%)
497 (25.1%)

.69 (.99) .68 (1.02)
1.96 (1.92)

.66 (.94)
2.1 (2.01)

F (4918)=4.2, p=<.01
F (4918)=3.2, p= .02

46 (20.9%)
677 (26.0%)

χ2(5068) =56.95, p = <.001
χ2(5068) =85.89, p = <.001

60 (10.0%)
116 (19.4%)
55 (7.2%)
212 (27.8%)
10.81(10.06) 10.71 (9.67)

χ2(4436) =6.78, p = .08
χ2(4436) =22.36, p = <.001
F(3920)= 10.01, p=<.001

33 (15.0%) 36 (16.4%)
232 (8.9%)
37 (6.2%)
-

Late Life
Depression
Only
n=1094

3.59 (1.16) 3.95 (1.64)
13.23 (5.32) 17.63 (9.86)

3.58 (1.14)
F(698)= 1.62, p=.18
19.63 (14.30) F(677)= 4.83, p=<.01
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Analysis of Variance (ANOVA) and chi square statistics were conducted to
examine differences in lifetime depression status with chronic life stressors and
covariates (See Table 3). Among chronic life stressors, the vast majority of those with
chronic pain reported no depression symptoms; there were also significantly more
participants who reported chronic pain and late life depression compared to chronic pain
and chronic depression. Of the BDNF-related genes, the vast majority of participants who
had the minor allele of rs2289656 had no depression symptoms; however, there were also
significantly more participants who had late life depression and carried the minor allele
of rs2289656 compared to early life or chronic depression. There was a significant mean
difference in the number of vascular health conditions by depression status, such that
those with no depression symptoms reported the highest number of vascular health
conditions; those with late life depression reported significantly more vascular health
conditions compared to those with chronic depression (See Table 3). Of the covariates,
there was a difference in age at study enrollment by depression status, such that those
who reported no depression symptoms tended to be older than those with early, chronic
or late life depression (See Table 4). There was a difference in corticosteroid use, such
that the majority of participants without depression symptoms reported use of
corticosteroids; among those with depression symptoms, significantly more participants
with late life depression reported use of corticosteroids compared to early life or chronic
depression (see Table 4). Finally, there was a significant difference in marital status by
depression status, such that the majority of the sample without depressive symptoms were
married. Among participants with depression, significantly more were married and
reported late life depression than early life or chronic depression (See Table 4).

Table 3
Means, Standard Deviations, F-Tests or Chi-Square Statistics of Lifetime Depression with Chronic Stressors

Variable
Chronic Pain Condition
Childhood SES
Adulthood SES
BDNF-Related Gene
rs6265
rs207244
rs2289656
rs561644
Vascular Health Conditions

Lifetime Depression
No depression Early Life
Early and Late Late Life
Symptoms
Depression
Life DepressionDepression Only
n=3251
Only
n= 393
n=1094
n= 331
n (%)/M(SD) n (%)/M(SD)
n (%)/M(SD) n(%)/M(SD)
F-test/Chi-square statistic
1158 (76.1%)
42 (2.8%)
165 (10.8%)
χ2(5069) =282.38 , p = <.001
3.04 (1.25)
3.01(1.27) 3.03 (1.22)
2.93(1.22)
F(3378)=1.37 p=.25
3.03 (1.27)
2.95 (1.29) 3.01 (1.23)
2.93 (1.26)
F(4082)=1.44 p=.23
1053 (63.6%)
240 (60.9%)
953 (62.1%)
353 (67.1%)
3.90(2.10)

116 (7.0%)
30 (7.6%)
94 (6.1%)
29 (5.5%)
-

135 (8.2%)
39 (9.9%)
142 (9.3%)
39 (7.4%)
.12(.33)

352 (21.3%)
85 (21.6%)
346 (22.5%)
105 (20.0%)
1.52(1.72)

χ2(4757) = 1.12 , p = .77
χ2(4709) =3.61 , p = .31
χ2(4685) =7.91, p = .05
χ2(4670) =2.89, p = .41
F(5061)=1045.43, p=<.001
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Table 4
Means, Standard Deviations, t-Tests or Chi-Square Statistics of Lifetime Depression with Covariates
Lifetime Depression
No depression Early Life
Early and Late
Symptoms Depression Life
n=3251
Only
Depression
n= 331
n= 393
Variable
Age at study enrollment
Corticosteroid Use
Marital Status
High school Education

n (%)/M(SD) n (%)/M(SD) n (%)/M(SD)
76.43 (7.51)
74.08 (6.84)74.03 (6.91)
673 (67.2%)
87 (8.7%) 68 (6.8%)
2217 (66.3%)
219 (6.7%) 220 (6.7%)
2616 (63.6%)
274 (6.7%) 329 (8.0%)

Late Life
Depression
Only
n=1094
n (%)/M(SD)
75.18 (6.76)
173 (17.3%)
637 (19.3%)
894 (21.7%)

F-Statistic/Chi-square statistic
F (5068)=24.75, p=<.001
χ2(5057) =21.89, p = <.001
χ2(5064) = 50.09, p = <.001
χ2(5053) =3.28, p = .35
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Research Question 1: Are Certain Types of Stressful Life Events, Specifically Acutely
Stressful Events and Chronic Life Stressors, Differentially Related to Early Life Onset
Depression and Late Life Onset Depression?

Exploratory (Bivariate) Associations between Risk Factors and Depression Outcomes
In exploratory analyses, bivariate relationships between each risk factor and
depression status were examined using binary logistic regression for each sex. Each
predictor was entered in a separate model.

Acutely Stressful Early Life Events and Lifetime Depression Status
Among males, death of a spouse in early life displayed a 2.95-fold increase in the
odds of also having early life depression. Death of a spouse in early life was also
associated with increased odds of having late life depression (See Table 5). With chronic
depression (both early and late life onset depression), late life hospitalizations of self,
spouse or child all displayed increased odds of having chronic depression (See Table 5).
Those who experienced sibling death in early life displayed reduced odds of chronic
depression (See Table 5).
Among females, death of a spouse in early life was associated with a 3.26-fold
increase in the odds of having early life depression, and a 2.88-fold increase in the odds
of having chronic depression (see Table 5). Death of a sibling in early life was associated
with reduced odds of having late life depression. No other acute stressors that occurred in
early life displayed a significant relationship with lifetime depression (See Table 5).
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Acutely Stressful Late Life Events and Depression Status
Among males, several acutely stressful late life events were associated with
significantly increased odds of late life depression. More specifically, death of a spouse
in late life was associated with a 1.92-fold increase in the odds of having late life
depression; as was death of a child in late life, with a 2.28-fold increase in the odds of
late life depression (See Table 5). Further, hospitalization of self, sibling, spouse, or child
were all associated with increased odds of having late life depression in males. The total
number of acutely stressful life events in late life was associated with increased odds of
late life depression only (See Table 5), whereas the total number of stressful life events in
early life was not associated with lifetime depression status.
Among females, death of a father, death of a spouse, self, spouse and child
hospitalizations were all significantly associated with increased odds of having late life
depression. Further, hospitalizations of self, spouse, or child were all associated with
significantly increased odds of having chronic depression (See Table 5). Finally, the total
number of late life stressors was associated with increased odds of late life depression
only.

Table 5
Bivariate Odds Ratios (OR) and Confidence Intervals (CI) for Lifetime Depression, All Acutely Stressful Life Events
for Males and Females
Variable
Early Life
Depression
Death of Father
Early Life
Late Life
Death of Mother
Early Life
Late Life
Sibling Deaths
Early Life
Late Life
Death of Spouse
Early Life
Late Life
Death of Child
Early Life

Male Sample
OR, (95% CI)
Early And
Late Life
Depression

Late Life
Depression

.66(.39-1.14) 1.06(.83-5.13) 1.15(.76-1.74)
-

.49(.20-1.21)

.87(.58-1.31)

Early Life
Depression
1.16 (.831.61)
-

Female Sample
OR, (95% CI)
Early And
Late Life
Depression

Late Life
Depression

1.00(.77-1.30)

.83(.69-1.01)

.99(.77-1.29)

1.20(1.001.44)

.85 (.56-1.30) .88(.54-1.44) .83(.63-1.10)
1.09(.67-1.77) 1.18(.90-1.55)

.94 (.69-1.29) 1.01(.78-1.31) .87(.73-1.04)
.94(.74-1.21) 1.15(.96-1.36)

.96(.81-1.14)
-

.92(.78-1.08)
-

.96(.80-1.17)
.85(.74-.98)

.99(.89-1.11)
.99(.93-1.07)

.93(.82-1.07)
.97(.91-1.03)

.88(.80-.96)
.99(.95-1.03)

2.95(1.40- 2.08(.81-5.40)
6.22)
1.03(.66-1.59)

2.04(1.133.68)
1.92(1.502.44)

3.26(1.992.88(1.845.33)
4.50)
1.10(.85-1.42)

.99(.64-1.54)

.96(.54-1.72) 1.40(.78-2.49) 1.15(.80-1.64) 1.03(.64-1.64) 1.38(.96-1.96)

.77(.58-1.03)

1.21(1.021.45)
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Variable

Male Sample
Female Sample
OR, (95% CI)
OR, (95% CI)
Early Life
Early And
Late Life
Early Life
Early And
Late Life
Depression
Late Life
Depression
Depression
Late Life
Depression
Depression
Depression
Death of a child.80(.40-1.62)
2.28(1.66.84(.60-1.17) 1.12(.90-1.39)
Late Life
3.13)
Hospitalizations1.01(.98-1.05)
1.03(1.011.02(1.001.02(1.01Late
1.05)
1.04)
1.04)
Early life
1.01(.69-1.47) 1.12(.74-1.68) 1.06(.85-1.33) 1.08(.73-1.60) 1.29(.99-1.67) 1.00(.81-1.23)
Late Life
1.02(.96-1.07)
1.03(1.001.00(.97-1.03)
1.02(1.001.06)
1.04)
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in boldface. “-“ indicates association not
calculated
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Chronic Life Stressors in Late Life Events /BDNF Genes and Depression Status
Among males, the bivariate relationships between chronic life stressors,
covariates and lifetime depression were examined using multinomial logistic regression
and binary logistic regression where appropriate. Having a chronic pain condition in late
life was associated with reduced odds of having chronic depression and late life
depression (see Table 6). Similarly, number of vascular health conditions was also
associated with decreased odds of having chronic depression and late life depression.
Childhood socioeconomic status displayed no relationship with lifetime depression status,
nor did adulthood socioeconomic status among males. Of the BDNF-related genes, only
rs2072446 displayed a significant relationship with lifetime depression, such that those
with at least one copy of the minor allele of rs2072446 were at 2.28-fold increased odds
of having early life depression (see Table 6). Among the covariates, those who were
married were at reduced odds of having chronic depression and those who were older at
baseline were less likely to also have chronic depression or late life depression (see Table
6).
Among females, having a chronic pain condition in late life was associated with
reduced odds of having chronic depression and late life depression (see Table 6).
Similarly, number of vascular health conditions was also associated with decreased odds
of having chronic depression and late life depression. Having a higher childhood
socioeconomic status and adulthood socioeconomic status were both associated with
having reduced risk for late life depression (See Table 6). Of the BDNF-related genes,
those with at least one copy of the minor allele of rs2289656 were associated with 1.39fold increased odds of having chronic depression, whereas those with at least one copy of
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the minor allele rs561644 were associated with reduced odds of having early life
depression (see Table 6). Among the covariates, corticosteroid use was associated with a
1.43-fold increased odds of having early life depression, and 33% reduced odds of having
late life depression. Being older at study enrollment was associated with reduced odds of
having chronic and late life depression (See Table 6).

Table 6
Bivariate Odds Ratios (OR) and Confidence Intervals (CI) for Lifetime Depression, All Chronically Stressful Life
Events and covariates for Males and Females
Variable
Early Life
Depression
Chronic Pain
Condition
Childhood
SES
Adulthood
SES
BDNF-Related
Gene
rs6265
rs207244
rs2289656

.98 (.82-1.16)

Late Life
Depression
.43 (.32-.59)

1.04 (.851.06 (.941.28)
1.19)
1.02(.85-1.21) 1.06(.96-1.17)

1.12(.76-1.65) 1.08(.70-1.67)

.98(.75-1.27)

2.28(1.35- 1.30(.64-2.65) 1.02(.64-1.64)
3.86)
.95(.63-1.42) 1.09(.70-1.69) 1.16(.90-1.51)
1.10(.63-1.94)
-

.85(.42-1.72) 1.05(.71-1.54)
.15 (.10-.24)
.73 (.68-.77)

Early Life
Depression
.99 (.85-1.16)
-

1.08 (.791.47)
.68 (.36-1.28)
.92 (.66-1.28)
.57(.32-.99)
-

Female Sample
OR, CI
Early And
Late Life
Depression
.24 (.16-.35)

Late Life
Depression
.29 (.24-.37)

.99 (.88-1.13)

.90(.82-.98)

1.03(.93-1.16)

.91 (.84-.98)

1.03 (.80- .96 (.80-1.15)
1.35)
1.33 (.881.03 (.752.03)
1.42)
1.39(1.07- 1.07(.89-1.29)
1.81)
.87(.57-1.30) .80(.59-1.06)
.13 (.09-.18)
.69 (.66-.73)
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rs561644
Vascular
Health
Conditions

-

Male Sample
OR, CI
Early And
Late Life
Depression
.30 (.16-.57)

Variable
Early Life
Depression
Corticosteroids

1.30(.86-1.97)

Male Sample
OR, CI
Early And
Late Life
Depression
.84(.49-1.41)

Late Life
Depression
.92(.68-1.24)

Female Sample
OR, CI
Early Life
Early And
Late Life
Depression
Late Life
Depression
Depression
1.43 (1.03- .82 (.59-1.13)
.67 (.53-.85)
2.00)
1.02(.76-1.36) 1.01(.79-1.29) .92(.78-1.09)
1.43(.94-2.19) 1.21(.86-1.71) 1.14(.91-1.43)
.95(.93-.97)
.95 (.93-.96)
.97 (.95-.98)

Marital Status
1.64(.87-3.1)
.43(.27-.69) .76(.55-1.06)
Education
.83(.54-1.28) 1.13(.67-1.91) .88 (.66-1.18)
Age at study
.94(.91-.97)
.93(.90-.96)
.98(.96-.99)
enrollment
Note. Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in boldface. “-“ indicates association
not calculated
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Fully Adjusted Logistic Regression Models for Acute Stressors in Predicting Depression
Outcomes
In the next series of logistic regression models, overall model significance/fit in
predicting depression status was determined by examination of model fit statistics, which
included chi-square statistics, Hosmer Lemeshow goodness of fit and Nagelkerke R2. In
the instances where the overall prediction model performed poorly (e.g., non-significant),
results of individual predictors were still provided in the interest of exploratory
information.

Model 1: Early Life Acute Stressful Events and Early Life Depression
Among males, the overall binary logistic regression for Model 1, which examined
early life acute stressors with early life depression as the binary outcome variable was not
significant, with χ2(8)=11.03, p = .200 (see Table 7). Despite the null model, we
examined risk factors for significant predictors and observed that the main effect of death
of a spouse in early life remained significant even after all other covariates were entered
into the model, such that those who experienced death of a spouse in early life were at
2.44 greater odds of also reporting early life depression (see Table 7). No other covariates
were associated with early life depression in this model.
Among females, the overall binary logistic regression for Model 1, which
examined early life acute stressors with early life depression was significant with
χ2(8)=23.27 p = <.001 (See Table 7). The main effects of death of spouse in early life
and corticosteroid use in early life were associated with increased odds of early life
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depression, with a 2.77-fold and 1.89-fold increase, respectively. No other covariates
were significantly associated with early life depression among females in model 1.

Model 2: Late Life Acutely Stressful Events and Late Life Depression
Among males, the overall binary logistic regression for Model 2, which examined
late life acute stressors with late life depression as the binary outcome, was significant
with χ2(10)=64.37, p = <.001. The main effects of death of a mother, death of spouse,
death of child and days of hospitalization of self and family all displayed significantly
increased odds (range of ORs=1.03-2.25) for also having late life depression even after
all other covariates were entered into the model (See Table 7). Additionally, those who
were older at baseline displayed significantly reduced odds of having late life depression.
Death of a father, death of a sibling in late life, corticosteroid use, marital status and
education displayed no significant relationship with late life depression in Model 2.
Among females, the overall binary logistic regression for Model 2, which
examined late life acute stressors with late life depression as the binary outcome, was
significant, with χ2(10) =55.15, p = <.001. The main effects of death of a spouse in late
life and days of hospitalization of self and family were associated with increased odds of
late life depression, with a 1.40-fold and 1.02-fold increase, respectively (See Table 7).
Additionally, the main effects of corticosteroid use in late life, marital status and age at
study enrollment were associated with reduced odds of late life depression. No other
covariates were associated with late life depression among females in Model 2.
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Model 3: Late Life Acutely Stressful Events and Chronic Depression
Among males, overall binary logistic regression for Model 3, which examined
late life acute stressors with chronic depression as the binary outcome, was significant
with χ2(10)=27.52, p = <.001. The main effect of days of hospitalization of self and
family displayed significantly increased odds of also having chronic depression by 3%
(See Table 7). Additionally, the main effects of marital status and age at study enrollment
were associated with reduced odds of having chronic depression. No other covariates
were associated with chronic depression in Model 3.
Among females, the overall binary logistic regression for Model 3, which
examined late life acute stressors with chronic depression as the binary outcome variable,
was not significant with χ2(10) =11.99, p = .15. Only the main effects of corticosteroid
use and age at study enrollment were associated with reduced odds of having chronic
depression. No other covariates were associated with chronic depression among females
in Model 3.

Table 7
Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life Events and Covariates on Lifetime
Depression in Male and Female Models
Variable

Death of Father
Early Life
Late Life
Death of
Mother
Early Life
Late Life
Sibling Deaths
Early Life
Late Life
Death of
Spouse
Early Life
Late Life
Death of Child
Early Life
Late Life

Early Life
Depression
.67 (.37-1.21)
-

Male Sample
OR, CI
Chronic
Late Life
Depression
Depression
.44(.15-1.24)

.91(.57-1.45)
1.08(.61-1.91)
.99 (.82-1.20)
-

.92(.78-1.09)

2.44(1.075.58)
1.30(.72-2.33)
.86 (.47-1.57)
-

.60(.25-1..43)

Early Life
Depression

Female Sample
OR, CI
Chronic
Late Life
Depression
Depression

1.14(.79-1.65)
.77(.47-1.25)
1.01(.73-1.40) 1.18(.94-1.48)
1.56 (1.132.16)

.95(.67-1.34)
-

.86(.63-1.18) 1.02(.82-1.27)

.97 (.89-1.06)

.95(.79-1.14)
-

.97(.89-1.05) 1.05(.99-1.11)

2.18(1.583.03)

2.77(1.614.77)
1.39(.96-2.01)

1.40(1.081.82)

.79(.53-1.18) 1.21(.94-1.57)
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1.16(.72-1.86)
2.25(1.573.23)

-

Variable

Hospitalizations
-Late
Corticosteroids
Marital Status

Early Life
Depression
1.09(.68-1.77)
2.33 (.995.41)
.86 (.53-1.40)
-

Male Sample
OR, CI
Chronic
Depression
1.03(1.001.05)
.77(.42-1.44)
.40(.19-.83)

Late Life
Depression
1.03(1.011.04)
.86(.60-1.22)

Early Life
Depression
-

1.89(1.302.73)
.90(.57-1.42) 1.11(.79-1.58)

Female Sample
OR, CI
Chronic
Depression
1.01(.99-1.03)
.63(.43-.96)

Late Life
Depression
1.02(1.011.03)
.65(.50-.86)

.77(.55-1.08)

.70(.55-.89)

Education
.81(.44-1.49) .86(.60-1.22) 1.12(.69-1.80) .93(.60-1.44) 1.12(.82-1.53)
Age at
.92(.88-.97)
.97(.94-.99)
.95(.93-.98)
.95(.94-.97)
enrollment
Nagelkerke R2
.02^
.06
.07
.03
.03^
.04
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in boldface. ^=indicates regression model was
not significant

53

54
Model 4: Chronic Life Stressors, BDNF-Related Genes, Covariates and Early Life
Depression
Among males, the overall binary logistic regression for Model 4, which examined
chronic life stressors with early life depression as the binary outcome, was not
significant, with χ2(7)=9.91, p = .19 (See Table 8). Only the main effect of rs2072446
was significant, such that those with at least one minor allele of rs2072446 were at 2.38fold greater odds of also having early life depression.
Among females, the overall binary logistic regression for Model 4, which
examined chronic life stressors with early life depression as the binary outcome, was also
not significant, with χ2(7) =5.18, p = .64 (See Table 8). There were no significant main
effects in Model 4 for the female sample, although the main effect of rs2072446 trended
towards significance.

Model 5: Chronic Life Stressors, BDNF-related Genes, Covariates and Late Life
Depression
Among males, the overall binary logistic regression for Model 5, which examined
chronic life stressors with late life depression as the binary outcome, was significant with
χ2(11) =107.74, p = <.001. The main effects of late life chronic pain conditions and
number of vascular health conditions were associated with significantly reduced odds of
having late life depression (See Table 8). No other main effects were associated with late
life depression among males in Model 5.
Among females, the overall binary logistic regression for Model 5, which
examined chronic life stressors with late life depression as the binary outcome variable,
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was significant, with χ2(11) =292.45, p = <.001. The main effects of late life chronic pain
conditions, number of vascular health conditions, were associated with significantly
reduced odds of also having late life depression, such that those who reported chronic
pain or a higher number of vascular health conditions tended to be less likely to also have
late life depression (See Table 8). Further, socioeconomic status in adulthood and age at
study enrollment were also associated with reduced odds of late life depression, such that
those with higher socioeconomic status and those who were older at baseline were less
likely to also have late life depression (See Table 8).

Model 6: Chronic Life Stressors, BDNF-Related Genes, Covariates and Chronic
Depression
Among males, the overall binary logistic regression for Model 6, which examined
chronic life stressors with chronic depression as the binary outcome, was significant with
χ2(11)=257.64, p = <.001. The main effects of late life chronic pain conditions and
number of vascular health conditions were significantly associated with reduced odds of
also having chronic depression (see Table 8). Additionally, the main effects of marital
status, and age at study enrollment were also associated with reduced odds of depression,
such that those who were married or older at baseline were less likely to also have
chronic depression (See Table 8). BDNF related genes were not associated with chronic
depression among males.
Among females, the overall binary logistic regression for Model 6, which
examined chronic life stressors with chronic depression as the binary outcome, was
significant with χ2(11)=451.80, p = <.001. The main effects of late life chronic pain
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conditions and number of vascular health conditions were associated with reduced odds
of having chronic depression (See table 8). Further, those who had at least one minor
allele of rs228956 were at 1.51-fold increased odds of having chronic depression. The
main effect of corticosteroid use was also significant, such that those who reported
corticosteroid use were at a 1.68-fold increased odds of having chronic depression (See
Table 8).

Table 8
Odds Ratios (OR) and Confidence Intervals (CI) for All Chronically Stressful Life Events and Covariates on
Lifetime Depression in Male and Female Models
Variable

Late Life
Chronic Pain
Vascular Health
Conditions
BDNF-Related
Genes
rs6265
rs2072446
rs228956

-

Late Life
Depression
.52(.36-.75)

.12(.06-.21)

.76(.71-.81)

Early Life
Depression
-

Female Sample
OR, CI
Chronic
Depression
.39(.26-.66)

Late Life
Depression
.39(.30-.52)

.14(.09-.21)

.71(.66-.75)

.93 (.57-1.51) .98(.55-1.74) .88(.65-1.19) 1.27(.85-1.92) .85(.59-1.22) .95(.75-1.19)
2.38(1.26- 1.34(.50-3.56) .88(.65-1.19) .32(.09-1.01) 1.30(.70-2.42) 1.13(.76-1.67)
4.47)
.92(.56-1.50) 1.67(.94-2.97) 1.18(.88-1.59) .82(.53-1.27)
1.51(1.06- .96(.77-1.21)
2.15)
.99(.49-1.98) .91(.38-2.18) 1.01(.66-1.55) .53(.24-1.17) 1.22(.72-2.05) .87(.61-1.24)
.96(.79-1.16)
1.05(.89-1.24)
1.03(.83-1.28) 1.10(.99-1.24)
.97(.84-1.12)
.89(.81-.98)
.83(.39-1.75) 1.15(.81-1.63)
1.65(.99-2.74) 1.01(.74-1.38)
1.80(.72-4.57)
.28(.14-.57) .83(.56-1.24) .75(.50-1.13) 1.03(.71-1.49) .97(.77-1.24)
.71 (.41-1.23) 1.18(.57-2.46) .88(.62-1.23) .85(.47-1.52) .84(.48-1.46) 1.07(.76-1.51)
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rs561644
Socioeconomic
Status
Early Life
Adulthood
Corticosteroids
Marital Status
Education

Early Life
Depression
-

Male Sample
OR, CI
Chronic
Depression
.42(.19-.95)

Variable
Early Life
Depression
-

Male Sample
OR, CI
Chronic
Depression
.91(.87-.95)

Late Life
Depression
.98(.96-1.00)

Early Life
Depression
-

Female Sample
OR, CI
Chronic
Depression
.98(.95-1.00)

Late Life
Depression
.97(.95-.98)

Age at study
enrollment
Nagelkerke R2
.02^
.47
.11
.02^
.44
.21
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in boldface. ^=indicates regression model was
not significant.
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Research Question 2: “Are There Differences In The Polymorphisms of Specific BDNFRelated Genes and Early and Late Onset Depression? Do These Genotypes Moderate the
Association of Stressful Life Events with Early and Late Onset Depression?”

Exploratory Analyses of BDNF-Related Genes by Stressful Life Events Interaction and
Depression Outcomes
In a series of exploratory analyses, bivariate binary logistic regression models
were developed to examine any interaction effects between each BDNF-related genes and
each stressful life event and depression outcomes. Separate models were run for males
and females (See Table 9). Interaction terms were computed by taking the product of a
BDNF-related gene (e.g., rs6265 minor allele) and an acutely stressful life event (e.g.,
death of spouse in early life). A hierarchical stepwise procedure was used to enter the
main effects of a BDNF-related gene and an acute life stressor in step 1. In step 2 the
interaction was entered.

BDNF-Related Genes by Early Life Acutely Stressful Life Events Interaction and Early
Onset Depression
For males, there were no significant interactions between any of the BDNFrelated genes and the acutely stressful life events that occurred in early life with early life
depression as the binary outcome variable (See Table 9). Similar results were obtained
for females (see Table 9).
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Table 9
Bivariate Odds Ratios (OR) and Confidence Intervals (CI) for interactions of BDNFrelated genes by acute life stressors in early life on Early Life Depression in Male and
Female Models.
Variable

Male Sample
Female Sample
OR, CI
OR, CI
Early Life Depression Early Life Depression
rs2289656xFather Death Early
2.23(.34-3.67)
1.08(.51-2.27)
rs2289656xMother Death Early
.40(.16-1.00)
1.21(.61-2.40)
rs2289656xSibling Death Early
.83(.56-1.24)
1.10(.78-1.55)
rs2289656xSpouse Death Early
.00(.0-.00)
1.24(.46-3.37)
rs2289656xChild Death Early
.38(.08-1.88)
1.34(.49-3.66)
rs56164415xFather Death Early
1.02(.19-5.42)
.70(.20-2.37)
rs56164415xMother Death Early
.57(.16-1.98)
1.21(.36-4.02)
rs56164415xSibling Death Early
1.34(.88-2.04)
1.00(.53-1.90)
rs56164415xSpouse Death Early
1.69(.27-10.75)
.57(.07-5.00)
rs56164415xChild Death Early
.62(.07-5.47)
2.27(.53-9.85)
rs6265xFather Death Early
2.63(.76-9.07)
1.08(.54-2.18)
rs6265xMother Death Early
1.02(.42-2.46)
.72(.37-1.37)
rs6265xSibling Death Early
1.04(.74-1.47)
1.23(.88-1.71)
rs6265xSpouse Death Early
.76(.16-3.70)
1.92(.74-4.98)
rs6265xChild Death Early
.93(.28-3.12)
1.30(.49-3.47)
rs2072446xFather Death Early
1.31(.24-7.05)
.82(.19-3.54)
rs2072446xMother Death Early
.62(.20-1.94)
1.73(.43-6.89)
rs2072446xSibling Death Early
.65(.34-1.23)
.62(.21-1.83)
rs2072446xSpouse Death Early
.42(.04-4.21)
.53(.06-4.74)
rs2072446xChild Death Early
1.91(.47-7.70)
2.78(.28-27.86)
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in boldface. N
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BDNF Genes by Acutely Stressful Events in Late life Interaction and Chronic/Late Life
Depression
For males, the interaction of rs2076446 by father’s death in late life was
significant, such that those who had at least one copy of the minor allele of rs2072446
and who experienced the death of their father in late life were at 1.67-fold increased odds
for having chronic depression (See Table 10). Additionally, the interaction between
rs6265 and death of a child in late life was significant, such that those who had at least
one copy of the minor allele of rs6265 and who experienced the death of a child in late
life were at significantly reduced odds of having late life depression (See Table 10).
Among females, several significant interactions were observed (See table 10).
More specifically, those with at least one minor allele of rs228965 and who experienced
death of sibling in late life was associated with a 1.11-fold increased odds of also having
late life depression. Further, those with at least one minor allele of rs6265 and who
experienced mother’s death in late life were associated with significantly reduced odds of
also having late life depression. Interactions were also observed among females with
chronic depression as the binary outcome. In particular, those who had at least one minor
allele of rs2289656 and who experienced mother’s death in late life had a 1.72-fold
increase in the odds of having chronic depression compared to those who had neither risk
factor. Further, the those with at least one minor allele of rs56164415 and had
experienced father’s death in late life had a 2.45-fold increase in the odds of having
chronic depression (see Table 10). The interactions between BDNF-related genes and
each of chronic pain conditions, socioeconomic status and number of vascular health
conditions were not significant in either male or female samples.

Table 10
Bivariate Odds Ratios (OR) and Confidence Intervals (CI) for Interactions of BDNF-related Genes by Acute
Life Stressors in Late Life on Late Life Depression and Chronic Depression in Male and Female Models.
Variable

.80(.43-1.41)

.83(.61-1.13)

Female Sample
OR, CI
Chronic
Late Life
Depression
Depression
.91(.52-1.57)
1.27(.86-1.88)
1.72(1.01-2.93)
.90(.62-1.32)
.91(.80-1.04) 1.11(1.01-1.21)
.87(.50-1.49)
1.43(.97-2.13)
.99(.49-2.02)
1.11(.70-1.80)
1.00(.97-1.04)
.99(.97-1.02)
2.01(.93-4.36)
1.24(.77-1.99)
.66(.30-1.44)
1.03(.93-1.14)
.95(.75-1.20)
.94(.80-1.12)
2.45(1.07-5.60)
.91(.49-1.67)
1.09(.48-2.49)
1.34(.73-2.44)
1.03(.84-1.25)
.97(.84-1.12)
1.14(.46-2.79)
.61(.33-1.12)
.48(.13-1.72)
1.51(.74-3.09)
.99(.95-1.03)
1.02(.99-1.05)
1.93(.70-5.37)
1.01(.49-2.07)
1.18(.39-3.53)
.93(.79-1.10)
1.16(.82-1.63)

1.09(.84-1.42)
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rs2289656xFather Death Late
rs2289656xMother Death Late
rs2289656xSibling Death Late
rs2289656xSpouse Death Late
rs2289656xChild Death Late
rs2289656xHospitalizations
rs2289656xChronic Pain
rs2289656xvascular health conditions
rs2289656xSocioeconomic status
rs56164415xFather Death Late
rs56164415xMother Death Late
rs56164415xSibling Death Late
rs56164415xSpouse Death Late
rs56164415xChild Death Late
rs56164415xHospitalizations
rs56164415xChronic Pain
rs56164415xvascular health
conditions
rs56164415xSocioeconomic status

Male Sample
OR, CI
Chronic
Late Life
Depression
Depression
1.22(.19-7.96)
.84(.34-2.08
1.07(.38-3.00)
1.33(.74-2.39)
1.10(.83-1.45)
.99(.86-1.14)
.74(.28-1.92)
.90(.53-.154)
.56(.11-3.01)
1.91(.95-3.83)
1.04(.98-1.09)
.98(.95-1.01)
1.17(.30-4.56)
1.14(.59-2.22)
2.32(.90-6.02)
1.02(.89-1.16)
1.22(.84-1.77)
.95).77-1.18)
.00(.00-.00)
1.29(.38-4.40)
.00(.00-.00)
1.24(.52-2.96)
1.26(.84-1.91)
1.08(.86-1.35)
1.11(.25-4.93)
.76(.34-1.68)
.00(.00-.00)
1.07(.41-2.77)
.96(.86-1.07)
1.01(.96-1.06)
.80(.09-7.31)
1.27(.51-3.16)
1.06(.26-4.31)
1.06(.88-1.27)

Variable

Male Sample
Female Sample
Variable
OR, CI
OR, CI
Chronic
Late Life
Depression
Depression
rs6265xFather Death Late
2.76(.42-18.01)
.87(.362.13)
.73(.41-1.28)
rs6265xMother Death Late
1.13(.41-3.11)
.95(.52-1.74)
.67(.39-1.14)
rs6265xSibling Death Late
.99(.75-1.32)
.89(.77-1.04)
.98(.87-1.12)
rs6265xSpouse Death Late
.70(.27-1.80)
.58(.34-1.00)
1.01(.57-1.74)
rs6265xChild Death Late
.50(.09-2.64)
.43(.20-.91)
1.13(.56-2.28)
rs6265xHospitalizations
.98(.93-1.03)
1.01(.97-1.04)
.99(.96-1.02)
rs6265xChronic Pain
1.33(.34-5.17)
.71(.34-1.45)
2.16(.99-4.68)
rs6265xvascular health conditions
1.03(.40-2.66)
.98(.85-1.11)
1.22(.66-2.48)
rs6265xSocioeconomic status
1.19(.82-1.74)
.99(.80-1.23)
.91(.71-1.16)
rs2072446xFather Death Late
1.67(1.36-8.36) 1.01(.200-5.13)
.66(.25-1.73)
rs2072446xMother Death Late
1.33(.28-6.34)
.76(.27-2.20)
2.18(.88-5.44)
rs2072446xSibling Death Late
1.34(.88-2.07)
.92(.67-1.27)
1.00(.80-1.26)
rs2072446xSpouse Death Late
2.33(.55-9.85)
1.58(.61-4.05)
.78(.34-1.83)
rs2072446xChild Death Late
.00(.00-.00)
1.14(.31-4.22)
.63(.17-2.34)
rs2072446xHospitalizations
.81(.63-1.04)
.99(.94-1.05)
1.02(.98-1.06)
rs2072446xChronic Pain
.00(.00-.00)
.61(.16-2.26)
1.22(.38-3.92)
rs2072446xvascular health conditions
1.77(.54-5.86) 1.22(1.00-1.48)
.00(.00-.00)
rs2072446xSocioeconomic status
1.07(.58-1.98)
1.16(.78-1.73)
.95(.63-1.44)
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in boldface.

Male Sample
OR, CI
Chronic
Depression
.81(.55-1.20)
.56(.39-.82)
1.07(.98-1.17)
.89(.61-1.30)
1.09(.69-1.75)
1.00(.98-1.02)
.92(.58-1.47)
.97(.87-1.07)
.99(.84-1.16)
1.69(.86-3.32)
1.13(.58-2.20)
.87(.72-1.04)
.94(.48-1.81)
1.17(.52-2.62)
.99(.96-1.03)
.95(.43-2.14)
1.01(.85-1.19)
1.19(.89-1.58)
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Fully Adjusted Logistic Regression Models for Acutely Stressful Life Events with
Significant Interactions with BDNF-related Genes in Predicting Depression Outcomes
In the next series of logistic regression models, significant bivariate interactions
between BDNF-related genes and acutely stressful life events were added to the model of
acutely stressful life events and covariates. A hierarchical stepwise procedure was used to
enter the main effects of each BDNF-related single nucleotide polymorphism (snp) and
the acutely stressful life event in step 1. In step 2 the interaction was entered. Overall
model significance/fit in predicting depression status was determined by examination of
model fit statistics, which included chi-square statistics, Hosmer Lemeshow goodness of
fit and Nagelkerke R2 and change in R2 (in Step 2 of the analysis).

Interaction of rs6265 by Child Death in Late Life and Late Life Depression in Males
The overall adjusted regression model of acutely stressful life events, BDNF gene
rs6265, rs6265xChild Death in late life and covariates with late life depression was
significant, with χ2 (12)= 62.01, p=.001. There were main effects observed for death of
mother in late life, death of spouse in late life, death of child in late life and total
hospitalized days of self and immediate family in late life, with positive associations to
late life depression (odds ratios ranging from 1.03-2.54; See Table 11). The interaction of
rs6265 by child death in late life was not significant after accounting for the effects of
other covariates (See Table 11).
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Table 11
Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life
Events in Late Life, BDNF Gene Rs6265, Interaction and Covariates on Late
Life Depression in Male Sample
Variable

Male Sample
Late Life Depression
OR, CI
.74(.45-1.22)
1.59(1.14-2.23)
.98(.90-1.08)
2.12(1.51-2.96)
2.54(1.65-3.91)
1.03(1.01-1.04)
.93(.65-1.33)
.88(.61-1.26)
.97(.94-.99)
.96(.60-1.55)
.95(.65-1.37)
.58(.24-1.39)

Death of Father-Late
Death of Mother-Late
Sibling Deaths-Late
Death of Spouse-Late
Death of Child-Late
Hospitalizations-Late
BDNF Gene rs6265
Corticosteroids
Age at study enrollment
Marital Status
Education
rs6265 x Child Death-Late
Nagelkerke R2 =.07
Model χ2 (12)= 62.01, p=,.001
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in
boldface. ^=indicates regression model was not significant.
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Interaction of rs2072446 by Father Death in Late Life and Chronic Depression in Males
The overall adjusted regression model of acutely stressful life events, rs2072446,
rs2072446 x father death in late life and covariates with chronic depression was
significant, with χ2 (12)= 29.86, p=.003. Main effects were observed for age at study
enrollment, such that those with higher ages at study enrollment had reduced odds of
chronic depression The interaction of rs2072446 by father death in late life was
significant after accounting for the effects of other covariates (See Table 12), such that
those with at least one minor allele of rs2072446 and who had experienced father death
were at a 10.65-fold increased risk for also having chronic depression (See Table 12).
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Table 12
Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life
Events in Late Life, BDNF Gene rs2072446, Interaction and Covariates on
Chronic Depression in Male Sample
Variable

Male Sample
Chronic Depression
OR, CI
.24(.06-1.01)
1.09(.60-1.96)
.93(.79-1.10)
1.41(.79-1.10)
.65(.27-1.55)
1.03(1.00-1.05)
1.05(-.40-2.72)
.66(.34-1.27)
.92(.88-.97)
.50(.24-1.05)
.88(.47-1.65)
10.65(1.03-110.14)

Death of Father-Late
Death of Mother-Late
Sibling Deaths-Late
Death of Spouse-Late
Death of Child-Late
Hospitalizations-Late
rs2072446
Corticosteroids
Age at study enrollment
Marital Status
Education
rs2072446 x Father DeathLate
Nagelkerke R2 =.07
Model χ2 (12)= 29.86, p=.003
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in
boldface. ^=indicates regression model was not significant.
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Interaction of rs2289656 by Mother Death in Late Life and Chronic Depression in
Females
The overall adjusted regression model of acutely stressful life events, BDNF gene
rs2289656, rs2289656 x mother death in late life and covariates with chronic life
depression was significant, with χ2 (12)= 28.42, p=.005. There were main effects
observed for corticosteroid use and age at study enrollment, with negative associations
with late life depression (See Table 13). The interaction of rs2289656 with mother’s
death in late life was not significant after accounting for the effects of other covariates
(See Table 13).
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Table 13
Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life
Events in Late Life, BDNF Gene rs2289656, Interaction and Covariates on
Chronic Depression in Female Sample
Variable

Female Sample
Chronic Depression
OR, CI
1.04(.7501.45)
.72(.48-1.09)
.98(.90-1.06)
1.25(.86-1.84)
.80(.53-1.20)
1.01(.99-1.03)
1.02(.63-1.65)
.65(.43-.98)
.96(.93-.98)
.74(.52-1.04)
.93(.59-1.47)
1.70(.90-3.21)

Death of Father-Late
Death of Mother-Late
Sibling Deaths-Late
Death of Spouse-Late
Death of Child-Late
Hospitalizations-Late
BDNF Gene rs2289656
Corticosteroids
Age at study enrollment
Marital Status
Education
rs2289656 x Mother DeathLate
Nagelkerke R2 =.03
Model χ2 (12)= 28.42, p=.005
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in
boldface. ^=indicates regression model was not significant.
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Interaction of rs2289656 by sibling Death in Late Life and Late Life Depression in
Females
The overall adjusted regression model of acutely stressful life events, rs2289656,
rs2289656 x sibling death in late life and covariates with late life depression was
significant, with Model χ2 (12)= 60.37, p=<.001. There were main effects observed for
death of spouse in late life (OR=1.48), hospitalizations of self and family (OR=1.02) and
marital status (.72) (See Table 14). The interaction of rs2289656 by sibling death in late
life was significant after accounting for the effects of other covariates (See Table 14).
More specifically, those with at least one copy of the minor allele of rs2289656 and who
had also experienced a higher number of sibling deaths in late life were at 12% greater
risk for also having late life depression (See Table 14).
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Table 14
Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life
Events in Late Life, BDNF Gene rs2289656, Interaction and Covariates on Late
Life Depression in Female Sample
Variable

Female Sample
Late Life Depression
OR, CI
1.15(.91-1.46)
1.01(.80-1.27)
1.00(.93-1.08)
1.48(1.13-1.95)
1.23(.95-1.61)
1.02(1.01-1.04)
.93(.65-1.32)
.66(.50-.88)
.95(.93-.97)
.72(.56-.92)
1.14(.82-1.58)
1.12(1.00-1.25)

Death of Father-Late
Death of Mother-Late
Sibling Deaths-Late
Death of Spouse-Late
Death of Child-Late
Hospitalizations-Late
rs2289656
Corticosteroids
Age at study enrollment
Marital Status
Education
rs2289656 x Sibling Death
Nagelkerke R2 =.05
Model χ2 (12)= 60.37, p=<.001
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in
boldface. ^=indicates regression model was not significant.
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Interaction of rs56164415 by Father Death in Late Life and Chronic Depression in
Females
The overall adjusted regression model of acutely stressful life events, rs56164415,
rs56164415 by father death in late life and covariates with chronic life depression was
significant, with χ2 (12)= 27.83, p=.006. There were main effects observed for
corticosteroid use and age at study enrollment, with inverse associations with late life
depression (See Table 15). The interaction of rs56164415 by father death in late life was
not significant after accounting for the effects of other covariates (See Table 15).
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Table 15
Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life
Events in Late Life, BDNF Gene Rs56164415, Interaction and Covariates on
Chronic Depression in Female Sample
Variable

Female Sample
Chronic Depression
OR, CI
.86(.60-1.23)
.89(.64-1.23)
.97(.89-1.05)
1.27(.87-1.85)
.80(.53-1.20)
1.01(.99-1.03)
.75(.39-1.44)
.63(42-.95)
.95(.93-.98)
.74(.53-1.05)
.92(.58-1.46)
2.41(.94-6.19)

Death of Father-Late
Death of Mother-Late
Sibling Deaths-Late
Death of Spouse-Late
Death of Child-Late
Hospitalizations-Late
BDNF Gene rs56164415
Corticosteroids
Age at study enrollment
Marital Status
Education
rs561644156 x Father DeathLate
Nagelkerke R2 =.03
Model χ2 (12)= 27.83, p=.006
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in
boldface. ^=indicates regression model was not significant.

74
Interaction of rs6265 by Mother Death in Late Life and Late Life Depression in Females
The overall adjusted regression model of acutely stressful life events, rs6265,
rs6265 x mother death in late life and covariates with late life depression was significant,
with χ2 (12)= 55.40, p=<.001. There were main effects observed for death of spouse in
late life (OR=1.45), hospitalizations of self and family (OR=1.02), corticosteroid use
(OR=.67), age at study enrollment (OR=.95) and marital status (.70) (See Table 16). The
interaction of rs6265 by mother death in late life was significant after accounting for the
effects of other covariates (See Table 16). More specifically, those with at least one copy
of the minor allele of rs6265 and who experienced mother death in late life were at
reduced odds of also having late life depression (See Table 16).
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Table 16
Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life
Events in Late Life, BDNF Gene Rs6265, Interaction and Covariates on Late
Life Depression in Female Sample
Variable

Female Sample
Late Life Depression
OR, CI
1.15(.91-1.45)
1.21(.91-1.61)
1.04(.98-1.10)
1.45(1.11-1.90)
1.19(.91-1.55)
1.02(1.01-1.03)
1.32(.94-1.84)
.67(.51-.89)
.95(.93-.97)
.70(.55-.90)
1.11(.81—1.54)
.62(.40-.98)

Death of Father-Late
Death of Mother-Late
Sibling Deaths-Late
Death of Spouse-Late
Death of Child-Late
Hospitalizations-Late
BDNF Gene rs6265
Corticosteroids
Age at study enrollment
Marital Status
Education
rs6265 x Mother Death-Late
Nagelkerke R2 =.05
Model χ2 (12)= 55.40, p=<.001
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in
boldface. ^=indicates regression model was not significant.
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Tabular Summary of Results
In summary, a number of risk factors were differentially associated with risk of
depression across the lifespan for males and females. Table 17 provides a summary of the
significant associations for early life, late life, and chronic depression by sex.
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Table 17
Overall Summary of Risk Factors for Lifetime Depression for Females and Males
Acute Life Stressors
Death of Mother
Death of Father
Death of Spouse
Death of Offspring
Hospitalized Days of Self and
Family
Chronic Life Stressors
Chronic Pain conditions
Vascular Health conditions

Males

Female

↑ LLD 56% (OR=1.56)
↑ EOD 144% (OR=2.44) ↑ EOD 177% (OR=2.77)
↑ LLD 118% (OR=2.18) ↑ LLD 40%% (OR=1.40)
↑ LLD 125% (OR=2.25)
↑ CD 3% (OR=1.03)
↑ LLD 2% (OR=1.02)
↑ LLD 3% (OR=1.03)
↓ CD 58% (OR=.42)
↓ LLD 48% (OR=.52)
↓ CD 88% (OR=.12)
↓ LLD 24% (OR=.76)

Socioeconomic Status
Rs6265
Rs2289656
Rs2072446
↑ EOD 138% (OR=2.38)
Rs56164415
Covariates
Age at baseline of study enrollment ↓ CD 8% (OR=.92)
↓ LLD 03% (OR=.97)
High school education
Marital Status
↓ CD 60% (OR=.40)
Corticosteroid use

↓ CD 61% (OR=.39)
↓ LLD 61% (OR=.39)
↓ CD 86% (OR=.14)
↓ LLD 29% (OR=.71)
↓ LLD 11% (OR=.89)
↑ CD 51% (OR=1.51)

↓ CD 5% (OR=.95)
↓ LLD 5% (OR=.95

↓ LLD 30% (OR=.70)
↑ EOD 89% (OR=1.89)
↑ CD 65% (OR=1.65)
↓ LLD 35% (OR=.65)
Note. ↓=decrease in odds; ↑= increase in odds; EOD= Early Life Onset Depression; CD=
Chronic Depression; LLD=Late Life Onset Depression; OR=Odds Ratio.
All OR’s calculated with 95% confidence interval.
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Discussion

The goal of the present study was to examine biological factors, stressful life
events and conditions that impact risk for depression across the lifespan. With respect to
biological factors, we further sought to understand if the associations of stressful life
events were altered by the presence of minor alleles of BDNF-related genes. The present
study utilized a population-based sample of 5069 older individuals who participated in
the Cache County Study on Memory in Aging (CCSMA) including examining
participants’ Medicare claims data from the Utah Population Database to empirically test
our hypotheses. In the study sample, rates of lifetime depression were comparable to the
prevalence rates in the United States, with the overall presence of lifetime depression
being approximately 21% (Djernes, 2006; Gatz et al., 1993; ; National Institute on Aging,
2007; NIMH, 2018). Findings from the present study revealed that several acutely
stressful life events were associated with increased odds of depression onset in early life,
late life and a chronic presentation (early and late life depression). Further, there were sex
differences observed that suggested certain life events were differentially related to the
odds of having depression among males and females; these key results are summarized in
Table 17.
In the present study, we conceptualized acutely stressful life events as events that
occur infrequently, but which cause a great deal of stress on an individual, such as death
of a family member or friend. Acutely stressful life events that were examined in the
present study included death of mother, death of father, number of deaths of siblings,
death of a spouse and death of a child. We also examined the days of hospitalization of
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self and of immediate family members (sibling, spouse and child) as a single variable.
Chronic life stressors were conditions or events that occurred with greater frequency and
which contributed to a consistent but less intense state of distress, such as daily pain or
health conditions. Chronic life stressors included in the analyses were chronic pain
conditions, the number of vascular health conditions, childhood socioeconomic status,
and adulthood socioeconomic status. BDNF- related genes were also included among
chronic “life stressors,” as they represented a genetic vulnerability factor.
Several acutely stressful life events and chronic life stressors that occurred in
early life showed associations with early life depression in both the males and females.
However, the overall model of early life acute stressors on early life depression was not
significant in males, likely due to sparseness of data. For example, there were only 126
males who reported early life depression and of those 126, only 14 experienced death of a
child in early life. Thus, we likely did not have enough statistical power to detect the
hypothesized relationships. Overall, the model of acute stressors in early life was a poor
fit for predicting early life depression among males. Nonetheless, in examining the
associations of this model of males, death of a spouse in early life was associated with
increased odds of early life depression. These results were consistent with results in
females, suggesting that death of a spouse in early life may be a useful predictor for early
life depression. However, given the limitations of the male model sample size these
results should be interpreted with caution. Another observed difference was that in
females only, corticosteroid use was associated with increased odds of early life
depression. Of the chronic life stressors utilized to predict early life depression in males
only rs2072446 (Neurotrophic growth factor/ BDNF receptor p75NTR) was associated
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with early onset depression, however the overall model failed to reach significance, again
indicating that the sparseness of males with early life depression and chronic stressors
may have resulted in limited statistical power. There were no significant chronic life
stressors that were associated with early life depression in females.
Extant research has identified several risk factors for early life depression that are
consistent with our findings. More specifically, a meta-analysis of 26 studies examining
depression in early adulthood observed that death of a parent or immediate family
member was associated with greater likelihood of depression in early life (See review,
Keller et al., 2007; Kessler & Magee, 1993; Mandelli et al., 2015; Riso et al., 2002;). Our
results were also consistent with another study that found males and females tended to be
more likely to report higher overall depression symptoms following the death of a spouse
in early-to-mid adulthood (Sasson & Umberson, 2014). Additionally, another study found
that death of a spouse in adulthood was reliably associated with chronic depression
symptoms (Keller, Neale & Kendler, 2007). These findings may suggest that our
analyses, though underpowered among males, were reliable in detecting death of a spouse
in early life as an established risk factor for depression in early life. Other studies have
linked additional stressful life events, such as abuse in childhood or adulthood (See
review, Mandelli et al., 2015) and witnessing or being victimized by domestic violence
(Kessler & Magee, 1993) to the onset of depression in early life; unfortunately these data
were not available for our cohort. One novel aspect of the present study is that we were
able in our (single) sample to separately model early/late life cutoffs of depression for
males and females. Indeed, among studies examining acutely stressful life events, only
Sasson & Umberson, (2014) explicitly compared differences in depression status among
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males and females following a stressful life event. Taken together, our results are
consistent with the literature on early life depression, suggesting that death of a spouse is
an important event that reliably increases risk for depression, however our analyses were
likely underpowered to detect associations of other acutely stressful life events with early
life depression.
Several chronic life stressors and acutely stressful late life events displayed
significant associations with lifetime depression in both males and females. Among
males, those who lost their mother in late life, those who lost a child in late life and those
who experienced a higher number of hospitalizations in late life were associated with
having increased odds of late life depression, whereas those who were older at baseline
displayed reduced odds of having late life depression. Similar associations of acutely
stressful life events in late life emerged in females, though there were some observed
differences. For example, death of a spouse and total days of hospitalization were
associated with increased odds of depression in late life for females, however
corticosteroid use, marital status and age were also associated with reduced odds of
having late life depression.
Several chronic life stressors were also associated with late life depression status
in both males and females. In late life, chronic pain conditions and number of vascular
health conditions were each associated with reduced odds of having late life depression
in both males and females. Socioeconomic status in adulthood and age were each
associated with decreased odds of late life depression among females, such that those
with higher socioeconomic status or who were older at baseline were associated with
reduced odds of depression in late life. These results were somewhat consistent with
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previously established work examining chronic life stressors and depression in late life,
though the results of several studies are inconclusive. More specifically, chronic pain has
shown mixed associations with depression in late life, such that some studies have
observed robust associations with chronic pain increasing or intensifying depressive
symptoms in late life (Jeuring et al., 2018; Ohayon & Shatzberg, 2003). Still others have
observed that chronic pain often co-occurs with depression in late life, making it difficult
to parse whether symptoms of depression are attributed to chronic pain or are attributed
to clinical depression (Gagliese & Melzack, 2003; Meeks et al., 2007). Our findings of
vascular health conditions being associated with reduced odds of depression in late life
were inconsistent with established work. For example, Valkanova & Ebmeier (2013)
found that diabetes, cardiovascular disease and stroke were each associated with higher
rates of depression in late life. Other studies have also observed a positive relationship
between vascular health/conditions and late life depression as well (see review, Sheline et
al., 2010; Taylor et al., 2013;). There are also certain medications used to treat
cardiovascular conditions (i.e., beta blockers) that are associated with increased risk of
depression as a side effect (Zimmerman, 1993). As our study relied primarily on selfreport data for determining the presence or absence of depression, it is possible that
participants who experienced depression as a side effect of medication attributed
symptoms of depression to the medication and did not separately endorse them as
indicative of depression. Taken together, the negative association of chronic pain and
depression is consistent with mixed findings reported in extant studies, however the
negative association with vascular health conditions and depression is inconsistent with
previous work. It is also possible that our results were influenced by the use of
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retrospective reports to identify the onset of vascular health conditions such that the cooccurrence of vascular health and late life depression was represented rather than
vascular conditions antecedent to depression. This may have been an issue with vascular
conditions obtained from Medicare claims data or chronic conditions for which onset
ages were less reliably obtained.
There were also significant associations between acutely/chronically stressful life
events in late life with chronic depression in both males and females. Indeed, those with a
chronic pain condition in late life and those with more vascular health conditions showed
reduced odds of having late life or chronic depression in both males and females. With
respect to a genetic vulnerability factor, females with at least one minor allele of
rs228956 (BDNF receptor trkB) were at significantly higher odds of having chronic
depression. These results were inconsistent with previous research that has linked some
BDNF- related genes to depression (Hwang et al., 2006; Taylor et al., 2007). More
specifically, the presence of the minor allele rs6265 (BDNF Val66Met) has research
support for increasing risk for depression, particularly in males (Hwang et al., 2006;
Taylor et al., 2007). However, in our sample we did not observe a relationship between
rs6265 (BDNF Val66Met) and depression status for males; in females, there was an
interaction with stressful life events, but presence of the minor allele and stressful event
was associated with a reduction in risk (see discussion below). Further, corticosteroids
were associated with increased odds of chronic depression among females but displayed
no significant relationships with chronic depression in males. Although there is evidence
that corticosteroids reduce serotonin levels that can increase risk for depression
(McAllister-Williams et al., 1998), no study that the author is aware of has examined the
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relationship between corticosteroids and depression in the context of stressful life events.
Thus, our findings regarding the associations of corticosteroids and lifetime depression
among males and females may be relatively novel. In particular, we observed a positive
association between corticosteroid use and early life depression in the statistical models
in females with acute life stressors, which was reversed when chronic depression and late
life depression were the outcome variables. One possible explanation is the low
frequency of women using corticosteroids in early life (n=54 women with early life
depression and corticosteroid use), relative to late life depression (n=110). Given these
limitations, these associations should be interpreted with caution, until replication with
larger samples can be done.
The findings of acutely stressful life events as risk factors for depression suggest
that certain life events, such as death of a spouse and hospitalizations of self/family are
relatively robust predictors of depression status. Indeed, it appears that in both males and
females, the odds of also having depression increase significantly following the death of a
spouse, whether that occurs in early or late life, which is consistent with previously
established research (Keller et al., 2007; Sasson & Umberson, 2014).
Further, although data on hospitalizations of self/family was not available in early
life, hospitalizations of self/family remained a significant predictor of depression status in
late life for both males and females even after other covariates were added into statistical
models. These results are consistent with extant research on bereavement following the
loss of a romantic partner and in depression research, which has shown robust
associations with depression following the loss of loved ones or threats to the health of
loved ones (Avasthi & Grover, 2018; Bonanno et al., 2002; Riso et al., 2002).
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Interestingly, there was a difference observed between males and females such that loss
of a child in late life and death of a mother in late life was associated with increased
depression in males but not females. These results may reflect a gender difference in
coping with loss, particularly in late life. Indeed, extant research on coping mechanisms
following grief has shown that males more often cope with grief and depression, with
increased physical activity and heavier drinking (Angst et al., 2002; Bonanno et al., 2002;
Meléndez et al., 2018), which in turn may exacerbate symptoms of depression (Avasthi &
Grover, 2018).
Our results of acutely stressful life events and depression were consistent with
other findings in extant literature that have observed deleterious effects of stressful life
events in increasing risk for depression (Keller et al., 2007; Mandelli et al., 2015).
Further, our results underscore the need for examination of sex differences in considering
risk factors for depression. Our results may also suggest that acute stressors in late life are
just as detrimental, if not more so than acute stressors in early life. As such, clinicians
may benefit from screening older adults for acutely stressful life events to better
understand risk and onset for depression. Further, family members and clinicians should
also strive to promote access to coping skills for building resilience to acutely and
chronically stressful life events for individuals in late life.
The present study also examined the interactive effects of BDNF-related genes
and stressful life events, although the interpretation and generalizability of our findings
may be limited by sparseness and low statistical power. As noted above, the bivariate
associations of -related genes (presence of minor alleles) BDNF genotypes were less
robust than previously established work (Hwang et al., 2006; Taylor et al., 2007). In the
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present study, two main effects for BDNF-related genes were observed these were
inconsistent with extant research. For example, extant research has primarily focused on
one gene type: rs6265 (BDNF Val66Met) and its associations with increasing depression
risk (Hwang et al., 2006; Taylor et al. 2007). However, in our study we did not observe
associations between the minor allele of BDNF Val66Met and depression in either males
or females. In the present study, among males, the minor allele of rs2072446
(Neurotrophic growth factor/ BDNF receptor p75NTR ) was associated with increased
odds of early life depression in the adjusted model with chronic life stressors. Further, the
minor allele of BDNF gene rs228956 (BDNF receptor trkB ) was associated with
increased odds of chronic depression in females. These findings are novel, considering
that extant research has primarily focused on the BDNF gene Val66Met as a vulnerability
factor for depression, and no work to this point has examined other genes related to
signaling BDNF genotypes in conjunction with stressful life events.
Another novel finding of the present study was the observation of significant
interaction effects for BDNF-related genes by specific acutely stressful life events. At the
bivariate level we observed six significant interactions, which were then examined in
adjusted models with the main effects of acutely stressful life events in late life and
covariates. Of the six significant interactions, three remained significant after accounting
for the effects of other predictors. To the author’s knowledge, this is the first study to
examine the interactive effects of these neurotrophin genes by acutely stressful life events
in predicting lifetime depression.
Our findings offer some preliminary evidence that the impact of certain life
events, specifically, death of a father in late life, death of a sibling in late life, and death
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of a mother in late life, may vary based upon genetic factors. Indeed, in the fully adjusted
model for acutely stressful events in late life among males, we observed risk for chronic
depression increased when participants had the minor allele of rs2072446 (Neurotrophic
growth factor/ BDNF receptor p75NTR) and who had also experienced their father’s death
in late life. In the female sample, the presence of the minor allele of rs2289656 ((BDNF
receptor trkB ) and experiencing sibling death in late life increased risk for late life
depression in the fully adjusted model. There was also a significant interaction for rs6265
(BDNF Val66Met) and death of mother in late life among females, such that those with
the minor allele of rs6265 who had experienced mother death in late life displayed
reduced risk for chronic depression. These results offer support for our hypotheses that
BDNF-related genes may moderate the associations of stressful life events and
depression, however given the low sample sizes and likely low statistical power, these
results should be interpreted with caution. Future work examining the above associations
in other samples is warranted. Additionally, the use of antidepressants have been shown
to alter BDNF levels (Baj et al., 2012). It is unknown how the use of antidepressants (or
other factors that influence BDNF levels) may interact with BDNF-related genes in
modifying risk for depression.

Implications of the Present Study
The present study highlights the multi-faceted and complex nature of risk factors
for depression and offers important findings for both clinicians and researchers. We
examined the impact of biological and psychosocial risk factors for depression in early
life, late life and a chronic presentation (early and late life). Taken together, our results
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reflect the complex and inter-dependent nature of risk factors for depression; we observed
direct associations between acutely stressful life events and lifetime depression, as well
as biological vulnerability factors (i.e., BDNF-related genes) that displayed both direct
associations and interactive effects with specific stressful events. We also found that the
presence of a health condition (i.e., chronic pain), resulted in lower odds of depression,
which may relate to co-occurrence of depression and the health condition and a possible
tendency to attribute the symptoms of depression solely to the health condition. Indeed,
the present study took a comprehensive approach to empirically examining risk for
depression, such that multiple classes of risk factors were examined in conjunction with
one another and further examined sex differences. The present study also utilized a novel
approach to determining the early life and late life cutoff for depression in males and
females, such that age of menopause was used to determine early life/late life in women.
This approach reflected the biological changes associated with menopause that can
impact risk for depression and allowed for a biologically based, rather than an arbitrary,
age cut off for early and late life depression.
Taken together these results have important implications for both clinicians and
researchers. In particular, acutely stressful life events in both early and life appear to
increase risk for depression in the time following the occurrence of the risk factor. These
associations varied slightly by sex, but in particular the death of a spouse and death of a
child appear to be events that reliably increase risk for developing depression in both
males and females. Among chronically stressful life events, chronic pain conditions and
vascular health both surprisingly displayed an inverse relationship with depression status,
which was contrary to our hypotheses. This might suggest that these conditions are co-
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occurring risk factors, such that the overlap of deleterious functioning associated with
these conditions might mask or create difficulties with assessing these conditions as risk
factors for depression. For example, given the detrimental impact of both chronic pain
and vascular health on behavior and mood, it may have been difficult for subjects and
their health providers to accurately parse apart the behavioral sequalae that are only
associated with depression (Gagliese & Melzack, 2003; Rethelyo et al., 2001). Further,
given the increased mortality rates associated with depression, vascular health conditions
and chronic pain conditions, it is also possible a portion of our sample who experienced
these co-occurring risk factors died prior to assessment at the relative wave where
depression was reassessed. In particular, with follow-ups every three to four years, it is
possible that interim episodes of depression were missed. However, in examining mean
age at death for males and females who remained free of dementia, mean ages for both
were approximately five or more years greater than the mean age of dementia onset
(which was the indicator for end of surveillance of depression; data not shown). Thus,
there was no evidence of earlier mortality at least with respect to the end of surveillance
for depression. Finally, this study also examined risk factors in separate models for males
and females and observed some differences. Given that rates of depression among
females are considerably higher than those in males, our results may underscore the need
for careful attention to sex-based risk factors.

Study Strengths, Limitations and Directions for Future Research
The present study has a number of strengths. First, the CCSMA was a large,
community-based sample that retained 90% enrollment of the base population. Thus,
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generalizability to similar communities is likely to be greater than studies that rely on
samples enrolled at medical centers or at academic universities. Further, the study
followed participants for up to 12 years and benefitted from multiple visits to gather data
and update risk factors. This rich dataset was further augmented with Medicare claims
and death certificate data via linkage to study participant’s records in the Utah Population
Database. This linkage provided greater follow-up of participant data beyond the end of
the study for key variables of depression in late life and vascular health conditions.
Another study strength was the utilization of a bio-psycho-social
conceptualization of risk factors to better empirically examine risk factors for depression
across the lifespan. Our broad inclusion of risk factors that included genetics, physical
health, stressful life events and established covariates allowed for an empirical model that
matches the complex nature of risk factors that impact depression throughout life.
Further, we utilized a novel approach to determining early and late life depression, that
was based on both extant literature (for males) and biological changes (for females),
which allowed for a potentially more meaningful determination of early and late life than
that has been utilized in much of prior research. Finally, our determination of depression
symptoms was comprised of a multi-faceted method, in which we utilized self-report
data, medication data, and examination of Medicare claims records to determine an
accurate diagnosis of depression across the lifespan. This approach offers a more robust
determination of retrospective depression symptomology than other extant literature has
utilized in examining history of depression onset (Bennett & Thomas, 2014; Jeuring et
al., 2018; Ownby et al., 2006).
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Like any study, ours was not without limitations. One key limitation of the
present study is the use of retrospective data to determine onset of depression and health
conditions. This may have been an issue for ascertainment of depression in early life
among males. For example, only 126 (5.8%) men out of 2164 who were included in the
sample reported depression in early life. These low self-reported depression rates may
underscore the negative public stigma against disclosing mental health conditions,
particularly depression, in this age cohort (Conner et al., 2010). Indeed, extant research
has observed low rates of disclosure of mental health conditions and treatment seeking
behavior among older adults of similar birth cohorts, particularly in men (Conner et al.,
2010). Although it is possible, given that males are approximately 63% less likely to be
diagnosed with depression compared to females (Abate, 2013), that the low rate of early
life depression in males accurately represents the population. Indeed, in the absence of
the gold-standard of clinical assessment of depression and health conditions across the
lifespan, these analyses relied on retrospective recall to determine the occurrence of
depression, as well as onset ages for the condition, vascular health conditions, and
chronic pain. Participants were interviewed in late life (over age 65), thus the length of
time of recall also likely impacted our coding of these variables.
Future research may wish to replicate and extend findings from the present study.
In particular, researchers should consider exploring the associations of specific acutely
stressful life events with specific depressive symptoms in early and late life and perhaps
with more specificity with regards to age of onset (i.e., childhood/adolescent depression,
young adult depression, mid-life depression and late life depression). Such an exploration
may contribute to the growing body of research that supports a “network”
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conceptualization of depression, which posits that specific events and conditions are
associated with specific symptoms of depression that lead to the activation of the network
of symptoms clinically defined as Major Depression (Fried et al., 2016; Keller et al.,
2007). Researchers may also seek to replicate and extend the findings of BDNF-related
gene interactions with acutely stressful life events. In particular, given the previously
established work on BDNF gene rs6265 (BDNF Val66Met), further exploration of
interactions of the minor allele of this gene with acutely stressful life events may be
warranted. Finally, clinician-scientists may be interested in exploring differences in
treatment response to various risk profiles of depression. More specifically, clinicianscientists in particular may be interested in better understanding differences in response
to treatment for individuals who report a high number of acutely stressful events vs those
who report a high number of chronic stressors. Such exploration may help individually
tailor intervention skills that are most useful to the patient for building resilience.
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Study 2
Early and Late Life Depression and Vascular Health Conditions as Risk Factors for
Alzheimer’s Disease and Related Dementias

Introduction

Dementia in late life is rapidly becoming a public health crisis as the global
population of older adults continues to increase. According to 2010 estimates, 35.6
million people worldwide suffered from dementia, and this number was expected to
double every two decades (Prince et al., 2013). Further, a large burden is being placed on
caregivers of those with dementia, with an estimated 16 million caregivers providing
approximately 18.5 billion hours of care in the United States (U.S.) alone (Gaugler et al.,
2019). According to the Diagnostic and Statistical Manual of Mental Health Disorders,
5th edition (DSM-5), dementia (or Major Neurocognitive Disorder) is not a single disease,
rather it reflects a constellation of symptoms related to declining cognitive functioning,
such as changes in memory and recall, communication and language deficits, decreased
ability to sustain attention, deterioration in executive functioning and worsening visual
perception (American Psychiatric Association [APA], 2013). The etiology of dementia is
complex, with symptoms developing from a variety of diseases and health conditions
(Nowrangi, et al., 2011; Viswanathan et al., 2009). The most common cause of dementia
in late life stems from Alzheimer’s Disease (AD), which accounts for approximately 6080% of all cases of dementia in the U.S. (Mayeux & Stern, 2012; Reitz et al., 2011),
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affecting over 5.8 million people which now accounts for the 6th leading cause of death
(Gaugler et al., 2019).
A major etiological model posits that the pathological process of AD includes the
accumulation of beta amyloid in the brain which results in the formation of beta amyloid
plaques; these are thought to interfere with interneuronal communication leading to
progressive neuronal damage or death (Braak et al., 2011; National Institutes of Health,
2018; Price et al., 1991). The pathology of the disease preferentially affects brain regions
implicated in cognition, learning and memory, such as the hippocampus, orbitofrontal
cortex and prefrontal cortex (Norwrangi et al., 2011). Additionally, neurofibrillary
tangles have also been observed within neurons, which are thought to further promote
cell death (Braak et al., 2011; Price et al., 1991). The specific cause of AD that initiates
the "amyloid cascade" is unknown.
Researchers studying the etiology of sporadic or late onset (after age 65) AD
increasingly posit a number of contributing factors including a combination of risk
factors, both modifiable and non-modifiable, rather than any single cause. Among nonmodifiable risk factors are biological factors such as age, sex, family history, and genes.
Older age is perhaps the most well-established risk factor (Hebert et al., 2010; Hebert et
al., 2013), with prevalence rates of AD and related dementias (ADRD) rising drastically
with increasing age: affecting 3% of individuals aged 65-74, 17% among those aged 7584, and 32% in those aged 85 or above (Hebert et al., 2010). Biological sex is an
additional factor, with the observation that nearly 3.5 million of the 5.6 million
Americans with ADRD are women (Gaugler, et al., 2019; Hebert et al., 2013). However,
the sex discrepancy in prevalence rates may be confounded by the fact that women live
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longer, on average, than men and older age increases risk for ADRD (Chêne et al.,2015).
Immediate (biological) family history, such as a mother, father, brother or sister with
ADRD, increases one’s risk for ADRD (Green et al., 2002; Loy et al., 2014) and those
with more than one relative show an even greater risk (Lautenschlager et al., 1996).
Recently, elevated risk for AD was found for those with a positive history in extended
family members (Cannon-Albright 2019).
A significant genetic risk factor for AD is the inheritance of the E4 allele of the
apolipoprotein E (APOE) gene (Saunders, et al., 1993). This gene aids in the
transportation of cholesterol in the bloodstream (Zannis et al., 1993). Carriers of one copy
of the E4 allele are at a three-fold risk for developing AD relative to those with the E3
allele and further, those with two copies of the E4 allele are at an 8-to-12-fold risk for
developing AD (Holtzman et al., 2012; Loy et al., 2014; Michaelson, 2014).
Interestingly, this association appears to differ by ethnicity, such that inheriting a copy of
the E4 allele increased risk for AD among individuals of Caucasian or Japanese ethnicity,
but not among those of African American or Hispanic ethnicity (Farrer et al., 1997). This
finding was replicated in a study of 6,158 individuals, in that inheriting an APOE E4
allele was associated with increased odds for AD among white participants but not
African American participants (Evans et al., 2003).
Psychiatric risk factors for ADRD have garnered research attention as well and
show both independent associations and indirect associations (i.e., affecting other
conditions or systems that subsequently increase risk for ADRD). Indeed, extant research
links several conditions, such as anxiety-related disorders (Gallagher et al., 2011) and
post-traumatic stress disorder (PTSD; Burnes & Burnette, 2013) to increasing risk for
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ADRD. Depression has been extensively studied in relation to increasing risk for ADRD
(see reviews, Diniz et al., 2013; Mourao et al., 2016), although the nature of the
relationship is unclear. One review summarized the current body of longitudinal and
cross-sectional research on the relationship between depression and ADRD and found
that three hypotheses were frequently tested: 1) depression is a cause or risk factor for
ADRD 2) depression is an outcome of ADRD and 3) depression is a coincidental finding
in response to ADRD (Bennett & Thomas, 2014).
With respect to the hypothesis of depression being a risk factor for ADRD,
several longitudinal studies have found evidence to support this notion (see reviews:
Bennett & Thomas, 2014; Ownby et al., 2006). One meta-analysis of 20 studies found
that those with a history of depression prior to the onset of dementia symptoms were over
two times more likely to develop ADRD in late life. Further, this study also found a
significant positive association for the interval between the first onset of depression
symptoms and diagnosis of ADRD, such that the greatest odds for developing ADRD
were among those with earliest onset depression symptoms (Ownby et al, 2006). These
results suggest that the timing of depression symptom onset (i.e., in early life or late life)
may also be an important aspect of the relationship between depression and dementia.
Further, findings from another large study found depressive symptoms were associated
with AD up to 25 years before the onset of AD (OR=1.71, 95% CI=1.03-2.82; Green et
al., 2003). Underscoring the relationship between depression onset and ADRD, a study of
503 randomly selected older adults from a longitudinal, population-based sample found
that a history of early onset depression symptoms (i.e., before age 60) was associated
with a 3.76-fold increase in risk for AD and those with late onset depression symptoms
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(i.e., after age 60) showed a 2.34-fold increase in risk (Geerlings et al., 2008). A wealth
of cross-sectional studies also have reported an association between depression and
ADRD (see reviews: Barnes et al., 2012; Baumgart et al., 2015; Bellou et al., 2017;
Bennet & Thomas, 2014; Diniz et al., 2013; Ownby et al., 2006; Tan et al., 2019)
although the specific mechanism through which they are related remains unknown.
Some studies have posited that depression is a prodrome of incipient dementia
(i.e., a detectable symptom of dementia before the emergence of all of the symptoms).
This hypothesis, often referred to as the ‘reverse causality hypothesis’ has proven
difficult to confirm, as many of the symptoms of depression overlap with early signs of
dementia (i.e., difficulties with memory or recall, decline in cognitive functioning, low
mood and affect). To test the reverse causality hypothesis, Bennett & Thomas (2014),
suggest that an onset of depression symptoms within 5 years of AD diagnosis may offer
support for this hypothesis. Studies using this framework to test the reverse causality
hypothesis, have been mixed. For example, one study found support of the hypothesis, in
that those individuals with late life depression within 5 years of dementia onset had an
increased risk for dementia relative to those without a history of depression or with a
history of depression in early life (Li et al., 2011). Another study found similar results, in
that the presence of depression symptoms one year before being diagnosed with AD was
associated with greater risk for AD (OR=4.57, 95% CI=2.87-7.31), compared to those
with depression symptoms that first occurred prior to the one year window of AD
diagnosis (OR=1.38, 95% CI= 1.03-1.85; Green et al., 2003). However, another study
examined the reverse causality hypothesis in a longitudinal sample of 917 older adults
over the course of 13 years and did not find support for the hypothesis (Wilson et al.,
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2008). Specifically, in this study, those who went on to develop AD did not show an
increase in depression symptoms in the years preceding the diagnosis of AD or after AD
diagnosis, compared to their baseline depression symptoms (Wilson et al., 2008).
Given the difficulties associated with symptom overlap and testing the reverse
causality hypothesis, some researchers have posited that depression occurs as a
coincidental consequence of the functional decline associated with dementia and AD
(Bennett & Thomas, 2014). The ‘coincidental outcome’ hypothesis regarding the
relationship between depression and dementia posits that depression occurs in response to
a decline in cognitive abilities. More specifically, when an individual is diagnosed or
becomes aware of significant cognitive decline, they may experience symptoms of
depression as a response to the realization that they may have a progressive and terminal
condition (Bennett & Thomas, 2014). Similar to the reverse causality hypothesis, the
coincidental hypothesis has been difficult to empirically test. This is further compounded
by the overlap in symptoms of dementia and depression, particularly apathy, which is a
key feature of dementia and is also commonly associated with depression (Bennett &
Thomas, 2014; Landes, Sperry & Strauss, 2005).
Notwithstanding the complexities described above, there are theoretical
explanations and empirical findings that support both early and late onset depression as
risk factors for ADRD. In particular, several studies have observed that depression
appears to negatively impact brain structures that are heavily involved in the
pathophysiology of ADRD (Ding et al., 2015; Lee & Kim, 2010; Rapp et al., 2006;
Warner et al., 2006). For example, reduced hippocampal volume was observed in patients
with a history of lifetime depression (Tsopelas et al, 2011) and similar reductions in
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hippocampal volume are associated with dementia of all types (Vijayakumar &
Vijayakumar, 2012), with the greatest reduction in those with AD-dementia (Schuff et al.,
2009; Vijayakumar & Vijayakumar, 2012;). Further, a post-mortem study observed that
certain key pathological signs of AD (i.e., neurofibrillary tangles and neuritic plaques)
were found in significantly higher levels in the hippocampus of those with AD and a
history of lifetime depression compared to those with AD and no depression history
(Rapp et al., 2006). Other brain changes that are considered biomarkers for signs of AD
(i.e., decreased volume, reduced neuron density and impaired cellular health) have been
reported in the orbitofrontal cortex (Cotter et al., 2005) and prefrontal cortex (Cotter et
al., 2002) in those with depression. Further, depression across the lifespan has been
linked to decreased production of neurotrophic factors, such as brain derived
neurotrophic factor (BDNF), a substance which promotes neuronal health, synthesis and
functionality. Higher levels of BDNF have been inversely related to the occurrence of
AD (see reviews: Lee & Kim, 2010; Phillips, 2017; Sen et al., 2008).
Risk factors for early life depression may relate to risk for ADRD through
physiological response to stress that lead to changes in the hippocampus. In early life
onset depression, risk factors include family history of psychiatric illness (Klein et al.,
2001) and psychosocial variables, such as adverse life events (Mandelli et al., 2015) and
low socioeconomic status (Jafee, 2002). Limited research exists examining the direct
pathway from early life stress to risk for AD, however one meta-analysis found that
chronic stress in early life negatively impacted neuroplasticity in the hippocampus and
was associated with increased risk for cognitive impairment and AD in late life (Rothman
& Mattson, 2010). This suggests that risk factors for early life depression may be related
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to ADRD risk through chronic activation of the body's response to stress that results in
detrimental effects to the hippocampus and other brain regions (Aznar & Knudsen, 2011).
Another avenue through which both early and late life onset depression may be
related to increased risk for AD-related dementia is through vascular health (Lewis, 2002;
Treadway et al., 2015). Poor cardiovascular health has been extensively linked to
increased risk for AD (see reviews, Barnes & Yaffe, 2011; Newman et al., 2005; Sparks
et al., 2000; Stampfer, 2006) and may be a potential consequence of depressive
symptomology. Indeed, neuroimaging studies have found that vascular damage is
common among patients with major depression in both early life and late life compared
to healthy controls (Lewis, 2002; Treadway et al., 2015). Further, the microvascular
damage observed in individuals in these studies closely mirrors damage observed in
neurodegenerative diseases, including AD (Kim, et al., 2016; Lewis, 2002; Treadway et
al., 2015;). This might suggest that one sequalae of depression is poor cardiovascular and
cerebrovascular health, which may subsequently increase AD risk. Thus, the timing of
depression onset (i.e., early life or late life) and its chronicity would become important
factors, as earlier onset depression (along with more chronic or recurrent episodes) would
likely result in poorer cardio- and cerebrovascular health over time and subsequently
affect risk for depression (Almeida et al., 2007) as well as ADRD (Barnes & Yaffe,
2011).
To date, no study has examined the direct and indirect relationships between early
onset depression, late onset depression (and their risk factors) and ADRD in a single
sample. The purpose of the present study was to examine these associations and
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determine if they are modified by the presence of vascular risk factors stratified by sex.
The research questions and hypotheses follow.
1. Is a history of early- or late-onset depression (and chronicity) associated with
risk for ADRD?
Hypothesis: I hypothesize that both early- and late-onset depression will be
related to greater risk for ADRD, but that the greatest risk will be for those with
an early-onset of depression.
2. Do vascular risk factors modify the relationship between early- and late-onset
depression and risk for ADRD?
Hypothesis: I hypothesize that vascular risk factors and conditions will moderate
the relationship between both early life onset depression and late life onset
depression and ADRD.
The present study addresses a gap in the literature by furthering the knowledge on
specific risk factors associated with early life and late life onset depression and their
impact on risk for ADRD.

Method

Participants
In the present study, participants were selected from an extant dataset comprised
of a large, population-based cohort of individuals living in semi-rural Utah. This sample
of participants was recruited to participate in the Cache County Study on Memory in
Aging (CCSMA), which examined risk factors related to cognitive decline and ADRD in
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older adults. The CCSMA began collecting data from participants in 1995 and completed
its data collection in 2007. Participants were assessed in four triennial waves during this
12-year period (Breitner et al., 1999). In total, the CCSMA collected data on 5,092
individuals who were over 64 years of age and resided in Cache County, Utah. Data from
these participants was further linked to records in the Utah Population Database (UPDB).
The UPDB includes records for over 11million individuals and is frequently used in
epidemiological and public health research (Norton et al., 2006; Cannon-Albright et al.,
2019). Reportedly, 5,091 of 5,092 (99.99%) participants in the CCSMA were
successfully linked to at least one record in the UPDB. The present study utilized data
from those participants who were successfully linked from the CCSMA to the UPDB
with non-missing data in relevant databases.

Procedure
All study procedures for the CCSMA were approved by the Institutional Review
Boards of Utah State University, Duke University and the Johns Hopkins University. In
1995, a cohort of 5,657 individuals were identified as being eligible for the CCSMA, of
which 5,092 (90%) were enrolled into the study (Breitner et al., 1999). A more detailed
description of all recruitment procedures, methods and participant selection is available
elsewhere (see Breitner et al., 1999). To summarize these procedures briefly, participants
completed a multi-staged screening and assessment protocol in waves 1-4 to determine
the presence or absence of dementia, along with the presence or absence of various risk
factors related to dementia. Each wave began with a cognitive screening process that
involved administration of an adaptation of the modified Mini-Mental State Examination
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(3MS; Tschanz et al., 2002). Those who were unable to complete the 3MS, or scored
below 60, or scored below 15 on the orientation section of the 3MS, or were otherwise
deemed unreliable were referred for a proxy interview. This interview, The Informant
Questionnaire for Cognitive Decline in the Elderly (IQCODE; Jorm and Jacomb, 1989),
is a structured clinical interview for informants/caregivers to assesses the symptoms of
dementia (Jorm & Jacomb, 1989).
Individuals who scored below 87 on the 3MS or above 3.27 on the IQCODE were
administered another informant interview, which utilized the Dementia Questionnaire.
The Dementia Questionnaire targets information regarding specific symptoms of
cognitive impairment, limitations in daily activities, and medical and health conditions.
Following this screening process, participant responses were reviewed by the study
neuropsychologists and geropsychiatrists, who referred those who were rated with
significant cognitive impairment or dementia for a clinical assessment. Additionally,
participants who matched in age, gender and APOE genotype to those with AD
(regardless of screening scores) were selected to constitute a designated subpanel of
participants to also complete the clinical assessment (Breitner et al., 1999).

Data Sources Linked with the UPDB
The UPDB was initially created as a large multigenerational family history
dataset for residents of Utah. Genealogy records, birth certificates, death certificates
census records, drivers license information and hospital records are linked to the UPDB,
resulting in over 16 million records for more than 11 million individuals (see
https://uofuhealth.utah.edu/huntsman/utah-population-database/). Additionally, claims
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data from Medicare, which provides health care coverage for qualifying individuals 65
years of age and over, are linked to the UPDB. The Institutional Review Boards of Utah
State University, the University of Utah and the Utah Resource for Genetic and
Epidemiological Research approved the usage of the UPDB in conjunction with data
from the CCSMA.

Dementia Diagnoses
The clinical procedures used to assess persons for dementia were designed based
on procedures of AD Research Centers at the time (Breitner et al., 1999), and included a
clinical assessment, neuroimaging and laboratory studies, and a physician visit. The
clinical assessment consisted of a nurse interview of health history (with a reliable
informant) and a physical and neurological examination with the participant. The health
history included an assessment of neuropsychiatric symptoms, cognitive status and daily
functional ability of the participant with a knowledgeable informant. A battery of
neuropsychological tests (approximately one hour in duration) was also completed with
the participant. Following completion of the clinical assessment, a geropsychiatrist and
neuropsychologist reviewed the entirety of the data with the assessment team and
assigned preliminary diagnosis of dementia (i.e., vascular dementia, Alzheimer’s
dementia, or other causes of dementia). Those with dementia were invited to complete
neuroimaging and laboratory studies to rule out other causes of cognitive impairment
(Breitner et al., 1999). Those with dementia or its prodrome were invited to complete a
physician exam and a follow-up clinical assessment approximately 18 months after the
initial assessment.
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The final assignment of dementia was determined by an expert panel of clinicians
consisting of geropsychiatrists, neurologists, neuropsychologists, and a cognitive
neuroscientist (Breitner et al., 1999) according to DSM-III-R criteria (American
Psychiatric Association, 1987). Diagnoses of AD, vascular dementia and other forms of
dementia followed standard research criteria at the time. For example, a diagnosis of AD
followed National Institute of Neurological and Communicative Diseases and
Stroke/Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) and
a diagnosis vascular dementia followed National Institute of Neurological Disorders and
Stroke-Association Internationale pour la Recherche et l’Enseignement en
Neurosciences(NINDS-AIREN; Roman et al., 1993). All those who were not diagnosed
with dementia at each wave were followed until they subsequently developed dementia,
refused further participation in the study, or died. Thus, at the end of the CCSMA,
individuals were classified as having dementia, with other cognitive disorders or noncase. Additionally, data from Medicare claims from 1992 – 2012 and death certificates
(through 2014) via linkage with UPDB were further examined for additional sources to
identify development of dementia. For Medicare claims, criteria from Nair and
colleagues (Nair, et al., 2018) were applied, requiring a minimum of two claims with
dementia diagnoses separated by a minimum period of 18 months. The presence of the
following ICD-9 codes were used to designate dementia status in Medicare claims and
death certificate databases: 294.20, 294.21, 291.20, 290.40, 290.41, 290.42, 290.43,
290.12, 290.90, 294.11, 294.10, 331.0, 331.9, 290.10. 331.20, 742.40. In the present
study, we used a binary code for dementia, such that those with any dementia diagnosis
were positively coded as having ADRD. Individuals who were deemed to be dementia
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free at the end of all study waves (i.e., evaluated or screen negative) were coded as a noncase and served as the comparison group. The following numbers of individuals were
classified with dementia from the above sources: 942 (CCSMA), 174 (Medicare claims),
and 238 (death certificates) for a total of 1354 individuals.

Lifetime Depression Status
At each wave, participants in the CCSMA were also assessed for depression
history and current depression symptoms. At baseline and each subsequent wave,
participants completed a depression history screener. The depression screening items
included: “1) In your lifetime, have you ever had a period of two weeks or more when,
nearly every day you felt sad, blue or depressed? 2) In your lifetime, have you ever had a
period of two weeks or more when, nearly every day you lost all interest and pleasure in
things that you usually cared about or enjoyed? 3) In your lifetime, have you ever had a
period of two weeks or more when, nearly every day you felt unusually cross or
irritable?” Those who endorsed at least one key symptom of depression from the screener
were further assessed via the Diagnostic Interview Schedule (DIS; Robins et al., 1981); at
waves 3 and 4 all participants completed the DIS (Steffens et al., 2000). Participants who
endorsed sufficient diagnostic criteria on the DIS (i.e., 5 of 9 possible depression
symptoms) were assigned a diagnosis of major depressive disorder (MDD; American
Psychiatric Association, 1987; Robins et al., 1981; Steffens et al., 2000). Those who did
not meet full criteria for MDD but who reported persistent depressed mood and at least
two other symptoms of depression were assigned a diagnosis of minor depression
(American Psychiatric Association, 1987; Robins et al., 1981; Steffens at el., 2000). The
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DIS has been extensively validated for its diagnostic accuracy, sensitivity and ease of
administration in large research studies (Regier et al., 1984; Robins et al., 1982).
Additional diagnoses of major depression were assigned through examination of
medication history, with the endorsement of an antidepressant for the indication of
depression being considered positive for a diagnosis of MDD or minor depression
(Steffans et al., 2000). Finally, in the absence of data within the CCSMA, Medicare
claims were examined for ICD codes related to depression. The presence of the following
ICD-9 codes were used to designate depression status in Medicare claims and death
certificate databases: 296.20. 296.21, 296.22, 296.23, 296.24, 296.25, 296.26, 296.30,
296.31, 296.32, 296.33, 296.34, 296.35, 296.36, 309.00, 309.10,309.28, 311.00, 300.40.
Those who did not report depression in the CCSMA but did have Medicare codes for
depression were added to the late life depression group.
Early life onset depression and late life onset depression were determined through
self-report of the approximate date that depression symptoms (lasting at least two weeks)
first began, or if lacking the approximate date, the date that anti-depressants were
prescribed or earliest Medicare claim of Major/Minor depression. Early life onset
depression was coded differently based upon sex. More specifically, for women early
onset depression was coded for those who met criteria for MDD, a single major
depressive episode or minor depression prior to their age at menopause. For men, the cut
off age for early life onset depression was determined based upon previous literature,
with those who met criteria for MDD, a single major depressive episode or minor
depression prior to age 60 being coded as Early Life Depression (Baldwin et al., 1995;
Fiske et al., 2009; Zisook et al., 2004;). Late life onset depression was coded as those
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who reported the above conditions but with first onset after menopause age for females
and after age 59 for males.
Data from Medicare claims was used to further ascertain any additional episodes
of depression not otherwise reported in CCSMA (see below). Including depression
diagnoses from Medicare claims, the present study used a multiple level variable for
depression, coded as 1= no reported symptoms of depression, 2=early onset depression
(major or minor) only, 3=Early and Late Life Depression (major or Minor) and 4= Late
Life Depression (major or minor) only.

Vascular Health
Vascular risk factors were assessed during interviews where medical and
medication information regarding risk factors was collected; these were administered at
each wave of the CCSMA. These items assessed the presence or absence of medical
conditions and/or medications related to vascular health: 1) Congestive Heart failure 2)
Diabetes Mellitus 3) Myocardial Infarction 4) Cerebrovascular Accident (e.g., stroke) 5)
Hypertension (high blood pressure) 6) Hypercholesterolemia 7) Atrial Fibrillation 8)
Atherosclerosis 9) Obesity 10) Other Dysrhythmia (see Appendix I). An example item
reads, “Have you ever been told by a doctor that you had hypertension or have you ever
been treated for hypertension?” Data on cardiovascular conditions was also drawn from
Medicare claims data. More specifically, ICD-9 codes for the above conditions were
matched to participants in the CCSMA if endorsed. The specific ICD-9 codes for
vascular conditions included: hypertension (401.1, 401.9), hypercholesterolemia
(272.39), type 2 diabetes mellitus (250, 205.12, 205.02, obesity (278, 278.01),
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myocardial infarction (410.01-410.91; 412), Cerebrovascular accident (stroke; 433.01,
433.11, 433.21, 433.31, 433.81, 434.01, 434.11, 435.8, 435.9), atrial fibrillation (427.31)
and other arrythmias (427, 427.1, 427.2, 427.32, 427.41, 427.42, 427.69, 427.61, 472.81,
427.89), congestive heart failure (428), and atherosclerosis (440.9, 440.8, 437, 440). All
vascular health conditions were coded for date of earliest onset or diagnosis and
compared to date of onset for ADRD. Those who experienced a vascular health condition
prior to age of dementia onset were retained for the present study, those whose age of
vascular condition onset was equal to or after their age of dementia onset were excluded
from analyses.

Covariates
Several established covariates for depression and ADRD were also included in
the present study. These were age at study enrollment, education, which was collapsed
into less than high school education or high school diploma and greater (Bjelland et al.,
2008; Scarmeas et al., 2006), marital status, which was collapsed into married and all
other statuses (Inaba et al., 2005; Steenland et al., 2009) and presence or absence of
APOE E4 allele (Saunders et al., 1993). Each of these covariates were included based on
extant literature that showed associations to depression and ADRD.

Analytic Plan
Inclusion criteria for the present study included: 1) Participant data successfully
linked to the UPDB 2) outcome data of non-case or all-cause dementia diagnosis.
Demographic characteristics of the sample were examined with respect to those with a
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dementia diagnosis compared to non-cases. Differences between groups were examined
using Independent Sample t-tests or Fisher’s Exact tests where appropriate. For
exploratory analyses, bivariate associations of lifetime depression status, ADRD and
covariates were examined using, independent samples t-tests or Fisher’s Exact tests,
correlations and logistic regression where appropriate.
To examine research question 1, which stated “Is a history of early- or late-onset
depression associated with risk for ADRD?” binary logistic regression models were built.
Each regression model was built separately for each sex. In each model, the association
of each covariate with cognitive status (dementia vs non-case) was examined as a main
effect with no other covariate in the model. Covariates that were deemed theoretically
important or that demonstrated a significant association (p=<.05) with cognitive status
(dementia vs. non-case) were retained in the final model. Additionally, interactions
between APOE4 gene status and all covariates were explored. As no interactions were
significant at the bivariate level, these were not included in further analyses. Covariates
in all models included lifetime depression status, age at study enrollment, education,
marital status and APOE 4 gene status, with cognitive status as the binary outcome
variable. The final model included all of the above covariates after completing the
variable selection process described above.
To examine research question 2, which stated “Do vascular risk factors and
conditions modify the relationship between early and late onset depression and risk for
ADRD?” binary logistic regression models were built in which interactions between
lifetime depression status and vascular variables were examined in predicting cognitive
outcomes. Due to the large numbers of vascular variables, a number of strategies were
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used to guide decisions for variable inclusion. First, frequencies, correlations (phi) and
2x2 Fisher’s exact tests between all vascular health conditions were determined and
assessed for multicollinearity between conditions and to guide whether collapsing highly
correlated conditions into a single variable was warranted. There were no conditions that
exceeded a correlation of r=.4, thus each vascular health condition was retained as an
independent condition. Next, the Least Absolute Shrinkage and Selection Operator
(LASSO) regularization procedure was used to quantitatively examine which amongst all
of the predictor variables were the most salient variables associated with the outcome
(cognitive status) to guide variable selection for the binary logistic regression model.
LASSO regression is a regularization technique that utilizes shrinkage to an absolute
value (lambda) that produces the lowest mean squared error possible. Predictors that
survive a penalty are retained to minimize variance and encourage sparse/parsimonious
models (Tibshirani, 1996). Thus, a LASSO regression model (run separately for each
sex) was built with cognitive status as the outcome and predictors including lifetime
depression status, age at study enrollment, APOE E4 status, marital status, education,
each vascular health condition and interaction terms between lifetime depression with
APOE E4 status and lifetime depression with each vascular condition.
Following the LASSO analysis, logistic regression analyses were conducted to
further explore relationships/interactions between lifetime depression status, each
vascular variable and the APOE gene. Each interaction was first examined in a bivariate
logistic regression model (separate models for each sex) which included only the main
effects of lifetime depression and a vascular health condition (e.g., atrial fibrillation),
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with the interaction (lifetime depression x atrial fibrillation) being entered in step 2 of the
model.
Following each of the above steps, variables to be tested in the final logistic
regression model were those that were either retained in the LASSO regression model or
those that were significantly associated with cognitive status in the exploratory logistic
regression analyses described above. Note that covariates of age at study enrollment,
education, and APOE E4 status were retained in the final model regardless of statistical
association with cognitive status as they are theoretically important factors in the
prediction of cognitive status.
Results

Demographics
There were 4214 participants who met eligibility criteria for the present study. Of
those 4214, 1354 were diagnosed with some form of dementia, with the majority (n=787;
58%) of those diagnoses being dementia due to Alzheimer’s Disease (AD). Those with
dementia were more likely to report depression in late life than non- case participants (see
Table 1). Further, those with dementia were more likely to be female and be older at
baseline than non-cases. In the overall sample, the majority of participants were more
likely to be female, white, married, have completed at least a high school education and
be over age 75 (See Table 1). Approximately 26% of the total sample were diagnosed
with dementia at the time of their death or at study completion (see Table 1). Further,
approximately 36% of the sample reported clinically significant depression in their
lifetime, with the highest occurrence being late life depression (See Table 1).
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Table 1
Descriptive Characteristics of the Total Sample.

Variable
All Cause Dementia
Alzheimer’s Disease
Lifetime Depression
Status
No depression
Early Life
Depression
Early Life
Depression and Late
Life Depression
Late Life Depression
Age at study enrollment

Dementia
n= 1354
n (%)/M(SD)

Non-case
n= 2860
n
(%)/M(SD)

787 (15.5%)
879 (65.5%)
88 (6.6%)

1861 (65.2%)
209 (7.3%)

77 (5.7%)

233(8.2%)

299 (22.3%)
77.76 (7.42)

550 (19.3%)
74.41 (6.86)

515 (38.0%)
839 (62.0%)

1256 (43.9%)
1604 (56.1%)

1344 (99.3%)
* (*%)
816 (60.3%)

2839 (99.3%)
18 (.07%)
1964 (68.7%)

Biological Sex
Male
Female
Ethnicity
White
Non-white
Married

χ2(4196) = 12.12,
p=<.01

T(4212) = -14.42,
p=<.001
χ2(4214) = 13.04,
p=<.001
χ2(4214) = 6.05, p=.42

χ2(4211) = 29.43,
p=<.001
High School Education
1087 (80.5%) 2349 (82.2%)
χ2(4206) = 1.83, p=.18
Note. * indicates number suppressed in compliance with Health Care Insurance
Portability and Accountability Act (HIPAA)
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Independent sample t tests and chi square statistics were conducted to examine
sex differences in cognitive status, lifetime depression, age at study enrollment, APOE
E4 gene status, marital status, education and vascular conditions where onset preceded
dementia onset. Males were more likely to be married, report no history of depression,
and have a history of diabetes, myocardial infarction, atrial fibrillation and other
dysrhythmias (See Table 2). However, females were more likely to report a history of
depression, particularly in late life, be older at baseline, have completed high school and
have a history of hypertension and obesity (see Table 2).
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Table 2
Means, Standard Deviations, t-Tests or Chi-Square Statistics of Cognitive Status,
Lifetime Depression, Age at baseline of study enrollment, Education, Marital Status,
APOE E4 status and Vascular Conditions Prior to Dementia, Stratified by Sex.
Males
(n=1771) M
(SD)/n (%)
515 (29.1%)

Sex

Females
(n=2443) M
(SD)/n (%) t-test/Chi-square statistic
839(28.7%) χ2(4214) =13.04, p = <.001
χ2(4196) =181.14, p = <.001

Variable
All Cause Dementia
Lifetime Depression
Status
No depression
1349 (76.5%) 1391 (57.2%)
Early Life Depression
112 (6.35%) 185 (7.6%)
Chronic Depression
76 (4.3%)
234 (9.6%)
Late Life Depression
227 (12.9%) 622 (25.6%)
Age at study enrollment
74.64 (6.87) 76.09 (7.40)
APOE E4 Status
536 (31.0%) 771 (32.2%)
Married
1531 (86.5%) 1249 (51.2%)
High School Education 1395 (78.9%) 2041 (83.7%)
Vascular Health Factors
Congestive Heart
742 (45.3%) 1038 (46.4%)
Failure
Diabetes Mellitus
604 (35.7%) 744 (31.7%)
Myocardial Infarction
627 (36.3%) 549 (23.0%)
Cerebrovascular
390 (23.0%) 593 (25.5%)
Accident
Hypertension
1378 (81.0%) 2019 (87.0%)
Hypercholesterolemia
980 (56.3%) 1310 (55.0%)
Atrial Fibrillation
664 (39.7%) 780 (33.6%)
Atherosclerosis
352 (20.7%) 469 (20.0%)
Obesity
115 (6.5%)
230 (9.5%)
Other dysrhythmia
711 (42.0%) 849 (36.5%)
Note. “-“ indicates statistic was not calculated.

T (4212) = -6.46, p = <.001
χ2(4121) = .67, p = .41
χ2(4211) = 570.85, p = <.001
χ2(4206) = 15.88, p = <.001
χ2(3875) = .50, p = .48
χ2(4036) = 6.92, p = <.01
χ2(4121) = 87.21, p = <.001
χ2(4021) = 3.28, p= .07
χ2(4023) = 26.36, p = <.001
χ2(4122) = .60, p = .44
χ2(3994) = 15.39, p = <.001
χ2(4046) = .33, p = .56
χ2(4187) = 11.81, p = <.001
χ2(4017) = 12.12, p = <.001
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Bivariate Analyses
Among males, correlations between risk factors, covariates and cognitive
outcomes revealed that a cognitive status of dementia was positively associated with
lifetime depression status, age at study enrollment and APOE E4 status, all with small
effect sizes. Cognitive status of dementia was negatively associated with congestive heart
failure, myocardial infarction, hypertension, hypercholesterolemia, atrial fibrillation,
obesity and other dysrhythmia, also with small effect sizes (see Table 3). Among females,
cognitive status of dementia was positively associated only with age at study enrollment
and APOE E4 status, all with small effect sizes. Cognitive status of dementia was
negatively associated with lifetime depression status, married status, high school
education, and all vascular conditions with the exception of cerebrovascular accident,
which displayed no significant association with the other variables (see Table 4). As
expected, many of the vascular health conditions were positively associated with one
another for both males and females. However, none of these associations were larger than
a small-medium effect, suggesting that multicollinearity was not problematically high.

Table 3
Correlations for All Cause Dementia with Lifetime Depression, APOE E4 status, Married, High School Education and Vascular
Risk Factors for Male Sample
Variable
1. Cognitive Status
2. Lifetime Depression Status
3. Age at baseline of study
enrollment
4. APOE4 Gene Status
5. Married
6. High School Education
7. Congestive Heart Failure
8. Diabetes Mellitus
9. Myocardial Infarction
10. Cerebrovascular Accident
11. Hypertension
12. Hyper-cholesterolemia
13. Atrial Fibrillation
14. Atherosclerosis
15. Obesity
16. Other dysrhythmia
Note. p = <.05 are in boldface..

1

.08
.18
.17
-.02
-.00
-.18
-.05
-.07
-.01
-.06
-.11
-.12
-.04
-.09
-.11

2

3

-.08

-

-.01
-.05
-.02
-.06
.05
.05
.06
.07
.07
.01
.08
.08
.04

-.06
-.27
-.17
.12
-.12
.00
.01
-.16
-.37
.02
-.05
-.14
-.01

4

5

6

7

8

9

10

11

12

13

14

15

16

.01
.04
-.05
-06
-.02
-.04
-.01
.03
-.05
-.01
-.04
.03

.07
-.02
.05
.02
.02
.07
.20
.01
.04
-.01
.07

-.07
.03
-.01
.02
.05
.12
.01
.02
.02
.04

.18
.33
.11
.20
.07
.38
.14
.14
.28

.12
.06
.22
.19
.07
.09
.16
.08

.10
.14
.20
.21
.11
.05
.26

.13
.07
.13
.13
.00
.09

.27
.18
.13
.10
.16

.11
.15
.09
.18

.12
.05
.33

.04
.12

.06

-
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Table 4
Correlations, for All Cause Dementia with Lifetime Depression, APOE E4 status, Married, High School Education,
and Vascular Risk Factors for Female Sample
Variable
.4
2
3
4
5
6
1. Cognitive Status
-.04
2. Lifetime Depression
Status
.23 -.13
3. Age at baseline of study
enrollment
.20 -.03 -.05
4. APOE E4 Status
-.09
-.02
-.44
.04
5. Married
-.04 .02 -.23 .03 .12
6. High School Education
-.14
.04
.12
-.08
-.08
-.12
7. Congestive Heart Failure
-.10 .04 -.14 -.07 .06 -.02
8. Diabetes Mellitus
-.14 .05 -.01 -.03 -.01 -.05
9. Myocardial Infarction
-.02 .03 .02 -.05 -.03 -.01
10. Cerebrovascular
Accident
-.08 .08 -.10 -.04 .03 -.02
11. Hypertension
-.17 .11 -.43 .03 .22 .12
12. Hypercholesterolemia
-.17 .01 .03 -.05 -.03 -.01
13. Atrial Fibrillation
-.06 .06 -.11 -.02 .05 .01
14. Atherosclerosis
-.08 .10 -.21 -.05 .09 .02
15. Obesity
-.11 .05 -.08 -.02 .07 .03
16. Other dysrhythmia
Note. p = <.05 are in boldface..

7

8

9

10

.18
.26
.15

.15
.09

.13

-

.21
.03
.42
.14
.10
.27

.16
.18
.13
.14
.18
.11

.15
.14
.19
.12
.05
.21

.15
.07
.14
.16
-.00
.14

11

12

13

14

15

16

.21
.15
.11
.08
.19

.06
.16
.12
.17

.11
.06
.37

.0
.15

.04

-
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Bivariate relationships between cognitive status and all study variables were
further examined using binary logistic regression. Among males, lifetime depression
status, age at study enrollment, APOE E4 gene status, and vascular health conditions with
the exception of cerebrovascular accident, hypertension and atherosclerosis displayed a
significant relationship with cognitive status (see Table 5). Among females, lifetime
depression status, age at study enrollment, APOE E4 status, marital status, high school
education, and vascular conditions with the exception of cerebrovascular accident
displayed a significant relationship with all cause dementia (see Table 5).

Table 5
Bivariate Odds Ratios (OR) and Confidence Intervals (CI) for Lifetime Depression, Age, Marital Status,
Education, APOE E4 Status and Vascular Health Conditions on Cognitive Status in Male and Female
Models.
Variable

Nagelkerke R2

Male Sample
OR, 95% CI

Nagelkerke R2

.75 (.54-1.05)
.56 (.41-.77)
.87 (.71-1.06)
1.07 (1.06-1.08)
2.40 (2.01-2.87)
.68 (.58-.81)
.89 (.80-.99)
.54 (.44-.65)
.61 (.50-.74)
.47 (.37-.58)
.91 (.74-1.11)
.47 (.40-.56)
.47 (.40-.56)
.42 (.34-.52)
.71 (.57-.89)
.53 (.38-.73)
.62 (.51-.74)
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Lifetime Depression Status
.01
.01
Early Life Depression
1.06 (.69-1.62)
Chronic Depression
.95 (.56-1.60)
Late Life Depression
1.77 (1.32-2.37)
Age at study enrollment
.04
1.06 (1.04-1.07)
.07
APOE E4 Status
.04
2.19 (1.76-2.72)
.05
Married
<.01
.86 (.64-1.16)
.01
High School Education
<.01
.99 (.88-1.13)
<.01
Vascular Health Factors
Congestive Heart Failure
.05
.41 (.32-.52)
.03
Diabetes Mellitus
<.01
.77 (.61-.98)
.02
Myocardial Infarction
<.01
.71 (.57-.89)
.03
Cerebrovascular
<.01
.97 (.75-1.25)
<.01
Accident
Hypertension
<.01
.73 (.56-.95)
.04
Hypercholesterolemia
.02
.62 (.50-.77)
.04
Atrial Fibrillation
.02
.54 (.43-.69)
.04
Atherosclerosis
<.01
.80 (.60-1.05)
<.01
Obesity
.01
.35 (.20-.61)
.01
Other dysrhythmia
.02
.60 (.48-.76)
.02
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in boldface.

Female Sample
OR, 95% CI
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Research Question 1: Are Early Life Depression and Late Life Depression associated
with increased risk for Dementia?
Among males, the overall binary logistic regression of cognitive status regressed
on lifetime depression status, age at study enrollment, APOE4 E4 status, marital status
and high school education was significant (χ2[7]=130.99, p=<.001; see Table 6). The
main effect of lifetime depression status remained significant after adding all covariates
into the model, such that those with late life depression were at 1.98 increased odds to
also be diagnosed with all-cause dementia (See Table 6). Two covariates, age at study
enrollment and APOE E4 status were also significant in the model after all other
covariates were entered into the model. More specifically, those who were older at
baseline were 7% more likely to be diagnosed with dementia and those with at least one
copy of the APOE E4 allele were 2.4 times more likely to be diagnosed with all cause
dementia (See Table 6).
Among females, the overall binary logistic regression of cognitive status
regressed on lifetime depression status, study enrollment, APOE E4 status, marital status
and high school education was significant (χ2[7]=246.02, p=<.001; see Table 6). The
main effect of lifetime depression status trended towards significance (p=.06) after
adding all covariates into the model, with those who reported early and late life
depression being less likely to also be diagnosed with all cause dementia (see Table 6).
Two covariates, age at study enrollment and APOE E4 status were also significant in the
model after the inclusion of all other covariates into the model. More specifically, those
who were older at baseline were 8% more likely to also be diagnosed with dementia and
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those with at least one copy of the APOE E4 allele were at 2.68 increased odds to be
diagnosed with dementia (See Table 6).
Table 6
Odds Ratios (OR) and Confidence Intervals (CI) of Lifetime Depression Status, Age
at baseline of study enrollment, APOE E4 Gene Status, Marital Status and
Education for Cognitive Status in Male and Female Samples
Male Sample (n=1717) Female Sample (n=2375)
Variable
OR, 95% CI
OR, 95% CI
Lifetime Depression Status
p=<.001
p=.06
Early Life Depression
1.23 (.79-1.92)
.87 (.61-1.23)
Chronic Depression
1.17 (.68-2.03)
.65 (.47-.91)
Late Life Depression
1.98 (1.45-2.70)
1.04 (.84-1.29)
Age at study enrollment
1.07 (1.05-1.09)
1.08 (1.06-1.09)
APOE4 Status
2.42 (1.93-3.03)
2.68 (2.22-3.23)
Married
1.24 (.89-1.72)
1.05 (.86-1.28)
High School Education
1.18 (.90-1.55)
1.08 (.84-1.38)
2
Nagelkerke R
.11
.14
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in boldface.

Research Question 2: Do Vascular Risk Factors Modify the Relationship between
Lifetime Depression Status and All Cause Dementia?
Exploratory bivariate binary logistic regression analyses were conducted to
examine any interaction effects between lifetime depression status and each vascular
health condition on cognitive status. Interaction terms were computed by taking the
product of lifetime depression and a vascular health condition (e.g., Congestive Heart
Failure). A hierarchical stepwise procedure was used to enter the main effects of lifetime
depression and a vascular health condition in step 1. In step 2 the interaction was entered.
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For males, there were no significant interactions between lifetime depression and any of
the vascular health conditions included in the present analyses. Similar results were
obtained for females, except for two interactions that trended towards significance: the
interaction of lifetime depression by hypercholesterolemia and the interaction of lifetime
depression by obesity. More specifically, those who had late life depression and
hypercholesterolemia displayed 69% greater odds of also having a diagnosis of dementia.
Further, those with a history of late life depression and obesity displayed approximately
1.32 greater odds of also having a diagnosis of dementia. Taken together there were no
significant interactions between lifetime depression and vascular variables for men,
however two interactions trended towards significance in the female sample and thus may
be important to consider in the final model.
LASSO Regularized Regression analysis was utilized to better understand the
most important predictors in the context of the most parsimonious model and to avoid
overfitting to the data. In both male and female samples, the LASSO regression included
cognitive status as the outcome variable with lifetime depression status, age at study
enrollment, APOE4 gene status, marital status, high school education, vascular health
conditions and the interactions of lifetime depression with APOE E4 status as well as
lifetime depression with each vascular health condition (e.g., lifetime depression x
congestive heart failure, etc.). A conventional 10-fold cross-validation level was used for
the LASSO analysis, with the first cross validation serving to optimize the regularization
parameters and the second evaluating predictive performance of the variables within the
optimal model. In both the male and female models a λ=.02 was selected as a
regularization parameter. In the male sample, LASSO regression revealed an optimal
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model that included only one predictor: the interaction of lifetime depression and
congestive heart failure with a penalty of .38. The optimal model was also selected as the
most parsimonious model, accounting for approximately 3% of the variance in predicting
the outcome (Adjusted R2; See Table 7). In the selected model the interaction of lifetime
depression by congestive heart failure was not a significant predictor (see Table 7).
For females, LASSO regression revealed an optimal model that included age at
study enrollment, the interaction of lifetime depression by congestive heart failure, the
interaction of lifetime depression by APOE E4 status and the interaction of lifetime
depression by atrial fibrillation. The optimal model was selected as the most
parsimonious model and accounted for 5% of the total variance associated with
predicting the outcome (See Table 7). In the selected model only the interaction of
lifetime depression by APOE E4 status and the interaction of lifetime depression by atrial
fibrillation were significantly associated with the outcome.
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Table 7
LASSO Regression Optimal Models; Lambda Penalty, Prediction Error, Adjusted R2
and Standardized Coefficients for Retained Variables
Penalty

Prediction
Error
.88

Adjusted
R2
.03

Beta,
(df), p value

Optimal Model for Male
.38
Sample
Lifetime Depression x
.01 (7), p=.99
Congestive Heart Failure
Optimal Model for Female
.22
.98
.05
Sample
Age at baseline of study
-.02 (1), p=.23
enrollment
Lifetime Depression x
<.01 (7),p =1.0
Congestive Heart Failure
Lifetime Depression x APOE
.05 (7),
E4
p=<.001
Lifetime Depression x Atrial
.05 (7),
Fibrillation
p=<.001
Nagelkerke R2
.11
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in boldface.
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The final binary logistic regression models to examine research question 2 were
determined through examination of theory, bivariate associations and LASSO regression
results. More specifically, in both the male and female models theoretical considerations,
dictated the inclusion of lifetime depression status and at least some vascular health
conditions as they were central to the research aims. Additionally, inclusion of APOE E4
status, age at study enrollment and educational status were warranted as established
predictors of dementia in the extant literature (Saunders et al., 1993; Bjelland et al.,
2006). After examining bivariate logistic regression analyses and correlations, marital
status was excluded from final analyses due to lack of theoretical importance and
association with cognitive status. The LASSO regularization was not used in the final
model due to restrictiveness of theoretically important variables. Among males, the final
model included 1465 participants with cognitive status as the binary outcome variable
being regressed onto lifetime depression status, age at study enrollment, APOE E4 status,
high school education, congestive heart failure, myocardial infarction,
hypercholesterolemia, atrial fibrillation, obesity and other-dysrhythmia (See Table 8).
Three vascular health conditions, diabetes, cerebrovascular accident and atherosclerosis,
as well as all interaction terms, were excluded from the final model due to non-significant
bivariate associations and elimination in the LASSO regression model.
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Table 8
Odds Ratios and Confidence Intervals (CI) of Lifetime Depression Status,
age at study enrollment, APOE4 Gene, Education and Vascular Conditions
with Cognitive Status in the Male and Female Sample
Variable
Male Model
Female Model
b, 95% CI
b, 95% CI
Lifetime Depression Status P=<.001
P=<.01
Early Life Depression
1.51 (.86-2.65)
.70 (.43-1.14)
Chronic Depression
.71 (.29-1.72)
.44 (.27-.74)
Late Life Depression
2.68 (1.81-3.95)
1.06 (.81-1.41)
Age at study enrollment
1.06 (1.03-1.08)
1.06 (1.04-1.08)
APOE E4 Gene Status
2.37 (1.75-3.19)
2.41 (1.89-3.08)
High School Education
1.30 (.89-1.90)
.97 (.70-1.34)
Congestive Heart Failure
.43 (.30-.62)
.68 (.51-.90)
Diabetes
<>
.98 (.75-1.29)
Myocardial Infarction
.93 (.66-1.31)
.64 (.46-.87)
Cerebrovascular Accident
<>
<>
Hypercholesterolemia
.79 (.57-1.08)
.94 (.72-1.23)
Atrial Fibrillation
.74 (.52-1.04)
.52 (.38-.71)
Atherosclerosis
<>
1.30 (.97-1.74)
Obesity
.56 (.26-1.21)
1.12 (.73-1.72)
Other Dysrhythmia
.81 (.58-1.13)
1.13 (.86-1.48)
2
R
.15
.13
Note: OR=Odds Ratio CI = 95% confidence interval; OR’s and CI’s with p
= <.05 are in boldface. < >: Indicates variable was not included in analysis
due to lack of significance.
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For males, the overall binary logistic regression model was significant
(χ2[13]=135.04, R2=.15; p=<.001; See Table 8) and several main effects were observed.
Lifetime depression status was associated with increased odds of dementia, with those
who reported late life depression being approximately 2.68 times more likely to also
report dementia (see Table 8). Further, age at study enrollment and APOE E4 status were
associated with increased odds of dementia, such that those with higher ages were 6%
more likely to also be diagnosed with dementia and those with at least one copy of APOE
E4 were 2.37 times more likely to be diagnosed with dementia (See Table 8). Of the
vascular health conditions included in the final model, only congestive heart failure
demonstrated a significant relationship with cognitive status, after accounting for the
other covariates. In particular, those with congestive heart failure were 57% less likely to
also be diagnosed with all cause dementia. No other vascular health conditions
demonstrated a significant relationship with dementia, although atrial fibrillation and
hypercholesterolemia trended towards significance displaying a negative association with
cognitive status (see Table 8.)
The final binary logistic regression model for females included 1939 participants
with cognitive status as the binary outcome variable. Predictors in the female model
included lifetime depression status, age at study enrollment, APOE E4 status, high school
education, congestive heart failure, diabetes mellitus, myocardial infarction,
hypocholesterolemia, atrial fibrillation, atherosclerosis, obesity and other dysrhythmias
(See Table 8). Marital status and cerebrovascular accident were excluded from the final
model due non-significant bivariate associations and elimination from the LASSO
regression analysis. Although the interactions of lifetime depression x APOE E4 and
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lifetime depression x atrial fibrillation were retained and significant in the LASSO
analysis, they were excluded due to a lack of bivariate association and poor model fit
when included in the model with other covariates.
For females, the overall binary logistic regression model was significant
(χ2[8]=20.32, R2=.13; p=<.001; See Table 8) and several main effects were observed.
Lifetime depression status was significantly associated with cognitive status, with those
who reported early and late life depression displaying significantly reduced odds of also
having dementia (see Table 8). Further, age at study enrollment and APOE E4 gene were
associated with increased odds of dementia, such that those with higher ages were 6%
more likely to also be diagnosed with dementia and those with at least one copy of APOE
E4 allele were 2.41 times more likely to be diagnosed with dementia (see Table 8). Of the
vascular health conditions included in the final model, congestive heart failure,
cerebrovascular accident and atrial fibrillation were each negatively associated with
dementia (see Table 8).

Discussion

The goal of the present study was to examine if the onset of depression in early
life, late life or a chronic presentation (both early and late), increased risk for dementia.
In our study, we also sought to examine if vascular health conditions modified the
relationship between depression and dementia. The present study utilized a populationbased sample of 4214 older individuals who participated in the Cache County Study on
Memory in Aging (CCSMA) and also augmented data by inclusion of Medicare claims
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data to empirically test these hypotheses. Rates of lifetime depression and dementia in
our sample were comparable to the prevalence rates in the United States (Djernes, 2006;
Gatz et al., 1993; National Institute of Mental Health [NIMH], 2018; World Health
Organization [WHO], 2017). Findings from the present study indicated that lifetime
depression status was associated with increased odds of dementia in males, particularly
for those with late life onset depression. Conversely, in females depression was a less
robust predictor and in fact only displayed an inverse relationship with dementia, such
that those with chronic depression (early and late life) were less likely to later be
diagnosed with dementia. It is possible that these results were influenced by our use of
self-report data in the determination of depression in older adults. More specifically,
older generations experience greater stigma for disclosing mental health conditions, and
are significantly less likely to seek treatment relative to younger generations, particularly
among older men (Conner et al ., 2010). Thus, our data may have only captured a subset
of the total sample who experienced depression symptoms, which may have contributed
to the low rates of depression in males and may serve to explain the lack of consistent
association between depression and dementia across sex.
Further, vascular health conditions did not modify the relationship between
depression and dementia in either the male or female samples and relatively few
conditions overall showed robust associations with dementia after accounting for other
established risk factors. These findings have several important implications for clinicians
assessing depression and dementia as well as future research investigating depression and
dementia. In particular, our results underscore the importance of open discussion of
mental health symptoms with older adults, particularly in normalizing the experience of
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depression and encouraging treatment for depression. Given that depression is largely
treatable (APA, 2013), such discussions may serve to increase treatment seeking
behaviors among older adults that could result in decreasing risk for dementia.
Extant literature has established an association between depression and dementia,
however few studies have thoroughly examined the onset age of depression and its
relationship with dementia (Manepalli et al., 2011). Indeed, the few studies that have
specified the onset age of depression in relation to dementia diagnosis have examined
either only early life onset depression or late life onset depression (Hegeman et al., 2012;
Manepalli et al., 2011). The present study utilized multiple sources of data to identify the
earliest onset of depression for participants in the sample. We determined the cutoff ages
for early and late life based upon biological factors (i.e., menopause) in the female
sample and extant literature (i.e., age 60) in the male sample. To our knowledge, this is
the first study to utilize this approach for defining onset ages in depression.
Our results confirm previous work that observed a relationship between late life
depression and dementia diagnosis in males (see review, Mourao et al., 2016;) and
underscore the need to examine males and females separately with regard to risk for
dementia as their onset and type of risk factors differed. Indeed, even after accounting for
established covariates associated with dementia and depression, males who reported late
life depression were at over a 1.5-fold risk for also having a dementia diagnosis. These
findings are consistent with previous work that found associations between depression in
late life and a cognitive status of dementia (Lewis, 2002; Treadway et al., 2015).
Inconsistent with previous findings, we did not observe any significant interactions
between vascular health conditions and late life depression. It is possible that these
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findings may be partially due to limitations associated with the measurement of vascular
health conditions in the present study. More specifically, the present study relied heavily
on self-report data and data from Medicare claims to determine the presence and onset
age of a vascular health condition, which is likely less reliable than medical assessment
and diagnosis. Further, early onset depression was not associated with a dementia
diagnosis in males, which might suggest that depression onset in late life is a more
problematic risk factor for males.
Older adults are frequently underassessed for mental health conditions, in
particular depression (Avasthi & Grover, 2018). Further, older adults tend to less
frequently seek treatment for mental health conditions than younger adults, which can
result in more severe symptoms and a chronic course of condition (Avasthi & Grover,
2018; Geerlings et al., 2008). Our findings underscore the importance of frequent and
accurate assessment of depression symptoms for males in late life and may suggest that
those who experience depression in late life should further be assessed for other warning
signs of dementia. Interestingly and in contrast to other extant literature, late life onset
depression was not associated with dementia diagnosis in females.
In the present study depression was only marginally significant in the female sample
and the direction of the association was the reverse of what was hypothesized. Indeed,
among females only those who reported chronic depression had a significant association
with dementia, with our results revealing that females with chronic depression showed
reduced odds of having dementia diagnosis. These findings may suggest a resilience
effect, such that those who have struggled with depression throughout their life may have
developed coping skills to survive and function that reduce their risk for dementia (Angst
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et al., 2002; Bonanno et al., 2002; Southwick et al., 2005). Although this study did not
evaluate treatments for depression and their associations with cognitive status, extant
research has linked the use of selective serotonin reuptake inhibitors (SSRI)
antidepressants for the treatment of depression to reduced odds of developing dementia
(Bartels et al., 2018; Kessing et al., 2009). Further, some extant research has observed
that consistent use of antidepressants for the treatment of depression increases the
production of Brain Derived Neurotrophic Factor (BDNF) and may have epigenetic
effects on BDNF genotypes (Baj et al., 2012). Thus, those participants in our sample who
were regularly taking antidepressants may have higher levels of BDNF production than
those not on medication. Given the higher rates of depression among females and the
frequent use of prescription medications to treat depression (Steffens et al., 2000), it is
possible that those with a more chronic course of depression were regularly taking
medication that reduced their odds of developing dementia (Bartels et al., 2018; Kessing
et al., 2009). However, other studies have observed that use of anti-depressants are
associated with increased odds of dementia (See review, Chan et al., 2019), thus further
research is likely needed to clarify this issue.
Also contrary to our hypotheses, vascular health factors did not modify the
relationship between depression and dementia and were less robustly associated with
dementia diagnoses than expected. Indeed, there were no significant interaction effects of
depression by vascular health conditions for either males or females. Even after removing
vascular health conditions that were not associated with dementia at the bivariate level,
only congestive heart failure was significantly associated with dementia for both males
and females; among females, myocardial infarction and atrial fibrillation were also
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associated with dementia. However, the direction of these relationships was also
unexpected, in that congestive heart failure in males and females was associated with a
57% and 32% reduced odds of dementia, respectively. Further, among females,
myocardial infarction and atrial fibrillation were associated with 36% and 48% reduced
odds of dementia, respectively.
These findings offer support for the hypothesis that there are sex differences present
in the onset of depression as a risk factor for dementia. In the present study late life
depression increased the odds of having a dementia diagnosis for males, with no
significant associations observed between early life onset or a chronic presentation of
depression, which was contrary to hypotheses. In contrast, late life depression was not
associated with dementia in females and in fact only chronic depression showed a
significant relationship with dementia onset, though in the opposite direction
hypothesized. One possible explanation for these findings is a gender difference in
coping mechanisms for depression that may serve to increase resilience to dementia.
Indeed, one longitudinal study of 561 men and 1321 women who were diagnosed with
depression found that men often coped with depression via increased alcohol
consumption, which can increase risk for dementia (see review, Xu et al., 2017), whereas
women tended to cope via emotional processing and religious activities that can promote
resilience against dementia (Angst et al., 2002; Meléndez et al., 2018;).
Taken together, the results of this study may lend support to the hypothesis that
depression, particularly late life onset depression, is a risk factor for dementia that should
be carefully assessed in men. Given the limitations of the present study in accurately
assessing the presence and onset of vascular conditions, further research is needed to
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better understand the role of cardiovascular conditions in conjunction with late life
depression and dementia in men. Among females, it is possible that other factors
associated with treatment of depression and resiliency impacted the association with
dementia. As prior literature has clearly documented a relationship that confers risk from
depression to dementia in both males and females these results should be interpreted with
caution and further explored to better understand the reduced risk for dementia among
those with chronic depression. Finally, the present study examined only all-cause
dementia; as such it is possible that these associations may vary by type of dementia (i.e.,
Alzheimer’s Disease vs vascular dementia) and may shed light on the direction of the
relationships observed.

Study Strengths, Limitations and Future Research Directions
The present study had a number of strengths. First, the CCSMA was a large,
community-based sample that retained 90% enrollment of the base population. Thus,
generalizability to similar communities is likely to be greater than studies that rely on
samples enrolled at medical centers or at academic universities. Further, the study
followed participants for up to 12 years and benefited from multiple visits to gather data
and update risk factors. This rich dataset was further augmented with Medicare claims
and death certificate data via linkage to study participants’ records in the Utah Population
Database. This linkage provided increased follow-up participants beyond the end of the
study for key variables of dementia, depression in late life, vascular health conditions and
death.
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Limitations of the present study included a reliance upon self-report data and
Medicare claims data to determine the age of onset for key study variables, depression
and vascular health conditions most notably. As retrospective self-report data can be
unreliable as more time passes, it is possible that determining ages of onset for these
variables was negatively impacted by inaccurate recall. In our study, we observed
relatively few males and females who reported early life depression and chronic
depression when compared to late life depression, which may have limited the statistical
power needed to understand the complex relationships that were hypothesized. Further,
given the limited available data on vascular health conditions in early life our analysis
was limited to examining the impact of cardiovascular health conditions with late life
onset, rather than across the lifespan and in conjunction with early life depression. As the
behavioral sequelae of depression have shown robust associations with worse vascular
health in extant research (Kim et al., 2016; Lewis, 2002; Treadway et al., 2015) this
limitation is notable for the present study. Another limitation of the present study is a lack
of generalizability to more ethnically diverse samples, as our sample was over 97%
White.
Future research might consider examining lifetime depression status with other
underlying dementia types, such as Alzheimer’s disease or vascular dementia. Utilizing
study methods that allow for clinical diagnosis of depression and vascular health
conditions across the lifespan would yield more precise incident diagnoses particularly
regarding mental health and cardiovascular, vascular conditions at younger ages, rather
than relying upon retrospective self-report data. Finally, researchers may also be
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interested in better understanding treatment of depression and any potential underlying
mechanisms as a potential protective factor for dementia, particularly among females.
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FINAL CONCLUSIONS

Depression and dementia are two conditions that result in significant functional
impairment, which are both widespread in the global population, affecting millions of
people worldwide (WHO, 2017). With the aging of large birth cohorts and medical
advancements that prolong life, the number of people affected by dementia globally is
likely to rise significantly in the coming years (Prince et al., 2013), highlighting the
importance of a comprehensive understanding of risk factors related to dementia onset.
The present study sought to examine multi-faceted risk factors related to the onset of
depression in early and late life, and further to understand depression onset as a risk
factor for dementia. The findings from this study offer support for examining multiple
bio-psycho-social risk factors in conjunction with depression onset throughout the
lifespan. Further, our results indicate that late life depression is a risk factor for dementia,
particularly for males. These results have several important implications for clinicians
and researchers. In particular, our results highlight the importance of discussing and
normalizing depression symptoms with older adults, particularly as a means of
counteracting negative stigma for disclosing and seeking treatment of depression in this
age group. Early intervention for depression symptoms is critical for this population, as
depression is largely treatable and may result in increased quality of life and subsequently
decrease risk for dementia.
Extant research has established that there are high prevalence rates of depression
in early life and late life (Djernes, 2006; Gatz et al., 1993; National Institute on Aging,
2007; National Institute of Mental Health [NIMH], 2018). This bimodal prevalence of
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depression may suggest that vulnerability to depression changes at different points
throughout the lifespan and thus that specific events and circumstances in early and late
life increase risk for depression (Baldwin & Tomenson, 1995). The present study sought
to elucidate these risk factors for early life, late life and chronic depression. We found
that certain life events, such as death of a spouse, death of a child, were reliably
associated with depression in both early and late life, which was consistent with extant
literature (Mandelli et al., 2015; Sasson & Umberson, 2014). We also observed that
corticosteroid use was associated with alterations in risk for females, but not males, and
that the direction of this relationship varied for early life onset, late life onset and chronic
onset, which was a novel finding relative to previous work on corticosteroids and
depression (McCAllister-Williams, 1998). Further, chronic pain conditions in late life
and number of vascular health conditions in late life were associated with reduced odds
of depression in our model, which was unexpected and somewhat consistent with the
mixed findings observed in extant literature (Gagliese & Melzack 2003; Sheline et al.,
2010; Taylor et al., 2013). Indeed, it is possible that the unexpected direction of these
relationships in our study may be due to data reflecting the co-occurrence of problematic
conditions (i.e., depression and chronic pain), rather than chronic pain being a risk factor
that leads to depression in late life. Our study also revealed novel findings regarding the
impact of genes BDNF genotypes in the presence of acute life stressors, which suggests
that the presence of a minor allele of certain genes associated with BDNF signaling may
act as a vulnerability factor for depression after the occurrence of specific stressful life
events. Finally, our study findings underscored the importance of examining multiple
classes of risk factors for depression across biological sex, as we observed several
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differences in the associations of acutely stressful and chronic life stressors with
depression onset over the lifespan.
Extant research has linked dementia and depression in several longitudinal
studies, such that a history of depression is often associated with increased risk for
dementia (see review: Bennett & Thomas, 2014; Geerlings et al., 2008). Typically, three
hypotheses have emerged from the extant literature: 1) Depression is an independent risk
factor for ADRD, 2) Depression is a prodromal feature of ADRD and 3) Depression is a
coincidental finding resulting from the loss of functioning associated with ADRD
(Bennett & Thomas, 2014). Our findings from the present study are consistent with the
majority of research featuring longitudinal samples, which support depression as an
independent risk factor for ADRD (Blazer, 2003; Ownby et al., 2006; Wilson et al.,
2008). Indeed, we found evidence that depression, particularly in late life, was associated
with increased odds of dementia in males, but not females, possibly revealing a sex
difference in resilience or co-occurrence of conditions. Biological explanations of
depression being a risk factor for dementia onset have posited that there are biological
changes that occur in key brain structures following a depressive episode that may confer
risk for dementia (Ding et al., 2015; Lee & Kim, 2010; Rapp et al., 2006; Warner et al.,
2006). Specifically, several studies have found evidence of reduced neuronal health and
functioning, as well as reduced hippocampal volumes in individuals following a
depressive episode (Lee & Kim, 2010; Warner et al., 2006), which are also key markers
for dementia onset (Vijayakumar & Vijayakumar, 2012; Schuff et al., 2009).
Taken together, this study utilized a robust and rich dataset comprised of multiple
data sources (CCSMA and UPDB) of older adults to retrospectively examine risk factors
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related to depression onset and subsequent risk for dementia in late life. The findings of
this study highlight the complex nature and relationships of risk factors for depression
across the lifespan. We examined broad classes of risk factors: acutely stressful life
events, chronic life stressors and BDNF-related genes and genotypes and discovered
unique pathways in which risk for depression is increased, with differences observed for
males and females. Subsequently, we also added to the literature that supports depression
in late life as an independent risk factor for dementia, particularly in males. These results
underscore the importance of accurate assessment and effective treatment of depression
throughout the lifespan, but in particular in late life, which may alter the trajectory of risk
for dementia onset.
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Appendix A. Medical History Questionnaire

MEDICAL HISTORY
Now I’m going to ask you some specific
questions about your medical history,
your medications and some other related
things.

D5.

D6.

Has a doctor or nurse told
you that you have
Parkinson’s Disease?

YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........1

Have you taken L-DOPA
or Sinemet?

YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........1

NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........2

NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........2
D7.

D8.
D9.

Has a doctor or nurse told
you that you had a stroke?

YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 1 NO (GO TO D11) . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . 2 RF (GO TO D11) . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . 7 DK (GO TO
D11) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

How many strokes have
you had in that interval?

NUMBER OF STROKES . . . . . . . . . . . . . . . . .
.....

When did the (last) stroke
take place?
a.

b.

Did one side of
your body, or one
arm or leg, become
weaker than the
other?
Did you lose the
ability to speak or
understand what was

MM

YY

YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........2
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........2

said to you, for a day
or more?
c. Did you see a doctor or go SAW DOCTOR (RECORD) . . . . . . . . . . . . . . .
to a hospital?
. . . . . . . . 1 WENT TO HOSPITAL (RECORD)
. . . . . . . . . . . . . . . . . 2 NO DOCTOR OR
HOSPITAL . . . . . . . . . . . . . . . . . . . . . 3 RF . . .
.......................................
. . 7 DK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
...........8

Have you had a TIA, ministroke, or funny spell
suggestive of a stroke?

YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . 1 NO (GO TO D12) . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . 2 RF (GO TO
D12) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
.7
DK (GO TO D12) . . . . . . . . . . . . . . . . . . . .
...........8

a. When did this first take place?

D1
1.

D1
2.

Has a doctor or nurse told you
that you have had a transient
ischemic attack, TIA or ministroke?

a.

When did this first take
place?

b.

Did you see a doctor or go
to a hospital?

RECORD NAME AND
ADDRESS OF DOCTOR OR
HOSPITAL.

MM YY
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . 1 NO (GO TO D13) . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . 2 RF (GO TO
D13) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
.7
DK (GO TO D13) . . . . . . . . . . . . . . . . . . . .
...........8
MM YY
SAW DOCTOR (RECORD) . . . . . . . . . . . .
. . . . . . . . . . . 1 WENT TO HOSPITAL
(RECORD) . . . . . . . . . . . . . . . . . 2 NO
DOCTOR OR HOSPITAL . . . . . . . . . . . . . .
. . . . . . . 3 RF . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . 7 DK . . . . . . . . . . .
................................8

NAME:
ADDRESS:

D1
3.

Have you had a head injury
so severe that you lost
consciousness, lost your
memory for a period of time,
or had to see a doctor?

YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . 1 NO (GO TO D17) . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . 2 RF (GO TO
D17) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
.7

#1 INTERVIEWER CHECKPOINT: IF D8=1 STROKE, GO TO D11

D10.When was the stroke before the last one?
a.
Did one side of your body,
or one arm or leg, become weaker
than the other?

YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
...........1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
...........2

D14. How many times did this happen?
DK (GO TO D17) . . . . . . . . . . . . . . . . . . . .

D20. Now I’d like you to tell me
how well you’re doing with
several routine daily
activities. Do you need
assistance with bathing or
grooming (for example,
running bath water, getting
into or out of the tub, or
washing body and hair)?

YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . 1 NO . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . 2 RF . . . . .
..................................
.....7

D21. Can you walk long distance
(>1 BLOCK) without any
sort of assistance?

YES (GO TO D22) . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . 1 NO . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . 2 RF . . . . .
..................................
. . . . . 7 DK . . . . . . . . . . . . . . . . . . . . . . . . .
..................8

a.

Do you use a cane, a
walker, or some other
form of assistance?

D22. Do you need help traveling
beyond walking distance
(such as using the bus
system or driving yourself)?

YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
............1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
............2
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
............1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
............2

. . . . . . . . . . . . . . . . . . . . . . . . 2 RF (GO
TO D18) . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . 7 DK (GO TO D18) . . . . . . . . . . . . .
..................8

YES (SPECIFY) . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . 1 NO (GO TO D18) . . . . . . .
D23.Do you need help getting into or out of a bed or a chair?
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

D24. Do you need help using the restroom (including adjusting clothing or getting onto
or off of the toilet)?
D25.Do you need reminders to use the restroom?
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
D26 Do you need help preparing meals for yourself
.
(for example a hot meal, a sandwich, a TV dinner
or microwaving food)?

YES . . . . . .. . 1

D27 Do you need assistance with eating (for example,
.
serving your food, using utensils, or drinking from
a glass or cup)?

YES . . . .. . . . . 1

D28 Do you need assistance doing the laundry? This
.
includes putting clothes into the washer and dryer,
starting the machines, and unloading them when
they’re finished.

YES . . . .. . . . . . 1

D29 Do you need help doing light housework such as
.
dusting, washing dishes, or sweeping?

YES . . . . .. . . . . 1

D30 Do you need help doing heavier chores such as
.
vacuuming, yard work, moving furniture, or
scrubbing?

YES . . . . .. . . . 1

D31 Do you need any kind of assistance using the
.
telephone, either answering the phone or placing
calls? (This would include an amplifier, larger
push button numbers, or preprogrammed phone
numbers.)

YES . . . . .. . . . . 1 NO
(GO TO D32) . . . . . . . . . .
.....................

NO . . . . .. . . . . 2

NO . . . .. . . . . . 2

NO . . . . .. . . . . . 2

NO . . . . .. . . . . . 2
NO . . . . . .. . . . . 2

2 RF (GO TO D32) . . . . .
.....................
......
7 DK (GO TO D32)

a. What type of equipment?
RECORD:________________________________
______

EQUIP

D32 Do you need assistance with any kind of shopping
.
(not including help with transportation)?

YES . . . . .1
NO (GO TO D33) . . 2
RF (GO TO D33)
7 DK (GO TO D33) .
8

a.
b.

Do you need assistance with shopping for
groceries and prescriptions?

YES . . 1

Do you need assistance with shopping for
things other than groceries and
prescriptions?

YES . . . 1

NO .. . 2
NO . . . 2

D33 Do you need assistance or reminders to take your
.
medications?

YES . . . 1

D34 Do you need help managing your finances, such
.
as paying the bills or balancing your checkbook?

YES . . . .1

D35 Do you feel that you have enough contacts with
.
other people or do you wish that you had more?

ENOUGH . . . . 1

D36. This next group of questions is
about cardiovascular or heart
problems. Have you had a severe
pain across the front of your chest
lasting for a half an hour or more?
RF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . 7 DK . . . . . . . . . . . . . . . .
...........................8

NO . . . 2
NO . . . .2
WANTS MORE
CONTACTS . . . 2

YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . 1 NO . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . 2 RF . . . . . . . .
....................................
7 DK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
............8

D37.Have you been told you had angina?

D38. Have you been troubled by shortness of breath
when walking up a slight hill or when hurrying
on level ground?

YES . . . . .
1 NO . . . .

2 RF . . . .
7 DK . . .
8
D39. Have you ever had high blood pressure or
been told that you had hypertension?

YES . . . .
1 NO(GO TO D40) . . .
2 RF (GO TO D40) . . . .
7 DK (GO TO D40) . . .
8

a.

How old were you when you first learned
you had high blood pressure?

AGE . . . . . . . . . . . . . . . . .
.................

b.

Did a doctor evaluate your high blood
pressure or prescribe treatment?

YES, EVALUATED . . . .
1 YES, EVALUATED
AND TREATED . . . . . . . .
. . . . . . . 2 NO (GO TO
D40) . . . .
3 RF (GO TO D40) . . .
7 DK (GO TO D40) . . .
8

c. Who was the doctor who evaluated your
high blood pressure?
NAME:

d.

Do you have high blood pressure now or
are you under current treatment for high
blood pressure?

YES . . . 1
NO . . . 2
RF . . . 7
DK . . . 8

D40. Have you been told you had high blood
cholesterol triglycerides (lipids)?

YES . . . 1
NO . . .. 2
RF . . . . 7
DK . . . .8

e.

How old were you when you first learned
you had high cholesterol or blood lipids?

AGE . . . . . . . . . . . . . . . . .
.................

f.

Did a doctor evaluate your high cholesterol
or blood lipids, or prescribe treatment?

YES, EVALUATED . . .
1
YES, EVALUATED
AND TREATED . . . . .. 2
NO (GO TO D41) . . . 3
RF (GO TO D41) . . . 7
DK (GO TO D41) . .. . 8

ADDRESS:
g.

Who was the doctor who
evaluated
your
high
cholesterol
or
blood
lipids?

NAME:
ADDRESS:
h.

Do you have high
cholesterol or blood lipids
now or are you currently
under treatment for this
condition?

RF . . . . . . . . . . . . . . . . . . . . . .
......................7
DK . . . . . . . . . . . . . . . . . . . . .
......................8

D41. Have you had coronary bypass surgery)?

YES . . . . . 1
NO (GO TO D42) . . . 2
RF (GO TO D42) . . 7
DK (GO TO D42) . . . 8

a.
b.

How old were you when you first had a coronary
.....................
Who performed the (last) bypass surgery?

AGE . . . . . . . . . . . . .

D42. Have you ever had a heart attack, a myocardial infarction, YES . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 or a coronary thrombosis?
NO (GO TO
D43) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
RF (GO TO D43) . . . . . . . . . .
......................7
DK (GO TO D43) . . . . . . . . .
......................8
a.

How old were you when you first had a heart attack
. . . . . . . . . . . . . . . . . . . . . . . . (coronary)?

b.

How many heart attacks have you had? # HEART ATTACKS . . . . . . . . .
. . . . . . . . . . . . . . c.

AGE . . . . . . . . . .

Who was the (last) doctor who treated you for a

heart attack?
NAME:
ADDRESS:

D43

Have you ever had diabetes, high blood
sugar or sugar in your urine?

YES . . . . . 1

a. Did a doctor diagnose this condition?

YES . . .. 1

NO (GO INT.
CHECKPOINT) . . 2
NO . . 2

D44. What sort of treatment was prescribed for
your diabetes?

DIET ONLY . . . 1
ORAL TREATMENT
(PILLS) .. 2 INSULIN . . . 3
NONE . . . . 4
RF . . . 7
DK . . . . . 8

YES (CONTINUE) . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . 1 INTERVIEWER CHECKPOINT: IS R. FEMALE?

D45. Have you ever taken calcium
supplements?

YES . . . . 1
NO . . . . 2
RF . . . . 7
DK . . . . 8

a. For how many years?

YEARS (ROUND TO
NEAREST INTEGER) . . . .
RF . . . 97

D46. Have you ever taken estrogen
supplements?

YES . . . 1
NO (GO TO E1) . . . 2
RF (GO TO E1) . . . . 7
DK (GO TO E1) . . . . 8

a. For how many years?

YEARS (ROUND TO
NEAREST INTEGER) . . . .
RF . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . 97

Appendix B. Depression History Questionnaire

SECTION F: DEPRESSION
Now I am going to ask you a few more questions about your mood.
F1. In your lifetime, have you ever had a period
of two weeks or more when, nearly every
day, you felt sad, blue or depressed?

YES . . . . . . . . . . . . . . . . . . . . .
. . . 1 NO . . . . . . . . . 2
RF . . . . . . . . . . 7
DK . . . . . . . . . 8

F2. In your lifetime, have you ever had a period
of two weeks or more when, nearly every
day, you lost all interest and pleasure in
things that you usually cared about or
enjoyed?

YES . . . . . . . . 1

F3.

YES . . . . . . 1
In your lifetime, have you ever had a period
of two weeks or more when, nearly every
day, you felt unusually cross or irritable?

NO . . . . . . . . 2
RF . . . . . . . .. 7
DK . . . . . . . . 8
NO . . . . . . 2
RF . . . . . . 7
DK . . . . . . 8

INTERVIEWER CHECKPOINT: DOES F1, F2 OR F3=YES?
NO (GO TO SECTION G) . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
F4.

How many episodes of two weeks or more of
this sort of
sadness, loss of interest, or irritability have
you had in your life?

EPISODES . . . . . . . . . . . . . .
..........
..........

COMMENT:

(RECORD
ANSWER
HERE AND
IN F30)

(last) episode

How old were you when this
AGE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . began?
a.

b.

How long did this episode last? WEEKS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
.....
IF ONLY 1 EPISODE, GO TO F7.

F5.

When was the first time that, nearly every day
for two weeks or more, you felt sad, blue, or
depressed, lost all interest and pleasure in
things, or felt irritable?

AGE . . . . . . . . . . . . . . . . . . .
...........

a.
How long did this episode last?
WEEKS . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . F6.
When was your most severe spell when, nearly every
AGE .
....................................
day for two weeks or more, you felt
sad, lue, or depressed, lost all
interest and pleasure in things, or
felt irritable? (IF MORE THAN 1
YEAR AGO) How old were you
then?
a. How long did this episode last?

F7.

At present, are you still
experiencing this sort of
sadness, loss of interest,
or irritability?

YES . . . . . . . . . . . . . . . . . . . . . .
.......................1
NO (GO TO F19) . . . . . . . . . . .
........................2
RF (GO TO F19) . . . . . . . . . . . .
.......................7
DK (GO TO F19) . . . . . . . . . . .
........................8
F8.
Have people told you
recently that you look sad or
down?

WEEKS . . . . . . . . . . . . . . . . . . . . . . . .
..........
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
...........1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
...........2

F18. Have you told a doctor about your current depression, loss of interest and pleasure,
or irritability?
RF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 DK . . . . . . . . . . . . . . . . .
.............................8
YES (GO TO F30) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 NO (GO TO F30) . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 RF (GO TO F30) . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 7 DK (GO TO F30) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 F19. During
your (most recent) episode when you felt sad, lost interest and pleasure, or felt irritable,
did people tell you that you looked sad or “down?”

F20 During your (most recent) episode, was your
.
appetite recently decreased or increased?

YES . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 1 NO . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . 2 RF . . .
..........................
..........................

F21 During your (most recent) episode, did you
.
lose or gain weight?

YES . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 1 NO (GO TOF22) . .
. . . . . . . . . . . . . . . . . . 2 RF (GO
..........................
F22) . . . . . . . . . . . . . . . . . . . . . .

a.

How much?

F22 During your (most recent) episode, did you
.
have difficulty sleeping, or did you sleep too
much?

LBS. . . . . . . . . . . . . . . . . . . . . .
YES . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 1 NO . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . 2 RF . . .
..........................
..........................

F23 During your (most recent) episode, did you feel YES . . . . . . . . . . . . . . . . . . . . . .
.
either slowed down, or restless and fidgety?
. . . . . . . . 1 NO . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . 2 RF . . .
..........................
..........................
F24 During your (most recent) episode, did you
.
have low energy, feel tired out, or fatigued?

YES . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 1 NO . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . 2 RF . . .
..........................
..........................

F25 During your (most recent) episode, did you
.
feel worthless or guilty?

YES . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 1 NO . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . 2 RF . . .
..........................
..........................

F26 During your (most recent) episode, did you
YES . . . . . . . . . . . . . . . . . . . . . .
.
have trouble concentrating, thinking, or making . . . . . . . . 1 NO . . . . . . . . . . . . .
decisions?
. . . . . . . . . . . . . . . . . . 2 RF . . .
..........................
..........................

F27 During your (most recent) episode, did you
.
have thoughts about death or suicide?

YES . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 1 NO . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . 2 RF . . .
..........................
..........................

DK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

Appendix C. Curriculum Vitae

Jordan Kugler, M.S.
1596 1300 East
Salt Lake City, Utah
JKugler05@aggiemail.usu.edu
402-578-7426
Education
August 2021
(anticipated)

July 2021

July 2018

May 2015

Ph.D., Combined Clinical/Counseling Psychology
Utah State University, American Psychological Association Accredited
Program
Dissertation Title: Risk Factors for Early and Late Onset Depression and
Subsequent Risk for Alzheimer’s Disease and Related Dementias in an Older
Adult Population
Dissertation Chair: JoAnn Tschanz, Ph.D.
Doctoral Internship in Psychology
VA Salt Lake City Health Care System, American Psychological Association
Accredited Program
M.S., Combined Clinical/Counseling Psychology
Utah State University, American Psychological Association Accredited
Program
Thesis Title: Posttraumatic Stress Disorder and Positive and Negative Social
Support as Components of the Interpersonal Psychological Theory of Suicide
in United States Military Veterans
Thesis Chair: Rebecca Blais, Ph.D.
B.A., Psychology, Minor: Religious Studies
University of Nebraska-Lincoln

Elected Positions, Scholarships and Awards
2020
CEHS Graduate Student Research Award, Utah State University
2020
Chief Intern, Salt Lake City VA Doctoral Internship
2017
CEHS Graduate Student Research Award, Utah State University
2017
Psychology Department Student Research Funding, Utah State University
2015
Harry K. Wolfe Undergraduate Research Award Honorable Mention,
University of Nebraska-Lincoln
2012-2015
University of Nebraska Dean’s List
2014
Award for Outstanding Service to the College of Arts and Sciences, University
of Nebraska-Lincoln
2014
Undergraduate Creative Activities and Research Experiences Funding Award,
University of Nebraska-Lincoln UNL

2013
2013
2013

Undergraduate Creative Activities and Research Experiences Funding Award,
University of Nebraska-Lincoln
Psi Chi Outstanding Member Award, University of Nebraska-Lincoln
Dr. Lillian G. Portenier Scholarship, University of Nebraska-Lincoln

Clinical Experience
August 2020-July Psychology Intern
2021
Salt Lake City VA Healthcare System
The Salt Lake City VA is a large VA medical hospital which employs more than
60 psychologists to service Veterans in Utah and its surrounding states. The
mental health team works with more than 7,000 unique patients in an
outpatient context annually and was designated as a Level III Polytrauma
Center to respond to the needs of Veterans of the Afghanistan and Iraq
conflicts who have suffered multiple traumatic injuries, including TBI and
PTSD.
Supervisors: Ben Swanson, Ph.D., Jason Goodson, Ph.D., Caitlin Mackay,
PsyD., Lisa Rambaldo, PsyD., Aaron Ahern Ph.D.
Clinical Training Rotations:
PTSD Team-Prolonged Exposure Emphasis (August 2020-February 2021):
Member of a large, interdisciplinary consultation team focused on providing
evidence-based treatment for PTSD. Conducted comprehensive diagnostic
PTSD assessments. Completed VA trainings for Prolonged Exposure (PE),
Cognitive Processing Therapy (CPT; standard and intensive) and Safety
Behaviors for PTSD (SBP). Maintained a caseload of 4-6 weekly individual
patients via telehealth. Interventions utilized included PE, CPT, and SBP.
Presenting Problems: Posttraumatic Stress Disorder, Acute Stress Disorder,
Other Specified Trauma-and Stressor-Related Disorder, Insomnia and
Adjustment Disorder.
Leadership and Telehealth (August 2020-November 2020):
4-month outpatient psychotherapy rotation that focused on developing
leadership skills for consultation teams in psychology and general outpatient
treatment via telehealth. Developed a training presentation to increase
inclusivity and awareness of diversity for consultation teams in VA and
community mental health settings. Maintained a caseload of 4-7 individual
clients via telehealth. Interventions utilized: Acceptance and Commitment
Therapy, Cognitive Behavioral Therapy for Insomnia, Motivational
Interviewing, Prolonged Exposure
Presenting Problems: Major depressive disorder, generalized anxiety
disorder, insomnia, adjustment disorder and alcohol dependence.
Outpatient Trauma and Addiction (November 2020-March 2021):

4-month outpatient psychotherapy rotation focusing on the unique
challenges of treating Veterans with PTSD and co-occurring addictive
behaviors. Emphasis on learning how to integrate Evidence-Based
Treatments for PTSD and addiction. Co-facilitated two groups, Relapse
prevention skills and Relapse prevention Processing. Received training on
integrating evidence based approaches with substance use as a presenting
problem.
Whole Health Mindfulness Center (March 2021-July 2021)
The Center aims to provide and to support front-line staff who are providing
mindfulness-based interventions (MBIs) throughout the facility, to expand
the availability of MBIs for Veterans and staff, to conduct research regarding
the effectiveness of new and existing MBIs, and to train staff to provide
mindfulness interventions. The majority of the caseload is group-based, with
possible groups including Mindfulness-Based Stress Reduction, MindfulnessBased Cognitive Therapy, Mindful Self-Compassion, and Foundations of
Mindfulness.
VITAL Program (February 2021-July 2021)
The VITAL program is focused on outreach to student Veterans and is
designed to connect them to campus resources, assist with the transition to
higher education and provide mental health service. VITAL is a collaborative
effort between Veterans Health Administration (VHA), Veterans Benefits
Administration (VBA), state and local governments, and the schools to get
student Veterans the tools they need to succeed.
Anticipated Direct Hours (July 2021): 500-700
Anticipated Supervision Hours (July 2021): 120-170
Anticipated Assessment Hours (July 2021): 70-100
Anticipated Support Hours (July 2021): 900-1200

May 2018-June Student Therapist
2020
Utah Center for Evidence Based Treatment (UCEBT):
UCEBT is a private practice that employs 10 licensed psychologists. UCEBT
serves adults, adolescents and children in Salt Lake City, UT and surrounding
communities and specializes in the treatment of complex psychiatric
conditions and behaviors.
Supervisors: Sheila Crowell, Ph.D., Robin Lange Ph.D., Karli Merideth, Ph.D.
Clinical Training Rotations:
Dialectical Behavior Therapy Consultation Team (May 2018-June 2020):
Participated in a comprehensive DBT team: active participation in weekly
DBT-consultation team, co-led two weekly adult DBT skills groups, developed

a DBT skills for addictive behaviors group, provided individual therapy and
phone coaching for a caseload of 2-5 DBT clients (Stage 1 and 2).
Presenting problems: Borderline Personality Disorder, Posttraumatic Stress
Disorder (PTSD), Avoidant Personality Disorder, Major Depressive Disorder,
recurrent, severe without psychotic features.
Assessment and Testing Team (January 2019-June 2020):
Participated in a bi-weekly assessment-focused consultation team: wrote
integrative psychodiagnostic reports, conducted personality and cognitive
assessments. Typical assessment batteries included: an objective measure of
personality (PAI or MMPI), a standardized measure of cognitive ability (e.g.,
WAIS IV), a structured clinical interview (e.g., SCID-5 and/or DIB-R), records
review and self-report measures based upon the referral question (e.g., PCL5, PHQ-9, Mood DQ, ASRS etc.).
Presenting problems: Major Neurocognitive Disorder, Attention Deficit and
Hyperactivity Disorder, Major Depressive Disorder, Borderline Personality
Disorder and Posttraumatic Stress Disorder.
Trauma Stress and Resilience Consultation Team (August 2018-June 2020):
Participated in a weekly trauma treatment-focused consultation team:
Conducted individual therapy for a caseload of 1-3 individuals with PTSD and
stress-related disorders. Interventions utilized: Cognitive Processing Therapy,
Trauma-Focused Cognitive Behavior Therapy and Acceptance and
Commitment Therapy. Developed and led a Cognitive Behavior Therapy for
Insomnia group (August 2019) for individuals with history of trauma.
Presenting Problems: Posttraumatic Stress Disorder, Acute Stress Disorder,
Other Specified Trauma-and Stressor-Related Disorder, Insomnia and
Adjustment Disorder.
Intake and Professional Development Team (May 2018-June 2020):
Participated in a weekly consultation team focused on development of case
conceptualization skills, report writing, diagnostic knowledge and evaluation.
Conducted brief diagnostic assessments with treatment recommendations
for new clients at UCEBT.
Presenting Problems: Generalized Anxiety Disorder, Major Depressive
Disorder, Acute Stress Disorder, PTSD, Borderline Personality Disorder,
Persistent Depressive Disorder, Social Anxiety Disorder and Complex
Bereavement.
Direct Hours: 582
Assessment Hours: 105
Supervision Hours: 378.5
Support Hours: 540

August 2017May 2018

Student Therapist
Utah State University Counseling and Psychological Services (CAPS):
CAPS is a university counseling center that employs 9 licensed psychologists
and serves students attending Utah State University (mostly young adults).
Supervisors: Mark Nafziger, Ph.D., Alberto Varela M.S. (psychology intern),
Charley Bentley Ph.D.
Clinical Training Rotations
Student Therapy Clinic (September 2017-May 2018): Conducted brief intake
assessments and individual therapy for students attending Utah State
University. Interventions utilized: Acceptance and Commitment Therapy,
Dialectical Behavior Therapy (skills only) Motivational Interviewing and
Cognitive Behavioral Therapy. Co-led an emotion regulation skills group
(January 2018-May 2018). Developed and led psychoeducational workshops
for test anxiety and interpersonal communication.
Presenting problems: Major Depressive Disorder, Generalized Anxiety
Disorder, Anxiety Disorder (NOS) and Adjustment disorder.
Direct Hours: 98
Assessment Hours: 0
Supervision Hours: 46
Support Hours: 126

August 2016May 2017

Student Therapist
Utah State Community Psychology Clinic (CPC):
The CPC is a training clinic for graduate students in the clinical/counseling
doctoral program at Utah State University that serves children, adolescents
and adults in Cache County, UT and surrounding communities.
Supervisors: Susan Crowley Ph.D. and Sara Boghosian Ph.D.
Clinical Training Rotations
Student Therapy Clinic (September 2016-June 2017):
Conducted brief intakes and individual therapy for children, adolescents and
adults. Interventions utilized: Acceptance and Commitment Therapy,
Cognitive Behavioral Therapy, Motivational Interviewing, Dialectical Behavior
Therapy (skills only). Conducted comprehensive cognitive and personality
assessments for adults and children. Assessment batteries included an
objective measure of cognitive ability (e.g., WAIS-IV or WISC V), an objective
measure of achievement (e.g., Woodcock Johnson) a review of records and
self-report measures based upon the referral question (e.g., PHQ-9,
Childhood Behaviors Scale etc.).
Presenting problems: Adjustment Disorder, Major Depressive Disorder,
Generalized Anxiety Disorder, Unspecified Personality Disorder, Childhood
trauma and child behavior problems.
Direct Hours: 113

Assessment Hours: 11
Supervision Hours: 72
Support Hours: 235

Peer Reviewed Publications
Kugler J., Andresen F. J., Bean R.C., & Blais R.K. (2019). Couple-based
interventions for PTSD among military veterans: an empirical review. Journal of
Clinical Psychology, 75, 1737-1755. https://doi.org/10.1002/jclp.22822
Andresen, F.J., Monteith, L. L., Kugler, J., Cruz R. A., & Blais, R. K., (2018).
Institutional betrayal following military sexual trauma is associated with more severe
depression and specific PTSD symptom clusters. Journal of Clinical Psychology, 75,
1305-1319. DOI:10.1002/jclp.22773
Blais R. K., Monteith L. L., & Kugler J. (2018). Sexual dysfunction is associated
with suicidal ideation in female service members and veterans. Journal of Affective
Disorders, 226, 52-67
Manuscripts in Progress
Sanders C. L., Wengreen H., Rattinger G. B., Kugler J., DeBerard S.M., Kauwe J. S.,
Buhusi M., & Tschanz J. T., (2019). Interaction of brain derived neurotrophic factor
(BDNF) and lifestyle factors in late life depression: The Cache County Study.
Manuscript accepted pending revision (resubmitted January 2021).
Vernon E. K., Kugler J., Rattinger G.B., DeBerard S.M., & Tschanz J.T., (2020). Sex
Differences in the Association between Pharmacological Agents to Treat Insomnia
and Risk of Alzheimer’s Disease: The Cache County Study (USA). Manuscript in
progress (to be submitted June 2021).

Professional Presentations
Oral Presentations
June 2021

Building a Life Worth Living: Components of Dialectical Behavior Therapy
Oral presentation to clinicians and community members at the Utah
Addictions Conference (upcoming). Developed and Conducted by Jordan
Kugler and the Utah Center for Evidence Based Treatment.

November 2020 Increasing Inclusivity in Consultation Teams
Oral presentation to Interdisciplinary team leaders at the Salt Lake City VA.
Developed and conducted by Jordan Kugler and Ben Swanson, Ph.D.
September 2019 Obtaining Commitment in DBT: A Guide to Pre-treatment
Oral presentation to clinicians at the Utah Center for Evidence Based
Treatment.

Developed and conducted by Jordan Kugler and Robin Lange, Ph.D.
May 2019

Working with Personality Disorders
Oral Presentation to Salt Lake City Police Department Crisis Intervention
Trainees.
Developed and conducted by Jordan Kugler and Sheila Crowell Ph.D.

April 2019

Acceptance and Commitment Therapy for Recurrent Major Depression: A
Comprehensive Case Presentation.
Oral presentation and written manuscript presented by Jordan Kugler to
Utah State faculty.

March 2019

Introduction to Dialectical Behavior Therapy: Distress Tolerance and Emotion
Regulation Skills
Seminar for University of Utah Psychiatry Medical Residents
Conducted by Jordan Kugler and Karli Merideth, Ph.D.

January 2019

Working with Personality Disorders
Oral Presentation to Salt Lake City Police Department Crisis Intervention
Trainees.
Developed and conducted by Jordan Kugler and Sheila Crowell Ph.D.

April 2018

Test Anxiety Workshop
Psychoeducation workshop conducted at Utah State Counseling and
Psychological Services.
Developed and Conducted by Jordan Kugler

Poster Presentations
Kugler J., (2019, May) Posttraumatic Stress Disorder from Institutional Betrayal: Treatment
Response to Cognitive Processing Therapy. Poster presented at the Utah Center for Evidence
Based Treatment Clinical Psychology Ph.D. Programs Open House, Salt Lake City, UT.
Kugler J., Andresen F. J., Bean R.C., & Blais R.K. (2018, November) Couples-Based Interventions
for PTSD and Relationship Satisfaction Among Military Veterans and Their Romantic Partners:
An Empirical Review. Poster presented at the Association for Behavioral and Cognitive
Therapies, Washington, D.C.
Kugler J., & Blais R.K. (2018, November) Frequency and Perception of Positive and Negative
Social Exchanges are Related to Heightened Suicide Risk in Male Service Members/Veterans.
Poster presented at the Association for Behavioral and Cognitive Therapies. Washington, D.C.
Kugler J., Livingston W. S., Andresen F. J., & Blais R. K. (2017, August) MST-Based PTSD Is
Related to Higher Disordered Eating Behavior in Female Veterans. Poster presented at the
American Psychological Association, Washington, D.C.
Kugler J. & Blais R. K. (2016, November) Perceived combat threat relates to higher PTSD stigma
from family in OEF/OIF military Veterans. Poster presented at the International Society for
Traumatic Stress Studies, Dallas, Texas.

Morton, A., Kugler, J., Brungardt, K. L., West, T., & Hansen, D. J. (2014,
November). Internalizing symptom presentation of sexually abused youth: Examination of
interpersonal predictors. Poster presented at the Association for Behavioral and Cognitive
Therapies Convention, Philadelphia, PA.
Huit T., Grandgenett H., Kugler J., Vanderheiden S., B.A., Morton A., B.A., Pittenger S., M.A.,
Hansen D., (2014 November) The ole of peer and parental Support in Presentation of
Internalizing Symptoms Following Child Sexual Abuse. Poster presented at the Association for
Behavioral and Cognitive Therapies Convention, Philadelphia, PA.
Kugler, J., Grandgenett, H., Morton, A., Brungardt, K. Predictors of residential treatment
outcomes (2014, April) Poster presented at the University of Nebraska-Lincoln Undergraduate
Research Fair.
Kugler, J., Grandgenett, H., Brungardt, K. L., & Morton, A. (2013, November). Loneliness,
gender, marital status and their interaction with depression and stress. Oral Presentation
presented at Nebraska Psychological Society Conference, Wayne, NE.
Morton, A., Kugler, J., Brungardt, K. L., West, T., & Hansen, D.J. (2014, April). Interpersonal
predictors of internalizing symptoms of sexually abused youth. Poster presented at the
Undergraduate Research Fair at the University of Nebraska-Lincoln.
Grandgenett, H., Kugler, J., Morton, A., & Brungardt, K. L. (2013, November). Social anxiety
levels and negative thoughts during a positive or negative conversation interact with selffocused attention and general anxiety among college students. Oral Presentation presented at
Nebraska Psychological Society Conference, Wayne, NE.
Clinical Trainings Completed
November 2020 Cognitive Processing Therapy for PTSD
2-day comprehensive VA training covering standard and intensive CPT with
supervision provided through core rotations. Ongoing CPT consultation
provided with 3 completed cases.
October 2020

Safety Behaviors for PTSD
1-day comprehensive VA training with supervision provided through core
rotation

September 2020 Prolonged Exposure for PTSD
2-day comprehensive VA training with supervision provided through core
rotation.
August 2020

Cognitive Behavior Therapy for Insomnia
Self-paced online VA training. Supervision in CBT-I cases completed through
rotations.

May 2019

Dialectical Behavioral Therapy Foundational Training
16 week intensive online foundational training course via Behavioral Tech;
see https://app.psychwire.com/courses/3vnl9i/about

April 2019

Diagnosis and Treatment of Dissociative Identity Disorder

Didactic training at Utah Center for Evidence Based Treatment conducted by
Donna Hunter, MA, CMHC
January 2019

Using Crisis Response Plans and Reducing Access to Means of Suicide
Attempts
Didactic training at Utah Center for Evidence Based Treatment conducted by
Craig Bryan, Ph.D.

October 2018

Introduction to Prolonged Exposure Protocols
Didactic training at Utah Center for Evidence Based Treatment conducted by
Michelle Ertl, Ph.D.

September 2017 Acceptance & Commitment Therapy-Intermediate/Advanced 2-day
Workshop
Two-day workshop at Utah State University conducted by Mike Twohig,
Ph.D.
April 2017

Implementing LGBT-Affirmative CBT: A Transdiagnostic Minority Stress
Treatment Approach
Webinar conducted by John Pachankis, Ph.D.

March 2017

Conducting Asylum Evaluations
Webinar conducted by the APA Refugee Mental Health Resource Network

August 2016

Introduction to Acceptance & Commitment Therapy 2-day Workshop
Two-day workshop at Utah State University conducted by Mike Twohig,
Ph.D.

Teaching Experience
Summer 2017 Instructor
Abnormal Psychology (Psych 3210)
Class Size: 17
Responsibilities: Designed a curriculum, led weekly lectures, developed
exams and assignments, held weekly office hours.
Spring 2017

Teaching Assistant
General Psychology (Psych 1010)
Instructor: Rebecca Blais Ph.D.
Class Size: 212
Responsibilities: Held office hours, graded weekly assignments and
conducted pre-exam review sessions for students. Delivered two guest
lectures on PTSD and Childhood Behavior Disorders

Fall 2016

Teaching Assistant
General Psychology (Psych 1010)
Instructor: Kathryn Sperry, Ph.D.
Class Size: 280
Responsibilities: Held office hours and graded weekly class assignments.
Delivered two guest lectures on PTSD and Therapy Interventions.

Spring 2016

Teaching Assistant
General Psychology (Psych 1010)
Instructor: Rebecca Blais, Ph.D.
Class Size: 204
Responsibilities: Held office hours, conducted pre-exam review sessions for
students and graded weekly class assignments.

Fall 2015

Teaching Assistant
Abnormal Psychology (Psych 3210)
Instructor: Rebecca Blais, Ph.D.
Class Size: 121
Responsibilities: Held office hours, conducted pre-exam review sessions for
students and managed student emails for the course. Delivered two guest
lectures with instructor feedback.

Research Experience
Summer 2017- Clinical/Counseling Psychology Doctoral Program Graduate Assistant (20 hours
July 2020
weekly assistantship)
Supervisors: JoAnn Tschanz, Ph.D. and Michael Levin, Ph.D.
Responsibilities: Worked directly with the director and associate director of
clinical training (Dr. Tschanz and Dr. Levin) in collecting data for accreditation,
maintaining quality of clinical training and developing data collection
instruments for the Combined psychology PhD program.
Fall 2015Spring 2017

Research Assistantship (10 hours weekly)
Supervisor: Dr. Rebecca Blais
Responsibilities: Supervised data collection for a study on academic
functioning of Veterans in college. Collaborated on a study involving
institutional betrayal and PTSD symptom clusters. Collaborated on a study
involving suicidal ideation and sexual dysfunction. Collaborated on a study
involving military sexual trauma and eating disorders. Presented a poster for
the International Society for Traumatic Stress Studies.

May 2014May 2015

Undergraduate Research Coordinator
Study: Project S.A.F.E.
Lab: Child Maltreatment Lab, UNL
Supervisor: Dr. David J. Hansen, Director Clinical Training
Responsibilities: Project SAFE (Sexually Abused Family Education) is a 12week standardized group intervention program for sexually abused youth and
their non-offending caregivers. Tasks included: a) coding empirically
supported assessment measures (SCL 90, MASC, CDI, YSR, CBCL, CSBI), b)
entering pre-treatment, and post-treatment data into SPSS and c) data
cleaning and updating the database d) conducting statistical analyses e)
assisting with the management of the research team and the training and
supervising of new research assistants to code and review the various
measures associated with Project S.A.F.E.

January 2014May 2015

Research Assistant
Study: Sleep and Psychopathology in Youth Project

Lab: Pediatric Health Lab, UNL
Supervisor: Dr. Timothy Nelson
Responsibilities: The purpose of this study was to examine the daily
bidirectional relationship between sleep and psychopathology in youth. Tasks
included: a) participation in recruitment from a treatment seeking sample, b)
performing a formal literature review of current research in the field and c)
administering questionnaires and collecting actigraphy data from subjects
participating in the study.
August 2014May 2015

Research Assistant
Study: Stimulant and Sleep Behavior Meta-Analysis
Lab: Pediatric Health Lab, UNL
Supervisor: Dr. Timothy Nelson
Responsibilities: The purpose of this project was to examine past literature on
the effects of stimulant medication on the sleep patterns of children and
adolescents with ADHD. My responsibilities included: a) conducting a literature
review through specific search engines and b) analyzing the relevance of each
article to the project.

August 2014May 2015

Research Assistant
Study: Pediatric Dentistry and Obesity Project
Lab: Pediatric Health Lab, UNL
Supervisor: Dr. Timothy Nelson
Responsibilities: This project examined the correlates of oral health in relation
to physical health in children, ages 3-5 years. Primary responsibilities: a) subject
recruitment at local pediatric dentist offices and b) administering questionnaires
associated with the study.

October 2013- Research Assistant
May 2015
Study: Growing Great Beginnings Project
Lab: Pediatric Health Lab, UNL
Supervisor: Dr. Timothy Nelson
Responsibilities: This project involved collecting parent-report data on children
aged infancy through 3 years. Data were collected through home visits in
collaboration with a community outreach program. Primary responsibilities
included: a) administering questionnaires, answering questions that arose
during the home-visit session b) assembling questionnaire packets, c)
conducting literature reviews, and d) contacting eligible participants
September
2012August 2013

Research Assistant
Study: Acute Alcohol Intoxication and Neurocognitive Processing on Intimate
Partner Aggression during Anger Arousal
Lab: Trauma, Violence and Abuse Lab, UNL
Supervisor: Dr. David Dilillo
Responsibilities: This project involved data collection for a study investigating
the effects of alcohol intoxication on intimate partner violence and

neurocognitive processing. Primary responsibilities included: a) running
participants through an established experimental protocol approximately 8
hours per week b) transcribing participant responses c) coding participant
responses for qualitative themes.
Professional Development
November 2018 Association for Behavioral and Cognitive Therapies National Conference
National conference in Washington D.C.
August 2017

American Psychological Association National Conference
National conference in Washington, D.C.

November 2016 International Society for Traumatic Stress Studies National Conference
National conference in Dallas, TX
November 2015 Association for Behavioral and Cognitive Therapies National Conference
National conference in Philadelphia, PA

Membership in Professional Organizations

March 2018- Association of Behavioral and Cognitive Therapies
December 2019 Student member
June 2017American Psychological Association
December 2017 Student member
March 2016- International Society for Traumatic Stress Studies
December 2016 Student member
October 2014- Association for Behavioral and Cognitive Therapies
December 2015 Student member

October 2014- Association for Behavioral and Cognitive Therapies; Child Maltreatment and
December 2015 Interpersonal Violence Special Interest Group
Student member

References
Jason Goodson Ph.D.
Clinical Supervisor
Salt Lake City VA Healthcare System
Email: Jason.Goodson@va.gov

Harrison Weinstein Ph.D.
Assistant Clinical Training Director
Salt Lake City VA Healthcare System
Email: Harrison.Weinstein@va.gov

Ben Swanson Ph.D.
Clinical Supervisor
Salt Lake City VA Healthcare System
Email: Leland.swanson@va.gov

Sheila Crowell Ph.D.
Clinical Supervisor
Utah Center for Evidence Based Treatment
Email: Sheila.crowell@ucebt.com

